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ABSTRACT 
 
The research in this thesis is concerned with the effect of chronic stress, caregiving and 
bereavement, and ageing on immune and endocrine parameters.  First, there was no difference 
in serum anti-CMV antibody titre between younger caregivers and controls, but CMV 
seropositive caregivers with negative health behaviours had higher CMV antibody titre.  
Second, there was no difference in neutrophil function between the groups in both younger 
and older cohort, while only younger caregivers showed a higher serum cortisol:cortisone 
ratio than controls.  Further, those caregivers that reported higher anxiety and burden 
symptoms had lower neutrophil phagocytosis.  Third, caregivers had more T cells expressing 
KLRG1 marker of senescence than controls, but comparable number of those expressing PD-
1 marker of exhaustion and thymic output.  Finally, young bereaved showed similar 
neutrophil function and serum cortisol and DHEAS levels as non-bereaved controls, whereas 
older bereaved had impaired neutrophil function and a higher cortisol:DHEAS ratio.  These 
findings suggest that chronic stress can have differential effects on immune and endocrine 
parameters, but in some cases, presence of immunosenescence is required for immune 
decrements to be observed.  Further, they emphasise the importance of focusing on the 
individual's response to chronic stress rather than their chronic stress status, per se.  
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1.1. OVERVIEW 
Ageing is a physiological process that emerged as a side-product of normal development and 
the metabolic processes involved in the reproductive potential of the species (Cutler 1982).  It 
has been developed most likely as a non-adaptive phenomenon with no biological function 
(Partridge and Gems 2002) and allowed to evolve through a trade-off mechanism termed 
antagonistic pleiotropy (Williams 1957), reviewed in (Partridge and Barton 1993).  According 
to Thomas Kirkwood's modification of Orgel's (1963) theory, ageing can also be linked to the 
attempt of the body to protect germ line cells at the expense of somatic cells, the so-called 
“disposable soma theory” (Kirkwood 1977).  Therefore, ageing is a phenomenon that evolved 
as a negative by-product of positive traits that were beneficial to organisms, such as fat 
deposition or sexual hormones, oxygen metabolism (generation of the reactive oxygen species 
(ROS)), but also stress and glucocorticoids (GC), as part of the fight or flight response.  
Among these, development and oxygen metabolism are constant and necessary involuntary 
forces, and hence unchangeable, but the stress response in humans and other primates has 
changed over time, gaining another characteristic; the capacity to be chronic and detrimental 
(Sapolsky 2007). 
In this chapter, the mechanisms by which stress can influence different aspects of immunity 
will be presented, as well as the interaction between ageing and stress and the consequences 
of this for immune health.  The content will first present stress as an adaptive phenomenon, 
and explain its relationship with the immune system generally.  Second, the focus will be on 
how psychological stress affects the immune system.  In the latter part of the introduction, the 
influence of ageing will be discussed, firstly describing the interplay between ageing and 
stress and then their additive effect on immunity.  Finally, the pathophysiological 
consequences of the interaction between stress, ageing, and immunity will be discussed.  
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Although the focus is mainly on humans, where applicable, studies using small animal models 
are included.      
 
1.2. STRESS  
A challenging life demands tough reactions and has led to the development of a number of 
physiological changes that constitute the stress response in animals and humans.  In a hostile 
environment, more complex organisms like vertebrates develop a response that Walter 
Cannon (1929) first introduced as 'fight or flight'.  The main function of this response is 
maintaining body homeostasis.  The key site involved in this process is the hypothalamus 
(Barrett 2005), a part of the brain that communicates by sending  nerve impulses to other parts 
of the body.  In this way, the hypothalamus acts within seconds and via sympathetic nervous 
system stimulates medulla of the adrenal gland to release catecholamines, CA (adrenalin and 
noradrenalin).  In addition, the hypothalamus also produces chemical messengers that act 
more slowly and in minutes travel through the hypothalamic-pituitary-adrenal (HPA) axis 
(Sapolsky et al. 2000).  Chemical messengers in this pathway include corticotrophin releasing 
hormone (CRH) which stimulates the anterior pituitary gland to release another hormone, 
adrenocorticotropic hormone or ACTH.  The target organ of ACTH is again the adrenal 
gland, but this time it is the cortical cells that synthesise and release species-specific GC into 
the blood. The tight control of these GC (mainly cortisol in humans) is sustained via negative 
feedback that controls and, in the end, terminates the release of CRH (Griffin and Ojeda 
2004).  
Clear distinction is made today between two types of stress, acute and chronic stress.  From 
an evolutionary point of view, the acute component is beneficial in that it provides organisms 
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with the mechanisms for protection from a changeable and threatening environment.  In that 
context, an interaction such as one between a lion and a zebra, even though there is no 
common interest for the outcome between these two animals, will trigger the same cascade of 
events in the body of both.  Adrenalin and noradrenalin mainly, but with GC potentiating the 
effects, will increase arousal, alertness and vigilance, focus attention and elevate core 
temperature.  In addition, they are responsible for the increase in the pain threshold (Kulkarni 
1980), cardiovascular output, respiratory rate (Coles et al. 1956), and blood flow to the brain 
and skeletal muscle (Brown et al. 1979, Charmandari et al. 2005, Coles et al. 1956, Dowd et 
al. 2009, Kulkarni 1980).  Skeletal muscle will gain the supply of the energy from the adipose 
and hepatic cells stores, whereas all other activities that are inessential in that moment, such 
as digestion, reproduction, feeding and growth, will be decreased through the action of GC 
(Cannon 1929, Selye 1956, Sorrells and Sapolsky 2007).  Although acute stress and the 
events that follow have evolved as an adaptation, and are therefore beneficial, too great or too 
long of a response can be detrimental to the body.  For example, synaptic plasticity in adult 
rats was negatively affected by prolonged stress exposure (Trentani et al. 2002).  In humans, 
continuous or repeated psychological stress is strongly associated with detrimental effects on 
the cardiovascular system, and through it, with obesity and hypertension (McEwen 1998, 
Phillips et al. 2012, Sedova et al. 2004).  However, despite the seemingly direct relationship 
between stress and different physiological functions, the general rule regarding the particular 
effects of GC alone on other organ systems is not sufficient to explain their action on the 
immune system, as described below.  In other words, the negative effect of stress on the 
immune system is actually a non-adaptive phenomenon,  as, using the analogy of Sapolsky, 
an injured animal would not survive and propagate the species if it escaped a predator only to 
then die of sepsis soon afterwards (Sorrells and Sapolsky 2007).   
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1.3. STRESS AND THE IMMUNE SYSTEM 
1.3.1. GC and CA effects of acute and chronic stress 
It was previously thought that the stress response, through the action of GC, strictly 
suppresses immunity.  There are several sources of evidence for this anti-inflammatory action 
of GC, such as: involution of the thymus explained by Selye in 1930s (Selye 1936, Viner 
1999); the shift from a cellular T helper cells (Th)1 to a humoral Th2 phenotype and inhibited 
production of the pro-inflammatory cytokines (interleukin (IL)-12, interferon gamma, IFN-γ, 
tumour necrosis factor alpha, TNF-α) (Franchimont et al. 2000, Hu et al. 2003, Steer et al. 
2000), accompanied by the increased secretion of anti-inflammatory cytokines (IL-4 and IL-
10) by Th2 cells (Elenkov and Chrousos 2002, Mozo et al. 2004, Wu et al. 1991); limitation 
of the capacity of dendritic cells (DC) to interact with immature T cells by preventing up-
regulation of major histocompatibility complex (MHC) class II and co-stimulatory molecules 
(Akdis et al. 1997, DeKruyff et al. 1998, Franchimont 2004, Ramirez et al. 1996).  It is now 
known, however, that the way stress impacts immunity is not always straightforward, and can 
be highly influenced by the duration of the stressor (Sorrells and Sapolsky 2007).   
Initially in the acute stress response, the immune system is activated rather than suppressed 
(Sorrells and Sapolsky 2007), and only after this first reaction, in the following stages of the 
stress response, when levels of GC further rise, their anti-inflammatory effects come on the 
scene (Munck et al. 1984).  Higher concentrations of GC will then help the organism to 
recover from the early phases of the stress response (Munck et al. 1984).  However, it is 
certain that upon repeated stimulation by stress, or through prolonged, chronic stress, the 
immune system is suppressed, and this is, at least in part, mediated by the action of GC 
(Sorrells and Sapolsky 2007).  The explanation for this dual behaviour of GC could be in the 
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way they transmit their effects through steroid hormone signalling (Sorrells and Sapolsky 
2007).  The actual mechanism by which GC exert these different effects is yet to be 
elucidated.  However, a potential explanation is that mineralocorticoid receptors, which 
paradoxically have much higher affinity for GC than GC receptors, are first to bind GC.  
Therefore, during the initial acute stress phase, when GC are present in lower levels, they will 
predominantly bind mineralocorticoid receptors, which are thus, together with CA release, 
responsible for the initial stress-induced increase in the immune function (Sorrells et al. 
2009).  In the following stages of the stress response, when mineralocorticoid receptors get 
saturated, GC receptors become increasingly occupied and can govern some of the anti-
inflammatory action.  On the other hand, it is uncertain if the same explanation could apply to 
the immune system in the periphery.  For example, even though expressed in macrophages, 
mineralocorticoid receptors do not seem to be involved in modulating immune cells function 
by GC.  Instead, that action is strictly confined to the concentration-dependent binding of the 
GC to the GC receptors (Lim et al. 2007).  Nevertheless, it seems likely that a similar type of 
concentration-dependent effect of GC could be responsible for the difference in the effect of 
acute and chronic stress on the peripheral immune system, too (Sorrells and Sapolsky 2007).  
It is important to reiterate here that GC are neither the only, nor the primary inducers of 
immune alterations during the chronic stress response (Moynihan 2003).  For example, the 
suppression of mitogen responses by rat lymphocytes was dependent only upon the 
production of β-endorphin and without any influence by corticosterone levels (Panerai 1997).  
Similarly, Shi et al. (Shi et al. 2003), showed that the apoptosis of lymphocytes during 
restraint stress was dependent on the state of opioid receptors only.  The adrenergic receptor 
(β2-AR) after binding CA through two different signalling pathways triggers DNA 
(deoxyribonucleic acid) damage as well as degradation of an important tumour suppressor in 
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the brain of rats (Hara et al. 2011).  Similar results were obtained after exposing rats to 
chronic restraint stress, whereas, the administration of propanolol, a β-blocker, diminished 
this effect.  Finally, the mutual action of GC and CA during chronic restraint stress will 
simultaneously affect migration of mononuclear cells in the peripheral blood of a specific 
mouse strain (Hermann et al. 1995), largely reduce cytokine expression from the lymph nodes 
and spleen (Dobbs et al. 1996), delay cytokine gene transcription in the lungs and lymph 
nodes (Sheridan et al. 1998), as well as diminish activation of cytotoxic T lymphocytes in the 
lymph nodes (Dobbs et al. 1993, Sheridan et al. 1998).  However, it was also shown that 
chronic stress-induced changes in the concentrations of GC alone can have different effects on 
different pro-inflammatory cytokines, TNF-α, IL-1β and IL-6 (DeRijk et al. 1997).  For 
example, daily fluctuations of these hormones were able to strongly affect TNF-α 
concentrations, whereas IL-1β responded only after exercise-induced increases in the levels of 
cortisol, and lowering IL-6 demanded pharmacological concentrations of GC (DeRijk et al. 
1997).  All three of these cytokines are predominantly produced by monocytes, but IL-6 can 
be produced by endothelial cells, fibroblasts and keratinocytes (Heinrich et al. 1990).  Finally, 
while TNF-α, IL-1β are strictly pro-inflammatory, IL-6 can have both pro-inflammatory and 
anti-inflammatory effects (Scheller et al. 2011).  Therefore, perhaps, the differential effects of 
stress hormones on TNF-α, IL-1β, and IL-6 are largely caused by the different roles of these 
cytokines.   
1.3.2. Immuno-enhancing and immunosuppressive effects of acute and chronic stress  
There is a well established difference in the effects that acute and chronic stress exert on the 
immune response, being immuno-enhancing and immunosuppressive, respectively.  The acute 
stress response and its associated immunological changes closely resemble those related to 
infection, and involve both energy mobilisation, and activities of cytokines and 
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neurotransmitters (Maier and Watkins 1998).  Acute brief restraint stress, applied before 
surgical sponge implementation into the rats has lead to more prominent increase in all blood 
leukocyte count comparing to the non-stressed group (Viswanathan and Dhabhar 2005).  
Similarly, the same type of acute stress administered before the immunisation increased the 
number of memory and effector Th cells following immunisation (Dhabhar and Viswanathan 
2005).  This also seems to influence more robust immune response upon repeated stimulation 
with the same antigen months later (Dhabhar and Viswanathan 2005).  This can be beneficial 
in cases when increased immunoprotection is needed, but detrimental in the cases of 
immunopathology such as allergic conditions and autoimmune disease (Atanackovic et al. 
2013, Dhabhar 2009, Dhabhar and Viswanathan 2005). 
Chronic stress is generally accepted as being immunosuppressive.  However, if it was strictly 
immunosuppressive, it would not be able to negatively influence disease outcomes in 
infectious and neoplastic disease (associated with inadequate immunity) on the one hand, and 
allergic and autoimmune disease (that emerge from an excessive immune response) on the 
other, as explained by Segerstrom and Miller (Segerstrom and Miller 2004).  One possible 
explanation for these seeming mutually exclusive consequences of chronic stress was given 
by Marshall et al.(Marshall et al. 1998), who suggested that chronic stress drives the Th1-to-
Th2 shift by altering patterns of cytokine expression.  In that way, stress-induced suppression 
of Th1 cytokines (such as IFN-γ) involved in the defence against many kinds of infection and 
some neoplastic diseases, would lead to activation of Th2 cytokine production, involved in 
allergies and different autoimmune diseases, such as IL-10 (Marshall et al. 1998).  In addition, 
it has been shown that chronic stress caused by immobilisation affects the number of 
lymphocytes in rats, but impacts on different subsets in different ways (Dominguez-Gerpe and 
Rey-Mendez 2001).  The overall decrease in the number of circulating lymphocytes was 
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accompanied by the increase in the number of mainly immature T lymphocytes, suggesting 
one of the potential mechanisms by which stress associated immunosuppression can affect 
and exacerbate autoimmune diseases (Moroda et al. 1997). 
In summary, acute stressors usually, with the exceptions of natural killer (NK) cell function 
(Cunnick 1988) and neutrophil superoxide production (Khanfer et al. 2010, Khanfer et al. 
2012) boost the immune system, particularly its innate component which is the one able to act 
quickly (Bosch et al. 2003, Dhabhar and McEwen 1997, Sapolsky 1998).  The majority of 
chronic stressors, on the other hand, are associated with global immunosuppression and have 
an impact on both innate and adaptive component of the immune system (Kiecolt-Glaser et al. 
1991a, Phillips et al. 2006a, Segerstrom and Miller 2004, Thaker et al. 2006) to mention a 
few.  
1.3.3. Beneficial and detrimental effects of acute and chronic stress  
Both the immune response and the fight-or-flight response provide an adequate defence for 
survival and further protection against infection after the injury occurs.  In that context, the 
relationship between acute stress and immune up-regulation can be viewed as an adaptive 
trait.  On the other hand, chronic exposure to stress appears to have detrimental effects on 
immunity through continual activation of the same mechanisms.  This overlap between the 
stress response and the immune response to infection could be the answer to some of the 
seemingly contradictory processes that arise as the consequence of different durations of the 
same stressor.  For example, in response to acute stressors, T cells in the rat react by 
redistributing into the skin, which is the organ that is the most likely to be affected in a life 
threatening situation when attacked by the predators.  On the other hand, prolonged action of 
the same type of stressor will lead to the progressive decrease in this stress-induced 
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redeployment of T cells, as well as to the suppression of delayed type hypersensitivity in the 
skin (Dhabhar and McEwen 1997).  Similarly, surgical operation in cancer patients after 
oesophagectomy has been associated with an increase in peripheral blood lymphocytes 
apoptosis (Kono et al. 2001).  The mechanism used to explain this rise was increased 
expression of Fas, a transmembrane protein that mediates apoptosis (Oka 1996), and changes 
in T lymphocyte signal transduction through down-regulation of T cell receptor ζ with a 
crucial influence of activated post-operative monocytes on the process overall (Kono et al. 
2001).  Negative effects on lymphocytes associated with surgical stress were also observed in 
combination with psychological (daily life hassles) and physiological (cold pressor) stress 
upon stimulation of lymphocytes with phytohemagglutinin (PHA) and pokeweed mitogen, 
respectively (Linn et al. 1988).  Through altering IFN-γ production and the ability to respond 
to both interferons and pro-inflammatory cytokines, e.g., IL-2, chronic restraint stress affects 
the activity of NK cells, components of the innate immunity important in resolving viral 
infections such as infection with herpes simplex virus (HSV) (Bonneau et al. 1991).   
 
1.4. PSYCHOLOGICAL STRESS AND IMMUNITY  
A relationship between the central nervous system (CNS) and immune system was first 
discovered in early animal experiments where it was revealed that immunosuppression could 
be induced through classical conditioning (Ader 2003, Ader and Cohen 1975, Garcia et al. 
1955).   A large number of studies have emphasised the behavioural changes that accompany 
chronic stress situations (such as alcohol consumption (Nguyen et al. 2012, Silva and Madeira 
2012), smoking (Lee et al. 2007), nutrition (Thompson et al. 2013), and sleep disturbances) 
that are already known to have direct and serious health consequences and could mediate the 
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negative effect of stress on health indirectly (Dallman et al. 2003, Hussain 2010).  Other 
indirect effects might be via changes in social roles and social support associated with stress 
at the same time affecting health and quality of life (Baron et al. 1990, Pressman et al. 2005, 
Rutledge et al. 2004, Segerstrom and Miller 2004).  However, many direct effects on 
immunity have also been demonstrated.  Several studies reported changes in cytokine profile 
in students during an academic examination period.  The general pattern seems to be the 
emphasis of Th2 response through the decrease in pro-inflammatory cytokines (TNF-α, IL-6, 
IL-1, INF-γ) and higher levels of anti-inflammatory cytokines (IL-10 and IL-4) (Kang and 
Fox 2001, Marshall et al. 1998).  Similar to these studies, delayed wound healing and a 
decrease in IL-1β, a key interleukin involved in this process, has been demonstrated in young 
healthy students during an examination period compared to a non-stressful holiday period 
(Marucha et al. 1998).  The opposite was the case in students with higher anxiety where levels 
of pro-inflammatory cytokines rose just before the important exam (Kamezaki et al. 2012, 
Maes et al. 1998).  The explanation for this seemingly contradictory effect of examination 
stress is seen in its duration, as it can be divided into acute examination stress (i.e. stress 
immediately before the exam, as in (Kamezaki et al. 2012, Maes et al. 1998)), and its 
prolonged, chronic component (i.e. during the examination period, as in (Kang and Fox 2001, 
Marshall et al. 1998)), for a review see (Bosch et al. 2002).   In one of the first studies that 
examined the relationship between psychological stress and the immune system in humans, 
the strong psychological stressor of bereavement was associated with the decreased function 
of T lymphocytes (Bartrop et al. 1977).  In a similar way, neutrophil killing ability was 
suppressed in the bereaved, the effect that was accompanied by the increase in 
cortisol:DHEAS (dehydroepiandrosterone sulphate) ratio (Khanfer et al. 2011).  This ratio has 
been previously used as a measure of the effect stress hormones have upon immune system 
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components (Butcher et al. 2005).  Further, homeless people who reported higher stress levels 
had lower density of lymphocyte β-AR (Dimsdale et al. 1994).  This could indicate either a 
down-regulation of receptors due to higher stress hormone levels (CA or GC) or simply a 
change in the lymphocyte subsets, both of which could be a consequence of prolonged 
exposure to a stressful lifestyle.  In addition, in children with a history of recurrent colds and 
flu who demonstrated higher levels of psychological stress, salivary immunoglobulin (Ig) 
A/albumin ratio was lower, indicating a potential link between stress and colds and flu 
(Drummond and HewsonBower 1997).   
Loneliness affects NK cell activity not only in psychiatric patients (Kiecolt-Glaser et al. 
1984b), but also in young and healthy medical students indicating general importance of 
social relationships for individuals’ wellbeing (Kang et al. 1998, Kiecolt-Glaser et al. 1984a).  
Marital quality and recent separation among young women were associated with depressive 
symptoms and poorer immune function, seen through poorer proliferation of lymphocytes 
after stimulation with different mitogens (concavalin A and PHA) (Kiecolt-Glaser et al. 
1987a).  More frequent marital concerns were associated with flatter cortisol profile (Barnett 
et al. 2005), an indicator of non-adaptive cortisol metabolism during chronic stress exposure.   
One commonly studied model of the impact of stress on immunity is role of caring for 
someone, be it a spouse or child with a physical or mental illness or disability.  Caregiving is 
now well established as having a serious effect on psychological well being, physical health 
and self-efficacy among caregivers when compared to matched non-caregiving individuals 
(Pinquart and Sorensen 2003).  For example, parents of cancer patients when compared to 
control parents had a decreased sensitivity to the anti-inflammatory effect of GC which could 
potentially contribute to the development of asthma, different cardiovascular and autoimmune 
diseases, as well as indicate dysregulation of the immune system that may become incapable 
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of resolving infections (Miller et al. 2002).  This is where we see the other side of stress 
effects on immune function where it exacerbates excessive immune response.  Another study 
of adaptive immunity in mothers of children with developmental disabilities showed a lower 
T helper: suppressor ratio, indicating again potentially less effective adaptive immunity for 
fighting the pathogens among the older age cohort of caregivers (Pariante et al. 1997).   
 One well researched indicator of immune challenge in the context of psychological stress is 
immunity to latent viruses, with reduced immunity indicated by raised antibody titres to latent 
viruses.  Generally, latency is the ability of a virus to lie dormant in the host cell after the 
initial infection, and emerge as an acute infection once the immune surveillance of the host 
weakens (Nowak 1991).  Therefore, even though asymptomatic in the immunocompetent 
hosts, these infections could cause serious harmful and even fatal effects in the 
immunocompromised (Pawelec et al. 2005, Rasmussen 1991).  In that context, separated 
women also had higher antibody titre against Epstein-Barr virus (EBV), indicating poorer 
control of the virus, as well as lower number of both NK cells and Th lymphocytes when 
compared to married women, with worse depression and immune outcomes seen in those with 
greater attachment to their ex-husbands (Kiecolt-Glaser et al. 1987a).  In the case of married 
and separated men, those who went through divorce were more depressed, lonelier, and had a 
higher antibody titre against both EBV and HSV (Kiecolt-Glaser et al. 1988).  Finally, more 
negative behaviour in marriage has been shown to adversely affect endocrine responses in 
women, and immunological activation, seen through antibody titres to EBV and the 
blastogenic response to T cell mitogens, in both genders (Kiecolt-Glaser et al. 1997).  Another 
study also demonstrated higher antibody titres against cytomegalovirus (CMV) in a group of 
caregiving individuals when compared to the controls, indicating poorer latent virus control 
(Pariante et al. 1997). 
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Vaccination produces immune memory against specific pathogens, ready to respond to an 
infection.  An inadequate response and failure to provide full protection after vaccination, 
measured in terms of antibody titre, is indicative of a poorer immune response in the recipient.  
Unmarried older adults and those who had poor marital quality had a weaker antibody 
response to the influenza vaccination than happily married older adults (Phillips et al. 2006a).  
Life events stress and perceived stress were also related to a lower antibody response after 
vaccination against flu and meningitis in students (Burns et al. 2003, Burns et al. 2002, 
Phillips et al. 2005), while greater social support enhanced antibody titres for some vaccine 
strains (Phillips et al. 2005).  However, studies that have examined the antibody response to 
vaccination in younger caregivers have reported inconsistent results.  The first study of this 
type compared hormonal and immune status between 41 partner of multiple sclerosis patients 
and 62 controls (Vedhara et al. 2002).  Multiple sclerosis was chosen as serious chronic and 
degenerative illness that usually causes physical and cognitive complications (Barcellos et al. 
2002), and as such thought to cause equivalent level of burden for caregivers as seen in 
spouses and partners of dementia patients.  Despite reporting higher levels of stress, but not 
anxiety and depression, caregivers showed no difference in either antibody response to an 
influenza vaccination, nor their IFN-γ and IL-4 levels.  Similarly, cortisol and DHEAS and 
their ratio was not different between the groups (Barcellos et al. 2002), supporting previous 
reports of preserved immune responses in stressed caregivers.  In contrast, a study conducted 
by Gallagher et al. (Gallagher et al. 2009b) showed a poorer antibody response to 
pneumococcal vaccination in caregiving parents of children with developmental disabilities 
when compared to age and sex matched control parents.  These findings were further 
supported in another study by Gallagher et al. (Gallagher et al. 2009a) which showed a 
reduced ability of caregiving parents to mount an adequate antibody response compared to 
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control parents after vaccination against the influenza virus.  It was argued that the difference 
in immune response in these studies could be due to characteristics of the care-recipient such 
as challenging behaviours, rather than the caregiving role per se, and that perhaps the 
caregiving experience, reported as more challenging in case of parents of children with 
developmental disabilities, is what drives this change in immune function (Gallagher et al. 
2009b).  Indeed within the caregiving group, those parents who reported higher child problem 
behaviours had a poorer antibody response to the pneumococcal vaccine (Gallagher et al. 
2009b).   
Stressed individuals also show significant changes in the DNA repair process.  Changes in 
DNA repair processes have been associated with different types of cancer such as cutaneous 
malignant melanoma (Wei et al. 2003), lung cancer (Wu et al. 2003), and breast cancer 
(Sharan et al. 1997).  One of the theories of ageing suggests that the accumulation of DNA 
damage is a potential cause of gradual frailty in living organisms (Freitas and de Magalhaes 
2011), emphasising the involvement of the repair mechanism in the ageing process (de Boer 
et al. 2002).  Several studies have shown correlations between stress and the efficiency of 
DNA repair (Yang and Glaser 2003).  This is also a demonstration of the complicated 
relationship between stress and body mechanisms, as it shows that in addition to the duration 
of the stressor, the consequences of its action depend also upon the capacity of the organism 
to adapt to change and maintain homeostasis.  The effect of stress was different depending on 
the population tested, with a decrease seen in the DNA repair mechanism after X-irradiation 
in psychiatric compared to non-psychiatric patients (Kiecolt-Glaser et al. 1985), whereas in 
young healthy students, stress during an examination period influenced the increase in the 
extent of DNA repair after UV radiation (Cohen et al. 2000).  As examination stress increases 
DNA damage and hence the need for its repair, it could be that the increase in the repair 
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process in young healthy students indicates their ability to meet this criteria, an ability that is 
not present in psychiatric patients who exhibit a decrease (Yang and Glaser 2003).  Forlenza 
et al. (Forlenza et al. 2000) confirmed this in a study that showed an increased rate of 
nucleotide exchange repair in students during an examination period when compared to the 
low stress holiday period.  Further evidence can be found in the rat studies where sister 
chromatid exchange, a process that is known to occur with higher incidence in the presence of 
agents with oncogenic potential (Banerjee and Benedict 1979), showed a doubling potential in 
the bone marrow cells of rats subjected to different types of behavioural stressors, such as 
swimming, white noise, and foot shock (Fischman and Kelly 1987).  On the other hand, a 
decreased DNA repair capability was reported after carcinogen administration in rats exposed 
to the rotational stress compared to a non-stressed group (Glaser et al. 1985).   
When considering factors, tightly regulated and controlled, and related to both maintaining 
and disturbing homeostasis on a cellular level, structures that emerge as one of the key 
controllers of the cell cycle are telomeres.  Telomeres are complexes of repetitive DNA 
sequences (TTAGGG) located on the very end of each chromosome surrounded by a large 
number of proteins.  They have several functions, but are mainly involved in maintaining 
chromosome stability (Dahse et al. 1997).  Due to the nature of the DNA replication process, 
telomeres protect the core of DNA, shortening by approximately 50 base pairs with every cell 
cycle. Telomeres eventually become so short that the DNA is exposed, replication ceases and 
cells enter replicative senescence (Dahse et al. 1997). Telomeres thus act as a “biological 
clock” counting the number of cell divisions a cell has made (Dahse et al. 1997).  Indeed, a 
large number of studies have suggested that telomere shortening is an important factor in the 
process of ageing, as well as diseases such as human immunodeficiency virus (HIV), 
hepatitis, Alzheimer's, inflammatory bowel disease, and cancer (Jiang et al. 2007).  The 
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importance of adequate telomere length is a key to the immune system, particularly adaptive 
immunity, as cell division in lymphocytes is necessary for their response to antigenic 
challenge (Kaszubowska 2008).  However lymphocytes express the enzyme telomerase, 
which can extend telomere length, giving them additional replicative capacity before they 
enter senescence (Kaszubowska 2008). Studies have indicated that chronic stress might in this 
case mimic or accelerate immunosenescence.  For example, telomere length in peripheral 
blood mononuclear cells (PBMCs) was shorter in parents caregiving for a chronically ill child 
and experiencing higher stress levels compared to those in the low stress caregiver group, 
even though there was no difference in telomere length between caregiving parents generally 
and their age and sex matched controls (Epel et al. 2004).   
Another very important mechanism inside the cell that needs to be carefully regulated and 
kept in balance in order for the cell to function normally is programmed cell death or 
apoptosis.  Apoptosis is essential for proper embryonic development, functioning of the 
immune system, as well as maintaining of the homeostasis in response to different 
physiological and pathological stimuli (Elmore 2007).  For example, apoptosis is an important 
mechanism in the regulation of neutrophil function.  Neutrophils are key effector white blood 
cells in defending the host from bacterial infection by producing various cytokines and ROS 
(Lloyd and Oppenheim 1992).  However, neutrophils are also important factors in regulating 
inflammatory processes, and the existence of an adequate regulatory mechanism is necessary 
to prevent these protective components becoming damaging to the host (Sendo et al. 1997).  
With a half-life of 10-12 hours, these cells are given enough time to perform their protective 
role and fight bacterial infection, but prevented from any deleterious effect on surrounding 
tissue by entry into apoptosis once they have engulfed bacteria (Sendo et al. 1997).  Intense 
exercise stress prolongs the survival of neutrophils, whereas longer lasting examination stress 
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inhibits the process (Sendo et al. 1997).  This extended lifespan could be useful at times of 
infection, but in its absence could be damaging, indicating the variety of ways in which stress 
can affect health and the complexity that lies behind that relationship.  
 
1.5. AGEING, STRESS AND THE IMMUNE SYSTEM 
One of the important components that should be taken into account when considering the 
effect of stress on immunity is age.  Even in the cases where the effect of stress on the 
immune system is strong, such as in the case of caregiving, this might be even more evident 
or might change once the immune system is challenged by both ageing and stress 
simultaneously (Segerstrom and Miller 2004).  Ageing is considered to weaken the body's 
ability to respond to stress, and with stress affecting organisms in a similar way as ageing, it 
may lead to accelerated ageing (Sapolsky 1999).  It has been suggested that one of the factors 
contributing to this exacerbated effect of stress in the aged organisms is their inability to 
terminate the production of GC in response to stress (Sapolsky et al. 1986).  According to the 
GC cascade hypothesis, failure of the control mechanism that should stop the production of 
GC after the effect of the stressor has ended is caused by the age-induced degeneration of the 
region of the brain responsible for communication with the endocrine system (Sapolsky et al. 
1986).  In that way, excessive amounts of GC further damages the target brain region, starting 
a positive feedback cascade (Sapolsky et al. 1986).  Functional connections between the 
immune and neuroendocrine systems stem from the existence of the interplay between their 
components, cytokines and hormones, on various levels (Ottaviani and Franceschi 1997), thus 
the GC response to stress and ageing has a significant impact on immune function.   
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The way ageing and stress simultaneously act to affect the immune response seems to be 
influenced not only by the way organisms age, but it could be highly influenced by early life 
event experience (Graham et al. 2006).  Long-term effects seem to emerge not only after 
negative maternal behaviours, such as poor prenatal nutrition, but also following external, 
psychological and environmental stress in mothers, reviewed in (Graham et al. 2006).  For 
example, early life stress through the excess of maternal stress hormones, mainly GC (Painter 
et al. 2012) has been shown to relate to emotional problems and learning deficits, and it could 
lead to the conditions such as type 2 diabetes and general depression and anxiety symptoms in 
the adulthood (Weinstock 2008). 
A theory of ageing known as the 'disposable soma' hypothesis emphasises the difference 
between the efficiency of the translational machinery in reproductive and somatic cells, where 
the latter have traded accuracy in order to save energy for other more important functions 
(Kirkwood 1977).  In the same manner, this theory explains longevity through the presence of 
the 'more successful' alleles of the genes involved in the protective mechanisms of the cellular 
response to a variety of physical stressors such as oxidative stress, radiation, and heat (Kapahi 
et al. 1999).  Further, it has been suggested that the immune system has been developed as a 
response to pathogens which are a specific type of stressors (i.e. antigenic stressors) 
(Ottaviani and Franceschi 1997).  In that way, immunosenescence in more complex 
organisms such as vertebrates will be the product of the continuous accumulation of damage 
due to lifelong exposure to antigenic stress (Franceschi et al. 1999). 
A typical consequence of ageing on immunity is involution of the thymus where T cells 
mature, but also changes in bone marrow stem cells that shift the number of circulating T cells 
from naive to a relative increase in memory T cells (Castle 2000, Miller 1996).  NK cells 
show decreased activity per cell (Castle 2000), and dendritic cells show decreased ability to 
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reach T cells as their target and promote adequate production of cytokines such as IFN-γ and 
IL-10 by influenza-specific T cells (Castle 2000).  Toll-like receptors, membrane proteins that 
recognise conserved structure from microbes, are present in lower levels on macrophages 
from aged mice than young mice (Renshaw et al. 2002).  Further, neutrophils from elderly 
donors have poorer phagocytic function, and diminished ability to fight of infections caused 
by Gram positive bacteria, such as pneumonia, which is one of the major causes of death in 
the older population (Butcher et al. 2001).  Ageing is also accompanied by the remodelling of 
the T cell profile and the increase in the number of T cells with a senescent and exhausted 
profile (Chou and Effros 2013, Wherry 2011).  Senescent T cells are characterised by the loss 
of cluster of differentiation (CD)28 co-stimulatory molecules corresponding to the decreased 
antiviral function and ability to produce robust protective response after vaccination (Effros 
2004, Strioga et al. 2011). Exhausted T cells are characterised by expression of the cell 
surface programmed cell death (PD)-1 marker (Wherry 2011).  These cells not only show 
reduced proliferative responses upon stimulation through the T cell receptor, but also have a 
more pro-inflammatory response. In addition the CD28 negative cells also express receptors 
normally associated with NK cells, such as a member of NKG2 family of C-type lectins 
(NKG2D), and killer cell lectin-like receptor subfamily G member 1 (KLRG1), which allow 
them to response to self antigens and increase the risk of autoimmunity in older adults 
(Abedin et al. 2005, Tarazona et al. 2000). 
The existence of compromised immunity in both younger stressed individuals (Cohen et al. 
1997, Gallagher et al. 2009b, Gallagher et al. 2009a), and older adults (Butcher et al. 2000, 
Butcher et al. 2001, Duggal et al. 2013b, Hazeldine et al. 2012, Hazeldine and Lord 2013, 
Pawelec et al. 2005) suggests a potential common mechanism that may be shared between 
stress and ageing in relation to the immune system.  Some forms of immunosuppression seen 
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in response to stressors are also present with age.  One example would be the change in 
cytokine production in the elderly, with cytokines from the Th2 response, such as IL-10 and 
IL-4, taking over from those typical for Th1 response, such as IFN-γ and IL-12 (Rink et al. 
1998).  Others are stress induced thymus changes in both animals (Kioukia-Fougia et al. 
2002) and humans (Gruver and Sempowski 2008), that are characteristic of normal ageing 
(Singh and Singh 1979), but also molecular changes seen as telomere shortening in 
chronically stressed (Epel et al. 2004) that also progressively occur with age (Cherif et al. 
2003, Mikhelson 2008). 
There is also an interesting association between age-related changes and stress in the pattern 
of adrenal steroid production (Arlt and Hewison 2004).  Even though its exact effect on 
immunosenescence is yet to be established, DHEAS, an adrenocortical steroid, is considered 
to have immune enhancing capacity (Hazeldine et al. 2010, Phillips et al. 2007).  Another 
characteristic of this hormone is that it reaches its peak in the third decade of human life and 
then gradually declines with age, termed adrenopause (Orentreich et al. 1984).  On the other 
hand, cortisol, a GC with known immunosuppressive effects, does not change with age, thus 
the cortisol:DHEAS ratio increases with age even in the absence of stress, giving an overall 
immunesuppressive endocrine environment. In addition, the systemic tissue based availability 
of cortisol may increase with age.  This idea comes from the fact that activity of the enzyme 
capable of converting cortisone to active cortisol, 11β-hydroxysteroid dehydrogenase Type 1 
(11β-HSD1), is increased with the higher pro-inflammatory status, which is considered 
typical in the ageing process (Tomlinson et al. 2004).  The result of this is a higher 
cortisol:DHEAS ratio in tissues expressing 11β-HSD1 .   
Many of the complex processes of ageing and the stress response remain unclear; 
nevertheless, research continues to suggest common pathways between them on all 
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organisational levels, from organ systems to intracellular pathways and their gene candidates.   
One component also involved in and frequently related to processes of ageing and the stress 
response is a transcriptional factor, nuclear factor-kappa B (NF-κB).  NF- κB is a whole 
family of transcription factors (Gilmore 2006), involved in regulation of both innate and 
adaptive immunity.  Its dysregulation leads to autoimmune diseases and cancer, but it is also 
studied as an ageing- and stress-related factor.  The suggested mechanism through which 
psychological stress can be transferred to the intracellular level to affect NF-κB functioning 
and increase its binding activity, involves a signalling pathway that is activated through 
binding of increased concentrations of noradrenalin to α1- and β-AR during stress (Bierhaus et 
al. 2003).  Another possible link between NF-κB and stress response is its interaction with GC 
receptors in a way that is yet to be elucidated (De Bosscher et al. 2003).  It is not surprising 
that a transcriptional factor that is involved in the response to so many key processes, such as 
oxidative stress, growth, immune function, DNA damage, like NF-κB, is also considered one 
of the components affected by ageing.  Other factors with a role in ageing, immunity and 
resistance to stress are the transcription factor forkhead box class O (FOXO3a) (Adler et al. 
2007) and the histone deacetylase sirtuin 1 (SIRT1) (Longo and Kennedy 2006).  
Interestingly, they both act by inhibiting activation of NF-κB, emphasising the significance of 
this factor in both ageing and stress (Adler et al. 2008). 
 
1.6. CHRONIC STRESS, AGEING AND THE IMMUNE SYSTEM 
The main danger to immunity, however, occurs with synergy of ageing and chronic stress.  In 
that respect, it might be that chronic stress is one of the main threats in an already immune-
compromised older age.  As mentioned above, severe stressors with a long term effect such as 
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a loss after death of a close family member or friend have been shown to relate to changes in 
the ability of aged neutrophils to produce ROS through which they kill rapidly dividing 
pathogens (Khanfer et al. 2011).  This detriment in neutrophil immunity was also 
accompanied by a higher cortisol:DHEAS ratio in the  bereaved older adults relative to age-
matched non-bereaved controls (Khanfer et al. 2011).  Bereavement in older adults has also 
previously been associated with a poorer antibody response to vaccination against the 
influenza virus (Phillips et al. 2006a).  Changes in the cortisol:DHEAS ratio with diminished 
immune function again suggest a potential mechanism through which stress could influence 
the body's defence mechanism against infection.  For example, older adults who had suffered 
the physical stress of a hip fracture and gone on to develop a bacterial infection post-surgery, 
showed decreased neutrophil superoxide production accompanied by a higher serum 
cortisol:DHEAS compared to age-matched controls (Butcher et al. 2005).   
Older caregivers have most commonly been studied in this context, using the  model of family 
dementia caregiving (Gouin et al. 2008).  The severity of the stress in these circumstances 
comes not only from the patient's progressive deterioration in performing daily activities that 
pose growing problem for caregivers (Potkin 2002), but also from the loss of cognitive 
function, such as the ability to recognise people around them, and changes in behaviour such 
as hoarding, anger, and repetitive behaviour (Grossberg 2002).  Both innate and adaptive 
immunity are affected by chronic stress experienced by older adults, and both of these 
components are necessary for the protection against different pathogens that can damage the 
body.  It was shown, for example, that wound healing was slower in older dementia 
caregivers when compared to age, sex and income-matched controls (Kiecolt-Glaser et al. 
1995).  Wound healing is a complex process comprised of various phases (immediate 
response, inflammatory response, proliferation, migration and contraction and resolution) that 
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activates many different cells and molecules (Shaw and Martin 2009).  Cells such as 
neutrophils and macrophages, and high concentrations of cytokines are main players in the 
inflammatory phase with a role to protect from invading pathogens and set the conditions for 
the repair process such as angiogenesis regulation (Shaw and Martin 2009).  Lower 
production of pro-inflammatory cytokines involved in the wound healing process such as IL-
1α, IL-8 (Glaser et al. 1999), as well as IL-1β (Kiecolt-Glaser et al. 1995) seen in caregivers 
compared to the controls, indicates the possibility of a direct effect of stress on cytokine 
production in wound healing.  NK cell activity between older dementia caregivers and 
controls showed no difference in the ability of these cells to kill K562 target tumour cells 
(Irwin et al. 1991), but in the presence of cytokine stimulation (recombinant IFN-γ and IL-2) 
this similarity between stressed individuals and controls was not preserved; NK cells from 
caregivers responded more weakly compared to those from the controls (Esterling et al. 
1994).  All this, together with the stress-induced reduction in IFN-γ production (Glaser et al. 
1986), indicates cytokines as a common target during chronic stress exposure, and a potential 
effector through which much of the immune suppression may occur.  
A further association between the chronic stress of caregiving was found for adaptive cell 
mediated immunity; elevated cortisol levels as well as poorer proliferation to PHA and lower 
IL-2 production was shown in the caregiving group (Bauer et al. 2000).  As observed in 
younger stressed participants (Marshall et al. 1998), caregiving stress in older adults has also 
been shown to be associated with the Th1-to-Th2 shift in cytokine responses, with the 
difference that in the older stressed individuals this was driven purely by an increase in IL-10 
production, with no difference in IFN-γ production by Th1 cells (Glaser et al. 2001).   
Vaccination responses are affected in older adults due to immunosenescence, which makes 
them particularly vulnerable to frequent infections such as pneumonia and influenza, among 
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the top five causes of high morbidity and mortality in this age group (Thompson et al. 2003).  
It would be expected that this aspect of immune incompetence would be further exacerbated 
in older adults affected by the chronic stress of caregiving.  This is indeed the case; a 
significantly lower percentage of older caregivers of dementia patients showed a four-fold 
increase in antibody titre in response to vaccination against the influenza virus, a response that 
is considered to be protective against infection (Vedhara et al. 1999).  This was accompanied 
by higher salivary cortisol concentration in this group when compared to the controls, 
pointing again to the role of HPA axis in immune regulation among stressed individuals.  
Most microbial antigens, however, trigger both humoral, i.e. antibody response which is 
generated by B lymphocytes, as well as cellular responses, mainly mediated by cytotoxic 
CD8+ T cells (Glaser et al. 2000, Kiecolt-Glaser et al. 1996, Siergist 2008).  In addition, CD4+ 
T cells are necessary as mediators between those two.  It has been shown that both the 
antibody response to vaccination against the influenza virus, as well as IL-2 production in 
response to antigen stimulation, was lower in caregivers compared to controls (Kiecolt-Glaser 
et al. 1996).  In the case of the pneumococcal pneumonia vaccine, even though caregivers 
managed to exert an adequate immune response initially, shown as a rise in IgG antibody titre, 
it declined over time more rapidly in this group than in the group of matched controls, likely 
either as a consequence of a decrease in number of antibody-specific B cells, or their ability to 
produce IgG (Glaser et al. 2000, Vedhara et al. 1999). 
 
As with other psychological stressors, a frequently used approach for assessing the severity by 
which caregiving stress affects the immune system of older caregivers is that of studies of 
latent virus antibody titres.  It is known, for example, that reactivation of latent viral 
infections, such as those initiated by Herpes viruses (HSV-1, EBV, CMV) is typical for 
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immunosuppressed patients such as HIV and transplant patients (Rasmussen 1991).  
Interestingly, older caregivers had higher IgG antibody titres against EBV virus capsid 
antigen (VCA) compared to matched controls, indicating poorer control of the latent infection 
in this group (Kiecolt-Glaser et al. 1991b).  Together with the higher antibody titre to total 
viral antigen of HSV-1, caregivers also had a decreased virus-specific T cell response; another 
and very important component of immune system necessary for controlling the infection 
(Glaser and Kiecolt-Glaser 1997).  Older parental caregivers have also been characterised by 
higher antibody titres against CMV when compared to the controls (Pariante et al. 1997).  
Another concept that often occurs in the literature when discussing ageing of the immune 
system is inflammageing.  Inflammageing indicates an imbalance between inflammatory 
factors (C-reactive protein (CRP), TNF, IL-1, IL-6) necessary to fight infection, and anti-
inflammatory components (IL-10) which act to resolve inflammation.  It has been suggested 
that the rate of ageing and age-related disease could be dependent on this balance (Franceschi 
et al. 2007).  One consequence of this might be that chronically stressed older adults, such as 
dementia caregivers, could have elevated inflammatory markers even when compared to non-
caregiving older adults who have immunosenescence.  Indeed, not only did older caregivers 
show higher levels of IL-6 (von Kanel et al. 2006), but its rate of increase was four times 
higher than in non-caregiving controls, leaving them particularly vulnerable to IL-6 related 
diseases such as physical frailty, cardiovascular diseases, osteoporosis and others (Ershler and 
Keller 2000).  
Finally, other molecular mechanisms in ageing appear to be exacerbated by chronic stress in 
older adults.  Caregivers of dementia patients had shorter PBMC, T cell and monocyte 
telomere lengths, and this was not due to having a higher number of these cells with shorter 
telomeres (Damjanovic et al. 2007).  On the other hand, they also showed an increase in basal 
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telomerase activity, which could indicate an attempt of these cells to compensate for the loss 
of their telomere length (Damjanovic et al. 2007).   
In summary, both the chronicity of stress and the ageing process are detrimental to an 
organism’s well being.  The mechanisms of these effects are yet to be elucidated more fully.  
However, it is clear that  many of the ways in which both ageing and stress affect the body are 
through shared mechanisms, with particular regard to the neuroendocrine and immune 
systems from the level of the tissues, cells and even intracellular components.  Less is known 
about the additive impact of ageing and stress on the innate immune system with the 
exception of studies of NK cells.  A better understanding of the processes by which stress and 
ageing affect health will lead to a greater capacity for intervention, be it behavioural or 
pharmacological.  
 
1.7. AIMS OF THE THESIS 
Given this three way relationship between ageing, stress and the immune system, the aim of 
this thesis was to examine the effects of both ageing and the chronic stress of caregiving and 
bereavement separately on different components and functions of the immune system, and to 
investigate the HPA axis stress hormones, cortisol and DHEAS, as potential effectors of any 
interactions seen.  The thesis addressed four specific research objectives, to determine: 
1. The influence of caregiving stress on the control of CMV by measuring serum 
anti-CMV antibody titres, testing the hypothesis that chronic caregiving stress 
negatively impacts on the adaptive immune system’s ability to control latent virus 
infection.  The study used serum samples of young parental caregivers and 
matched controls collected on two different occasions; one sample from a cross-
sectional study of caregiving stress, ageing and immune function and the second, 
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from a previously published case-control vaccination response study from our 
group using only baseline samples from that study.   
2. The effect of the chronic stress of caregiving and ageing on neutrophil function, 
serum cytokine levels and serum cortisol, cortisone and DHEAS concentrations, to 
test the hypothesis that stress and immunosenescence would interact to give 
greater neutrophil functional decline in the older stress group.  This was achieved 
using four groups of participants; young parental caregivers of children with 
developmental disabilities and older spousal caregivers of dementia patients, as the 
model of chronic stress without and with immunosenescence, respectively, and 
corresponding age- and sex-matched controls for each group.   
3. The relationship between caregiving stress, ageing and T cell phenotype, 
examining T cell senescence and exhaustion markers, thymic output assessed by 
levels of T cells bearing T cell Receptor Excision Circles (TREC) and CMV serum 
antibody titre using the same four groups of participants as in 2.  The hypothesis 
tested was that the chronic stress of caregiving would be associated with decreased 
immune functioning relative to controls indicating that stress accelerates immune 
ageing, and in that respect would mimic (in younger stressed group) and 
potentially act additively to (in older stressed group) the effect of ageing.    
4. The effect of different type of chronic stress, that of suffering bereavement, in a 
young population, and compared this to an older sample combined with data from 
a previously published study from our group on bereavement effects in older 
adults.  It was hypothesised that the stress of bereavement, even in the absence of 
immunosenescence, might still exert a negative impact on neutrophil function.  
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CHAPTER 2 
 
 
ANTI-CYTOMEGALOVIRUS ANTIBODY 
TITRES AND CAREGIVING BURDEN IN 
YOUNGER CAREGIVERS 
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2.1. ABSTRACT     
The analyses presented in this chapter examined whether or not young caregivers, 
parents of children with developmental disabilities, differed from controls in terms of 
CMV seropositivity and CMV-specific antibody titre. Second, it examined whether any 
particular socio-demographics, health behaviours, or psychological/caregiving variables 
were associated with a higher CMV antibody titre among caregivers.  Young caregivers 
and age- and sex-matched controls were compared with respect to their reported health 
behaviour and psychosocial status as well as latent virus control. 117 parents of children 
with developmental disabilities and 52 control parents completed standard measures of 
health behaviours, socio-demographics, perceived stress, depression and anxiety, 
caregiver burden, child problem behaviours.  They also provided a blood sample 
assayed for presence of CMV-specific antibody.  Caregivers were no more likely to be 
CMV positive than controls and did not have higher antibody titres against CMV.  In 
addition, there was no association between CMV antibody titre in seropositive 
caregivers and any of the psychological/caregiving variables.  However, higher CMV 
antibody titres were significantly associated with a higher body mass index (BMI), 
lower exercise levels, smoking and lower fruit and vegetable and fat intake among 
seropositive caregivers.  These data suggest that in the absence of immunosenescence, 
the chronic stress of caregiving is not sufficient to compromise the immune response to 
persistent CMV infection.  However, an indirect mechanism to poorer health in 
caregivers might be via adoption of disadvantageous health behaviours in response to 
stress. 
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2.2. INTRODUCTION 
CMV is a ubiquitous β-herpes virus with prevalence rates of infection as high as 60% (Dowd 
et al. 2009).  The means of transmission are through bodily fluids such as saliva, tears, urine 
and breast milk, and it can also be transmitted sexually.  As with any virus from the 
Herpesviridea family, CMV has the ability to remain in the body in the latent phase, typically 
in myeloid and dendritic cell progenitors, where its activation is initiated by inflammatory 
factors (Hahn et al. 1998).  Clinical symptoms and activation of CMV virus in general is 
highly unlikely in healthy adults. On the other hand, immunocompromised individuals, such 
as those with HIV infection and organ transplant patients (Riddell and Greenberg 1997), can 
display symptomatic CMV infections (Rasmussen 1991).  CMV infection may also contribute 
to the age-related decline in immunity, immunosenescence (Olsson et al. 2000, Pawelec and 
Derhovanessian 2011), and thus to an increased susceptibility to infectious disease and risk of 
mortality, at least in the very old (Almanzar et al. 2005, Pawelec et al. 2005, Simanek et al. 
2011, Strandberg et al. 2009).  The link between CMV seropositivity and increased mortality 
was proposed to be due to an increase in pro-inflammatory cytokines (Forsey et al. 2003, 
Franceschi et al. 1999, Licastro et al. 2005, Trzonkowski et al. 2009), though recent data from 
own laboratory has refuted this by showing that inflammation increased with ageing 
irrespective of CMV serostatus in one large cohort study (Bartlett et al. 2012). 
It has been shown that psychosocial factors, such as the chronic stress of caregiving, are 
associated with immune decrements.  For example, older spousal caregivers of a person with 
dementia exhibit a range of immunological features such as a decreased percentage of T 
lymphocytes, and higher antibody titres to EBV (Kiecolt-Glaser et al. 1987b).  In addition, 
caregivers showed lower levels of salivary antibodies compared to non-caregivers, but this 
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was observed only in the elderly cohort of three age groups (Gallagher et al. 2008), suggesting 
accelerated immune ageing in individuals experiencing periods of chronic stress.  
Younger parental caregivers of a child with developmental disability, particularly those who 
experience greater child problem behaviours, have also been shown to have significantly 
lower responses to both influenza and pneumococcal vaccinations compared to sex- and age-
matched controls (Gallagher et al. 2009a, Gallagher et al. 2009b).  In only one other study 
were immune decrements shown in younger caregivers compared to controls; and caregivers 
had a lower T helper:suppressor cell ratio than controls (Pariante et al. 1997), an indicator of 
an early immunosenescence. This suggests that perhaps irrespective of the caregiver’s age, 
caring for someone with severe cognitive and behavioural problems may compromise 
immunity.  In addition, older spousal caregivers of dementia patients showed changes in 
health behaviours which include changes in diet, smoking behaviour and sleep patterns that 
can also contribute to, and further damage their health (Gallant and Connell 1998) and may be 
an indirect mechanism through which caregiving stress impacts on immunity.   
What is unknown is whether stress in younger caregivers can specifically compromise the 
ongoing immune response to CMV. Anti-CMV antibody titre is a good marker of an ongoing 
immune response such that a higher titre would be indicative of compromised immune 
function. In one study, older but not younger caregivers had higher serum antibody titres 
against CMV compared to controls (Pariante et al. 1997).  However, this in part might be 
driven by the increased likelihood of CMV infection with ageing or the response to episodes 
of sub-clinical viral reactivation in older adults (Pawelec and Derhovanessian 2011).  In 
addition, even though CMV and risky health behaviour changes such as smoking, bad diet 
and inadequate sleep pattern have all been linked to adverse health consequences, the 
potential interplay between these factors, to our knowledge, remains unknown.  
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Given the negative effects of caregiving stress on other indices of immunity, this study aimed 
to examine the influence of caregiving stress on CMV antibody titre in younger caregivers.  
Further, the present study assessed associations between CMV antibody titre and various 
indices of health behaviours and other psychosocial variables within the caregivers group.  It 
was hypothesised that caregivers of children with developmental disabilities, particularly 
those with the greatest caregiver burden or child behaviour problems, would have higher 
antibody titres against CMV than non-caregivers.   
 
2.3. METHODS 
2.3.1. Participants  
117 parents caring for children with developmental disabilities and 52 parents of 
normally developing children were recruited to the study and provided a blood sample 
for CMV analysis.  Developmental disability is the term used to describe conditions 
including but not limited to Autism spectrum disorders and Down syndrome (Eunice 
Kennedy Shriver National Institute of Child Health and Human Development - 
http://www.nichd.nih.gov/health/topics/idds/conditioninfo/Pages/default.aspx#f1).  These 
parental caregivers were recruited via invitation letters distributed by their respective 
disease support group associations, by advertising in associated newsletters, or by direct 
contact with family support groups.  Inclusion criteria for these parents were: caring for 
at least one child with Autism Spectrum Disorder (ASD), Angelman, Down, Cornelia de 
Lange, fragile X, or Smith-Magenis syndromes.  These disorders evidence a range of 
problem behaviours, which are particularly common among children with syndromes 
other than Down (Arron et al. 2011, Blacher and McIntyre 2006, Chadwick et al. 2000).  
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Since the emotional reaction of parental caregivers is highly influenced by the diagnostic 
process (Graungaard and Skov 2007), this study aimed to avoid this particular event and 
focus on the parents’ stressful experiences of caring per se.  Thus, in keeping with 
existing research (Hastings et al. 2006), children with developmental disabilities had to 
be aged between 3 and 19 years and living at home during the school term.  The majority 
of parents reported caring for a child with Angelman syndrome (28.3%) and Smith-
Magenis syndrome (25.7%); followed by the parents of a child with fragile X syndrome 
(17.7%) and ASD (15%); the remainder were caring for a child with Cornelia de Lange 
(8.8%), or Down (4.4%) syndromes.  Controls, i.e. parents of typically developing 
children who were in the same age range as the sample of children with disabilities, were 
recruited via posters in local schools, the university, and the local area (e.g. sports centres 
and clubs).  None reported suffering from an ongoing chronic immune disease, being 
acutely ill, taking immunosuppressive medication, or reported being pregnant in case of 
female participants.  Attempts were made to match the groups as closely as possible on 
age, sex, socioeconomic position, ethnicity, and marital status, by recruiting individual 
parents of normally developing children that matched as near as possible individual 
parents of children with developmental disabilities.  The total time period for the 
recruitment of the controls was less than three years. All participants provided written 
informed consent and the studies had ethical approval from the appropriate local research 
ethics committees. 
2.3.2. Study design and procedure 
The current sample size was comprised of two separate groups of participants that were 
part of two separate younger caregiving studies focussing on different elements of 
immune function.  The first was a part of a prospective case-control vaccination response 
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study involving three testing sessions; details elsewhere (Gallagher et al. 2009b).  The 
analysis of CMV status and antibody titre and caregiving variables reported from that 
study involved baseline sampling only where parents completed questionnaires and then 
provided a blood sample.  The second study was a part of a cross-sectional assessment of 
neutrophil function comprising one blood sampling session.   
2.3.3. Questionnaires 
Health behaviours 
A questionnaire adapted from the Whitehall II study (Marmot et al. 1991) was used to 
assess the health behaviour in parents.  This questionnaire has been consistently used in 
previous stress and immunity research (Burns et al. 2003, Phillips et al. 2005).  Parents 
were asked about their sleep, smoking status, how much alcohol they drank, and simple 
categorical scoring system was used in all cases.  They were also asked about their 
exercise engagement (if and how many hours are they involved in the mildly, moderate, 
or vigorous exercise).  They also reported consumption of various food items, which 
gave a measure of how healthy (fruit and vegetable), or high in fat (snacks, chips, 
processed meat) their diet was.  Categorically scored health behaviour variables with 
little overall variability were split at the median and converted to binary variables e.g. 
smoker versus non-smoker, > 20 alcohol units consumed per week.  Fruit and vegetable 
and fat intake were scored from 0 ‘never’ to 6 ‘more than once per day’ for a range of 
foods consumed per week; fruit and vegetables listed were then summed along with fatty 
foods to produce two separate scores.  Exercise frequency was scored categorically from 
0 ‘none to 5 ‘11+ hours per week’ for mild, moderate, and vigorous activity.  A total 
weighted score was then produced from mild + (moderate * 2) + (vigorous * 3). 
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All of the caregiver measures were also appropriate to parents of non-developmentally 
disabled children, as they cover the general parental caring role and child behaviours.   
Sleep  
Sleep quality was measured by the 19-item Pittsburgh Sleep Quality Index (Buysse et al. 
1989).  These 19-items are then combined to create seven component scores with scores 
ranging from 0, no problems in area, to 3, high problem area.  Higher total scores 
indicated poorer sleep quality.  Adequate internal consistency (Cronbach’s α =.69) has 
been demonstrated previously (Spira et al. 2012).  In the present sample, the Cronbach’s 
α = .77. 
Depression and anxiety 
The Hospital Anxiety and Depression Scale (HADS) was used for measuring psychological 
morbidity (Zigmond and Snaith 1983).  The scale consists of two subscales with seven items 
in each, one assessing anxiety and the other largely anhedonic aspects of depression.  The 
answers are scored from 0 (not present) to 3 (considerable).  Scores for both scales had a 
range from 0 - 21, with the scores 0-7 being classed as normal, 8-14 as moderate and 15-21 as 
severe depression and anxiety respectively.  The HADS has good concurrent validity 
(Bramley et al. 1988, Herrmann 1997), and boasts good internal consistency, Cronbach’s α of 
.90 for depression and .93 for anxiety (Moorey et al. 1991); and test-retest reliability, .85 for 
depression and .84 for anxiety (Herrmann 1997).  The internal consistency in this sample was 
.78 for depression and .80 for anxiety. 
Time spent caregiving  
Amount of time spent caregiving was assessed using a modified version of the Caregiver 
Activity Survey (CAS) (Davis et al. 1997).  Parents were asked how much time they 
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spend on five specific (transport, dressing, eating, bathing and supervision) caring 
activities.  The total daily score for time spent caregiving was obtained by summarizing 
hours for each caring role.   
Caregiver Burden 
Parental caregiver burden was assessed using an adapted form of the Zarit Burden 
Interview (BI) (Zarit et al. 1980), originally designed to assess the burden experienced by 
family caregivers of elderly persons with dementia.  Questions in the scale used in the 
current study had ‘your relative’ amended with ‘your child’, for example ‘Overall, how 
burdened do you feel in caring for your child?  Responses ranged from 0, never, to 4, 
nearly always, and the overall score ranges from 0 to 48.  Internal consistency in current 
sample was .93. 
Child behaviour difficulties and problems 
Child behaviour difficulties were measured using the Strengths and Difficulties 
Questionnaire (SDQ) (Goodman 1997).  Questions are rated as 0, not true, 1, somewhat 
true, or 2, certainly true, and higher score indicates more problem behaviour.  Some 
items are reversed scored (e.g. generally liked by other children, has at least one good 
friend).  The overall score for child problematic behaviours can vary from 0 to 50.  The 
scale has been shown to be reliable (Cronbach’s α = .76) and effective at identifying 
behavioural problems in children (Goodman and Scott 1999) and has been used 
extensively in research with children with developmental disabilities (Hastings et al. 
2006).  Internal consistency for the scale in this study was .80.    
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Perceived stress 
This 14-item perceived stress scale (PSS) assessed control over and overload with the 
daily life stress during the past month.  It has been frequently used in caregiver research 
(Glaser et al. 2000, Vedhara et al. 2002), and measures both participants' subjective 
feeling of how much control they feel they have over daily events, as well as their 
inability to cope with things.  The scale ranges from 0 to 4 and higher scores indicate 
higher perceived stress.  The overall score can range from 0 to 56.  The scale shows good 
test–retest reliability (r = .80) and internal reliability (Cronbach’s α = .75).  Internal 
reliability in the present sample was 0.79.   
Social support 
The 12-item Support Functions Scale (SFS) – short form (Dunst et al. 1988) was used to 
assess types of support available to parents.  The support is assessed by 5-point Likert 
scale with 1 meaning support is not available and 5 that it is available quite often.  The 
total score on this scale varies from 0 to 60.  This scale has been shown to be reliable 
(Cronbach’s α = .86) and has been used previously in developmental disability research 
(White and Hastings 2004).  In the present study internal consistency was 0.88. 
2.3.4. Blood sampling and CMV analysis 
Venous blood was collected from an ante-cubital vein into a plain 6ml tube (BD Vacutainer, 
Oxford, UK).  The samples were allowed to clot for at least one hour, were centrifuged at 
1325xg (MSE Centaur 2, MSE (UK) Ltd, London, UK) for 10 min, and the separated serum 
was frozen at −20 °C until assayed.  Serum was analysed for the presence of CMV infection 
using CMV a standardised enzyme-linked immunosorbent assay (ELISA) developed by the 
Antiviral Immunology lab, Cancer Sciences, University of Birmingham as previously 
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reported.  The method consists of coating the plate with appropriate dilutions of CMV- and 
mock-lysate (negative control) on the first day, using carbonate/bicarbonate buffer (pH=9.6), 
then covering with parafilm and incubating over night at 4°C.  On the day 2, serum samples 
were thawed and 600µl of 1:600 dilutions were made using phosphate buffered saline (PBS) + 
1% bovine serum albumin (BSA) + 0.05%Tween20 as a dilution buffer.  For standard curve 
mix of three healthy, CMV positive donors was used.  For 7-point standard curve 1:4 dilution 
series were made up from initial 1:50 dilution.  Previously coated plate was washed three 
times with PBS+0.05%Tween20, discarding supernatant each time to remove any unbound 
particles.  100µl of standards, blank and samples were added onto the plate, with testing 
samples present in one lysate and one mock well, and the plate was incubated for an hour at 
room temperature (RT).  Plate was washed 3 times and supernatant discarded as before, after 
which 100µl of the secondary anti-human IgG-horsereadish peroxidise (HRP) antibody (goat 
anti-human IgG; Southern Biotech #2040-05), prepared in 1:8000 dilution in 
PBS+1%BSA+0.05%Tween20 was added, and left to incubate for 1 hour at RT.  After 
washing the plate three times following the same procedure described above, 100µl of 
tetramethyl benzidine (TMB)-solution was added into each well and incubated for 10 minutes 
at RT in the dark, after which the reaction was stopped  by adding of 100µl 1M HCl.  The 
readings were done at 450nm on The Wallac 1420 VICTOR2™ Multilabel Counter.  The 
standard curve measured up to 1000 arbitrary units of IgG and those with more than 10 units 
were considered as CMV positive. 
2.3.5. Statistical analyses  
Based on our previous caregiver research we attempted to detect a medium sized effect (f 
= 0.29) giving an overall sample size of N = 96, with at least 48 participants in each 
group.  Chi-square and analysis of variance (ANOVA) were used to determine group 
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differences (caregiver versus control) in health behaviour, socio-demographics and 
psychosocial variables.  Any significant group differences in socio-demographic 
variables and health behaviours were controlled for in subsequent analyses. Prior to 
statistical analysis of CMV data, these were checked for normality.  Due to the skew of 
the data, antibody titres were subjected to log10 transformation.  Four caregivers and two 
controls were removed from analyses due to outlying CMV antibody values or finding 
out post-consent that their child was < 3 or > 19 years.  Chi-square was used to establish 
whether CMV status differed between the groups (caregiver versus control) or related to 
any socio-demographic, health behaviour, or psychological/caregiving variables.  
ANOVA was used to compare CMV antibody titre between the caregivers and controls 
among those who were seropositive only.  For CMV titre, among the seropositive 
participants only, correlations were conducted within the caregiver group alone to 
determine if any of descriptive, health behaviour or psychological/caregiving variables 
related to antibody titre.  The effect size (ϕ, η2, r) was reported for all the analyses 
conducted, followed by observed power.  Any variations in the degrees of freedom 
reflect occasional missing data. 
 
2.4. RESULTS  
2.4.1. Socio-demographic, childcare and psychosocial characteristics of parental 
groups 
The demographic and summary childcare characteristics of the two parental groups are 
presented in Table 1.  Caregivers and controls did not differ on key socio-demographics , 
but parents of children with developmental disabilities had a higher body mass index 
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(BMI), depression and anxiety symptoms, perceived stress, alcohol intake, fat intake, 
poorer sleep quality, and spent more time caregiving.  As might be expected, parents 
caring for a child with a developmental disability had a greater caregiving burden, and 
their children had more child behaviour difficulties than parents of typically developing 
children (see Table 1).  Further, social support questionnaires revealed poorer quality of 
support (SFS) than that received by controls. 
2.4.2. CMV status  
Of the group as a whole, 76 (47%) participants were CMV positive; the number CMV 
seropositive within each group is shown in Table 1.  The percentage of CMV positive 
individuals among caregivers and controls were almost identical, χ2(1) = .01, p = .92, ϕ = 
.008, <.26.  Overall, CMV status was also not associated with any of the socio-
demographic, health behaviour, or any of the psychological/caregiving variables.  
 2.4.3. Caregiving and CMV antibody titre  
For the CMV positive subset (N = 76), socio-demographic, caregiving and psychosocial 
characteristics are presented in Table 2.  This time, in addition to higher alcohol intake, 
higher BMI, depression and anxiety symptoms, higher perceived stress and lower social 
support, caregiving parents differed in occupational group (more likely to be manual), 
ethnicity (more likely to be White), and smoking behaviour (more likely to be smokers) 
compared to control parents, but showed similar fruit and vegetable and fat intake.   
Although CMV positive caregivers had higher CMV antibody titres than controls, the 
difference was not statistically significant, even after controlling for the significant socio-
demographic and health behaviour variables, F(1,50) = 0.14, p = .71, η2 = .003, 1-β=.06, 
and significant psychosocial variables, F(1,60) = 1.73, p = .19, η2 = .028, 1-β=.25.   
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2.4.4. Characteristics of all participants and CMV antibody titre  
CMV antibody titre overall was also not associated with most of the socio-demographic, 
health behaviour, and psychological/caregiving variables, although women had 
significantly higher titres, F(1,69) = 4.38, p = .04, η2 = .060, 1-β = .54, as did those with 
higher BMI, r(64) =.26,  p = .03, .69.  Adjustment for sex and BMI as covariates did not 
alter the previous lack of group difference. 
2.4.5 Characteristics within the caregiving group and CMV antibody titre 
When seropositive caregivers were considered as a group, there was no association 
between CMV antibody titre and age, age of child, sex, ethnicity, occupational status, 
marital status, or sleep quality.  However, there was a positive correlation between CMV 
antibody titre and BMI, r(44) = .29; p=.05, .63, as observed in the whole group, and 
smokers had higher antibody titre than non-smokers, F(1,47) = 5.92, p = .019, η2 = .112, 
1-β = .66.
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Table 1.  Socio-demographics, childcare and psychosocial characteristics of caregiving and control parents.  
 Mean (SD) / N (%) Analyses 
 Caregivers  
(N = 113) 
Controls  
(N = 50) 
 
 
Socio-demographic characteristics 
Sex (Female) 70 (67) 30 (61) Χ2(1) = .54, p = .46, ϕ = .060, .23 
Marital status (Partnered) 90 (87) 40 (82) Χ2(1) = .63, p = .43, ϕ = .064, .23 
Ethnicity (Caucasian) 96 (92) 42 (86) Χ2(1) = 1.64, p = .20, ϕ = .103,.23 
Occupational status (non-manual) 66 (71) 38 (79) Χ2(1) = 1.10, p = .29, ϕ = .088, .22 
Age (years) 40.8 (6.83) 40.2 (4.72) F(1,151) = .301, p = .58, η2 = .002, 1-β 
= .17 
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Health behaviour characteristics 
Smoking (smoker) 37 (36) 19 (40) Χ2(1) = 0.28, p = .60, ϕ = .043, .23 
Alcohol (>20 units per week) 23 (22) 1 (2) Χ2(1) = 9.67, p = .002, ϕ = .253, .69 
Body Mass Index (kg/m2) 26.7 (5.40) 24.3 (3.14) F(1,142) = 7.45, p = .007, η2 = .050, 1-
β = .77 
Fruit and vegetable intake score 13.7 (3.92) 12.8 (3.38) F(1,149) = 2.21, p =.14, η2 = .015, 1-β 
= .32 
Fat intake score 19.9 (6.97) 17.0 (8.06) F(1,149) = 5.02, p =.03, η2 = .033, 1-β 
= .61 
Exercise score 10.1 (6.31) 10.4 (6.22) F(1,140) = 0.95, p =.76, η2 = .001, 1-β 
= .06 
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Sleep total score 9.3 (3.21) 7.1 (2.83) F(1,140) = 17.09, p < .001, η2 = .109, 
1-β = .98 
Number CMV seropositive 53 (47) 23 (46) Χ2(1) = 0.01, p = .92, ϕ = .008, <.25 
Raw CMV antibody titre  110.2 (162.97) 92.3 (142.98) F(1,161) = 0.45, p = .50, η2 = .003, 1-β 
= .10 
 
Psychosocial/caregiving characteristics 
Age of main care recipient (years) 9.1 (4.14) 7.9 (4.34) F(1,161) = 2.95, p = .09, η2 = .018, 1-β 
= .40 
Hours spent caregiving per day 12.5 (9.48) 6.8 (12.50) F(1,148) = 9.63, p = .002, η2 = .061, 1-
β = .87 
HADS depression 8.5 (3.66) 4.0 (3.29) F(1,149) = 51.54, p = <.001, η2 = .257, 
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1-β =1.00 
HADS anxiety 10.3 (4.26) 5.9 (2.52) F(1,151) = 45.13, p = <.001, η2 = .230, 
1-β =1.00 
Perceived stress score (PSS) 30.3 (7.33) 23.6 (6.47) F(1,151) = 30.00, p = <.001, η2 = .166, 
1-β =1.00 
Caregiver burden score (BI)   27.3 (9.10) 13.0 (7.58) F(1,151) = 53.43, p = <.001, η2 = .261, 
1-β =1.00 
Child behaviour difficulties (SDQ) 19.3 (5.17) 7.7 (4.34) F(1,150) = 182.41, p = <.001, η2 = 
.549, 1-β = 1.00 
Social support (SFS) 30.1 (9.01) 37.9 (10.48) F(1,147) = 22.25, p = <.001, η2 = .131, 
1-β = 1.00 
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Table 2. Socio-demographics, childcare and psychosocial characteristics of CMV seropositive caregiving and control parents. 
 Mean (SD) / N (%) Analyses 
 Caregivers (N = 53) Controls (N = 23)  
Sex (Female) 35 (71) 13 (59) Χ2(1) = 1.06, p = .30, ϕ = .122, <.20 
Marital status (Partnered) 41 (84) 16 (73) Χ2(1) = 1.15, p = .28, ϕ = .127, <.20  
Ethnicity (Caucasian) 46 (94) 17 (77) Χ2(1) = 4.19, p = .041, ϕ = .243, .39 
Occupational status (non-manual) 24 (57) 18 (86) Χ2(1) = 5.15, p = .023, ϕ = .286, .64 
Age (years) 42.1 (5.99) 40.6 (5.05) F(1,69) = 1.00, p = .32, η2 = .014, 1-β = .166 
Smoking (smoker) 25 (51) 5 (24) Χ2(1) = 4.44, p = .035, ϕ = .252, .39 
Alcohol (>20 units per week) 9 (18) 0 (0) Χ2(1) = 4.43, p = .035, ϕ = .251, .39 
Body Mass Index (kg/m2) 26.8 (3.85) 23.8 (2.87) F(1,64) = 9.51, p = .003 η2 = .129, 1-β =.859 
Fruit and vegetable intake score 12.9 (4.18) 13.6 (2.73) F(1,69) = 0.54, p = .46, η2 = .008, 1-β =.112 
Fat intake score 17.2 (7.67) 19.5 (7.21) F(1,68) = 1.40, p = .24, η2 = .020, 1-β =.214 
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Exercise score 9.0 (6.71) 10.6 (4.92) F(1,64) = 1.00, p = .32, η2 = .015, 1-β =.166 
Sleep total score 9.6 (3.48) 6.8 (2.62) F(1,65) = 10.95, p =.002, η2 = .144, 1-β =.903 
Raw CMV antibody titre   234.1 (166.50) 199.5 (152.49) F(1,74) = 0.73, p = .40, η2 = .010, 1-β =.134 
Age of main care recipient (years) 9.7 (4.37) 7.8 (4.53) F(1,74) = 3.06, p =.08, η2 = .040, 1-β =.408 
Hours spent caregiving per day 12.1 (8.04) 10.1 (17.62) F(1,67) = 0.44, p =.51, η2 = .006, 1-β =.100 
HADS depression 8.7 (3.76) 3.5 (2.97) F(1,69) = 32.44, p < .001, η2 = .320, 1-β =1.00 
HADS anxiety 10.2 (4.08) 5.5 (2.06) F(1,69) = 26.04, p < .001, η2 = .274, 1-β =.999 
Perceived stress (PSS) 30.3 (7.58) 22.7 (5.20) F(1,69) = 18.33, p < .001, η2 = .210, 1-β =.988 
Caregiver burden score (BI)   34.1 (14.44) 14.9 (7.94) F(1,69) = 34.19, p < .001, η2 = .331, 1-β =1.00 
Child behaviour difficulties (SDQ)  20.4 (5.18) 6.8 (4.45) F(1,68) = 110.38, p < .001, η2 = .619,1-β =1.00 
Social support (SFS) 28.9 (8..93) 36.0 (10.90) F(1,67) = 8.22, p = .006, η2 = .109, 1-β =.807 
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Other variables that showed significant associations with CMV antibody titre in the 
caregivers group were fruit and vegetable consumption, r(47) = -.28, p = .048, .63, fat 
intake, r(46) = -.34, p = .019, .63, and exercise score, r(42) = -.37, p = .013, .61, such that 
those who consumed fewer fruit and vegetables and fat, and undertook less exercise had 
higher CMV antibody titres.  There were no associations between CMV antibody titre 
and psychological/caregiving variables, as shown in Table 3.   
Table 3. Correlations between CMV titres and the caregivers' psychosocial characteristics 
 r df p 
    
Hours spent caregiving per day -.14 45 .35 
HADS depression .03 47 .81 
HADS anxiety .03 47 .82 
Perceived stress (PSS) -.11 47 .44 
Caregiver burden score (BI) .13 47 .37 
Child behaviour difficulties (SDQ) -.04 47 .77 
 Social support (SFS) .12 46 .42 
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2.5. DISCUSSION 
Despite differing on all main psychological/caregiving variables but not on socio-
demographics, parents caring for children with developmental disabilities were no more likely 
to be CMV seropositive than parents of typically developing children.  Caregivers were also 
no more likely to have significantly higher antibody titres against CMV.  Finally, although 
CMV antibody was not associated with any of the psychological/caregiving variables or most 
socio-demographics, women and people with higher BMI had higher antibody titres.  This 
gender difference is consistent with previous research (McVoy and Adler 1989, Haarala et al. 
2012), the exact reason being unknown.  One possibility might be that hormonal changes, 
specifically the increase in oestrogen that occurs during pregnancy relates to reactivation of 
CMV, and consequently higher titres later in life (McVoy and Adler 1989, Kleinman et al. 
1986).  Higher CMV antibody titres in those with higher BMI is also in concordance with a 
previously reported findings in immunocompetent adults (Gkrania-Klotsas et al. 2013).  This 
is perhaps due to associations noted between obesity and inflammation (Forsythe et al. 2008) 
 and CMV and inflammation (Hummel and Abecassis 2002), although this has not been 
observed in all studies (Bartlett et al. 2012). 
Within the seropositive caregiving parents, there was no association between CMV 
antibody titre and any of the psychological/caregiving variables.  However, those with 
higher CMV antibody titres, potentially indicating poorer latent virus control, generally 
did have poorer health behaviours, including being more likely to smoke, have a higher 
BMI, intake less fruit and vegetables, and undertake less exercise.   
This finding is consistent with that of Pariante et al. (Pariante et al. 1997), who did not 
find a greater likelihood of CMV infection or higher titres among the younger age range 
of their caregiving sample, as well as with studies in caregivers for a person with a 
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physical disorder which found no group differences in comparison to controls (Baron et 
al. 1990, Epel et al. 2004, Provinciali et al. 2004).  These studies suggest that younger 
caregivers and those caregiving for a more physical than mental disorder are less 
vulnerable to immune decrements.  However, the present findings contrast with the other 
caregiving and immunity studies in younger adults, which suggested poorer immunity 
among young caregivers, at least in response to vaccination (Gallagher et al. 2009a, 
Gallagher et al. 2009b) and lymphocyte proliferation to mitogen (Gennaro et al. 1997).  
This may reflect greater resilience of the CD8+ T cell-mediated anti-viral immune 
response to stress, compared with the many components of the vaccination response 
which include macrophages and dendritic cells in the skin as well as T and B cell co-
operation to generate antibody. 
A similar percentage of CMV positive parents in both caregiving (47%) and control 
(46%) groups indicated no difference in infection rate consistent with the fact that 
disparities in CMV infection rate among parents are mainly attributed to ethnicity and 
income (Colugnati et al. 2007), which did not differ between the groups. In addition, 
other studies have shown that children in day care have a higher CMV prevalence (Pass 
and Hutto 1986), which might in turn lead to greater infection in their parents.  However, 
information regarding day care or children’s CMV titres was not available in the present 
study.  Nevertheless, exposure to CMV-shedding children alone is not sufficient for 
infection in parents (Yamashita et al. 2003), thus parents exposed to children with 
developmental disabilities who may have a high burden of infection themselves (Arron et 
al. 2011, do Canto et al. 2000) are not necessarily more likely to be seropositive. 
Caregiving and control groups also had comparable CMV antibody titres.  The 
determinants of CMV-specific antibody titre are unclear but are likely to be related to the 
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frequency and magnitude of subclinical viral replication in vivo.  In addition, a high level of 
circulating antibody will not prevent reactivation of the virus (Glaser and Kiecolt-Glaser 
1994), but rather indicate that it has likely been reactivated.  Viral reactivation events are 
believed to become more common with increasing age and it is of interest that an effect of 
caregiving stress and burden on CMV antibody titre was noted in a study of older adults 
(Pariante et al. 1997) in contrast to the present younger caregiving group.  This perhaps 
indicates that in earlier life, caregiving per se is not sufficient to induce significant immune 
decrement seen here as greater viral reactivation, which is again consistent with some 
studies in young caregivers (Gallagher et al. 2008, Epel et al. 2004, Vedhara et al. 2002), 
but in contrast with others (Gallagher et al. 2009a, Gallagher et al. 2009b).  Testing of the 
age x caregiver group interaction in this study did not reveal any significant interaction 
effect.  Further, although Pariante et al. (Pariante et al. 1997) demonstrated a higher 
antibody titre in caregivers when compared to the controls in their eldest cohort, the sample 
size used for the analysis was only 18 female participants which was further reduced to 9 
participants in each group after splitting by age.  Therefore, it could be argued that the 
evidence for poorer control over this latent virus in older caregivers is only weak.   
CMV is also suggested to have a role in the ageing of the immune system, and has been 
used to explain the difference in the various immune components between CMV infected 
and CMV non-infected elderly (Pawelec et al. 2009).  In addition, older caregivers of 
Alzheimer's patients showed dramatic increase in antibody titre to EBV, another latent virus 
from Herpesviridae family, pointing to impaired control of cellular immunity towards virus 
replication (Kiecolt-Glaser et al. 1991b).  This suggests that as caregivers age, they are at 
higher risk of poorer latent virus control and its consequences.    
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Among CMV seropositive caregivers, smokers had higher antibody titre than non-smokers.  
This is not surprising as the T and B cell response against different antigens is severely 
reduced by smoking (Sopori 2002, Holt and Keast 1977), which could influence susceptibility 
to infection (Evans et al. 2000), and perhaps in this particular case, control of latent virus 
reactivation.  Other health behaviour characteristics that were associated with CMV titre were 
fruit and vegetable and fat intake and amount of exercise.  To our knowledge there is no 
previous evidence of the effects of dietary intake on latent virus control. Thus, what we may 
be picking up on here are a range of negative health behaviours which have an impact on a 
several health outcomes and processes, including a flattening in the diurnal rhythm of cortisol 
similar to that observed in immunosenescence (Heaney et al. 2012) and now control of CMV 
reactivation.  Further, an indirect mechanism between the stress of caregiving and the poor 
health reported in caregivers under high levels of stress and burden (Forbes et al. 2007) might 
be via engagement in negative health behaviours such as poor diet and lack of exercise, 
resulting in poorer immunity as well as worse health generally.  However, longitudinal studies 
including markers of health and more thorough assessment of health behaviours in caregivers 
would need to be conducted in order to test this theory in depth.  That these associations with 
CMV titre only emerged in the caregiver group rather than overall might be due to the 
increased importance of these behaviours in combination with existing stress.  This argument 
has been made previously with regard to the emerging impact of a psychosocial/behavioural 
factor in combination with an existing source of stress which itself had no direct impact on 
immunity.  For example, only older hip fracture patients who developed depression showed 
suppressed immunity, rather than those who had the stress of hip fracture alone (Duggal et al. 
2013a).  In younger non-stressed groups, although still detrimental in the long term, these 
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health behaviours might not demonstrate their impact on particular aspects of immunity until 
later in life.   
The present study has a number of limitations.  First, even though the initial sample size 
might be regarded as small, it was substantial when compared with the other caregiving 
studies (Gallagher et al. 2009b, Pariante et al. 1997, Vedhara et al. 2002).  We also recruited 
fewer controls than caregivers, as our key interest lay in the potential associations between 
elements of caregiver stress and CMV titre which might have explained any caregiver-control 
group differences.  However, once focusing on seropositive caregivers our sample size has 
significantly decreased and as such may have limited power, but, again, it is of similar 
magnitude or larger than other caregiver studies (Glaser et al. 2000, Pariante et al. 1997, 
Vedhara et al. 1999) and we have reported observed power throughout.  Nonetheless, the 
number of tests might have increased the likelihood of a Type I error.  Second, even though 
antibody titre has been commonly used as a measure of the adequacy of an individual’s 
immune system to control latent virus, it is known that cellular immunity and the T cell 
response in particular are key components needed for suppression of CMV reactivation 
(Vasto et al. 2007, Pawelec and Derhovanessian 2011). However, such assays require large 
quantities of whole blood and for the present analyses only stored sera were available.  Third, 
assessment of other antibodies besides IgG such as IgM would be useful in order to ascertain 
how recent infection and re-infection occurred in caregivers and controls as well as 
reactivation, but we did not have data on IgM levels.  Fourth, this study was cross-sectional at 
one time point, and therefore unable to determine whether comparable CMV antibody titres 
between the groups were indeed a consequence of adequate latent virus control in the stressed 
group, or they were related to other factors such as different times of initial infection.  
Measuring burden and CMV antibody titre over several time points in future research would 
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help to clarify this.  For example, in a study of antibody titres against EBV between older 
caregivers and controls, comparable titres were found at baseline but a greater increase was  
observed in the caregiver group over time (Kiecolt-Glaser et al. 1991b).  Finally, there is an 
inevitable limitation in the method of recruitment for this study, as the contact with caregiving 
parents was made mainly via family support groups and on the particular syndrome 
conference days, thus might have been biased towards those caregivers who have an access to 
adequate support and therefore, at least in part, obtain relief from the burden of caregiving.  
However, in our experience, those who attend syndrome days in order to gain relief would not 
have this support available to them generally in their daily life, thus are still a very stressed 
group. 
In conclusion, there was no evidence of an association between caregiving and CMV 
seropositivity or anti-CMV antibody titres.  This suggests that caregiving in younger adults 
may not accelerate all elements of immunosenescence, but that such decrements are only 
observed in older caregivers.  However, there was some evidence of an association between 
caregivers engaging in unhealthy behaviours (dietary intake, exercise and BMI) and CMV 
antibody titre, suggesting that an unhealthy lifestyle in response to stress in some individuals 
could be an indirect pathway through which health is affected in caregivers. 
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CHAPTER 3 
 
NEUTROPHIL FUNCTION, STRESS 
HORMONES AND CAREGIVING STRESS IN 
YOUNGER AND OLDER ADULTS 
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3.1. ABSTRACT    
The aim of this chapter was to examine the combined effects of caregiving stress and ageing 
on neutrophil function and stress-related hormones (cortisol, cortisone and DHEAS) in young 
and older individuals.  As a model of caregiving in young adults, parents (mean age 38) of 
children with developmental disabilities were recruited and compared to older spousal 
dementia caregivers (mean age 69 years). Age- and sex-matched controls for both groups 
were also assessed.  Participants completed a questionnaire pack assessing health behaviour, 
psychosocial, and caregiving characteristics, and provided a blood sample for neutrophil 
function (phagocytosis of Escherichia (E.)coli and generation of ROS), and serum hormone 
cortisol, cortisone and DHEAS concentrations as potential mechanisms.  Caregivers in both 
age groups scored worse on the majority of psychosocial and caregiving variables than 
matched controls.  Despite this, neutrophil function was comparable to that in controls and 
was unexpectedly higher in older adults when compared to younger adults overall.  However, 
those caregivers who reported higher psychological morbidity and more burdensome 
caregiving showed poorer neutrophil phagocytosis.  Further, there was no effect of caregiving 
in either group on cortisol and DHEAS concentrations or their ratio. However, the 
cortisol:cortisone ratio was higher in young caregivers compared to controls.  Overall, 
neutrophil function and stress hormone levels were preserved in caregivers and neutrophil 
phagocytosis was only compromised in those with the highest levels of distress.  This 
suggests that more attention should be paid to individual differences among caregivers rather 
than caregiving status per se.  
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3.2. INTRODUCTION 
There is now substantial evidence that chronic psychological stress can impair immunity 
(Glaser and Kiecolt-Glaser 2005, Kiecolt-Glaser et al. 2002, Vedhara and Irwin 2005).  
For example, the experience of a large number of negative life events has been 
associated with reduced antibody responses to vaccination (Burns et al. 2003, Phillips et 
al. 2005) and lower levels of sIgA (Phillips et al. 2006b).  Specific chronic stress 
exposures, such as bereavement, have been related to poorer NK cell function (Irwin et 
al. 1987), reduced neutrophil superoxide generation (Khanfer et al. 2011), and a reduced 
response to the influenza vaccination (Phillips et al. 2006a).    
Caregiving for a sick or disabled relative has frequently been employed as a model for 
examining the effects of chronic stress on immune function (Cohen and Pollack 2005, 
Vedhara et al. 1999, Vitaliano et al. 1998).  For example, in comparison to matched 
controls, caregivers mounted a poorer response to influenza and pneumococcal vaccinations 
(Glaser et al. 2000, Vedhara et al. 1999), had reduced NK cell cytotoxicity (Cohen and 
Pollack 2005), took longer to heal from punch biopsy wounds (Kiecolt-Glaser et al. 1995), 
and displayed poor control of latent viruses (Kiecolt-Glaser et al. 1987b).  However, the 
majority of these studies have been conducted in older adults.  This raises the issue as to 
whether effects of caregiving stress are only observed in the context of immune ageing.  
For example, sIgA secretion rates were found to be lower in non-routine caregivers relative 
to controls, but only for the oldest of three distinct age cohorts (Gallagher et al. 2008).   
Further, the study found that young caregivers of patients with multiple sclerosis had 
similar antibody responses to influenza vaccination as control participants (Vedhara et al. 
2002).   In contrast, more recently, parents caregiving for children with developmental 
disabilities showed lower antibody responses to influenza and pneumococcal vaccinations 
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relative to matched control parents  (Gallagher et al. 2009a, Gallagher et al. 2009b), and 
those parental caregivers reporting more child conduct problems mounted a poorer antibody 
response (Gallagher et al. 2009a, Gallagher et al. 2009b).  This suggests that the 
behavioural characteristics of the care-recipients may be a key determinant of whether or 
not immunity is compromised, and that an ageing immune system is not a pre-requisite for 
a poor response to vaccination or other immune response in caregivers. Nevertheless, older 
caregivers tended to have a poorer antibody response to one of the influenza vaccine strains 
(Gallagher et al. 2009a), suggesting that we cannot dismiss the hypothesis that chronic 
stress and immune system ageing may have additive effects (Graham et al. 2006).   
The effects of ageing per se on the immune system, termed immunosenescence 
(Pawelec 2007), are well established (Gruver et al. 2007).  In terms of adaptive 
immunity, lower thymic output of naive T cells (Gruver and Sempowski 2008) and a 
shift from naive T cells towards memory CD8+ T cells (Pawelec 2007) are some of the 
changes commonly observed in older age.  These alterations are considered to underlie 
the age-associated decline in antibody response to vaccination (Kovaiou et al. 2007).  In 
innate immunity,  NK cells (Hazeldine et al. 2012, Mocchegiani and Malavolta 2004) 
and macrophages (Plowden et al. 2004) are also affected by age.  Neutrophils show 
diminished phagocytosis and superoxide production (Butcher et al. 2001, Panda et al. 
2009).  This leaves them less able to fight bacterial infections, such as pneumonia, one 
of the major causes of morbidity and mortality among the elderly (Solana et al. 2006).   
To date, the effects of chronic stress have not been examined on younger and older 
samples simultaneously.  In addition, research into caregiving stress has mainly 
focussed on adaptive immunity, with the exception of NK cells (Esterling et al. 1994, 
Kiecolt-Glaser and Glaser 1999).  Bereavement, another source of chronic stress, was 
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seen to reduce neutrophil superoxide production in older adults relative to matched 
controls (Khanfer et al. 2011).   
Potential mechanisms underlying stress and neutrophil function associations include 
stress hormones known to modify immunity: cortisol (Bekesi et al. 2000) and DHEAS 
(Radford et al. 2010).  Cortisol is mainly immunosuppressive, whereas DHEAS is 
considered immune-enhancing (Phillips et al. 2007).  An imbalance between these two 
hormones, resulting in a higher cortisol:DHEAS ratio, can arise in response to stress 
(McCraty et al. 1998), and ageing (Orentreich et al. 1984), and has negative implications 
for immunity.  The ratio between serum cortisol and cortisone is a good indicator of 
systemic 11β-HSD1 activity such that a higher ratio could indicate increased activity of 
this enzyme (Homma et al. 2001), as is seen with ageing and increased pro-
inflammatory status (Tomlinson and Stewart 2005).  Finally, psychological and 
caregiving-specific characteristics have been given less attention in previous studies, but 
may be responsible for any caregiving effect on neutrophil function. 
   
The present study aimed to elucidate the associations between stress, ageing, and 
neutrophil function through studying four participant groups: parents of children with 
developmental disabilities; age- and sex-matched parents of typically developing 
children; older dementia caregivers; and age- and sex-matched healthy older adults with 
immunosenescence.  This allowed comparison of effects of caregiving stress on 
immunity with and without concomitant immunosenescence.  Potential endocrine and 
psychological mechanisms were also examined. 
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3.3. METHODS 
3.3.1. Participants  
57 young parental caregivers and 34 matched parental controls, and 40 older caregivers 
and 42 matched older controls participated.  Young caregivers had at least one child 
with a developmental disability, defined as described in chapter 2; older caregivers were 
aged 60+ years and full time spousal dementia carers.  Parental caregivers were mainly 
recruited at national syndrome support group conferences; their children were aged 
between 3 and 18 years and living at home during the school term.  The caregiver group 
consisted of 27 parents of a child with Smith-Magenis syndrome (47%), 22 parents with 
at least one child with fragile X syndrome (39%), seven parents of a child with Cornelia 
de Lange syndrome (12%), and one parent of a child with ASD (2%). Control parents of 
typically developing children were recruited locally and from media campaigns and 
newspaper advertisements.  Older caregivers were recruited from different NHS trusts 
(Birmingham and Solihull Mental Health NHS Foundation Trust, Lincolnshire NHS 
Trust, North Staffordshire NHS Trust and Bradford District Care Trust).  Older controls 
were recruited through the Birmingham 1000 Elders group 
(http://www.birmingham.ac.uk/research/activity/mds/centres/healthy-
ageing/elders.aspx).  Demographic characteristics are shown in Table 1.  Exclusion 
criteria were: taking medication known to alter immune function and/or steroid 
synthesis and metabolism; an ongoing chronic immune-related disease (e.g. cancer, 
glandular fever, diabetes, rheumatoid arthritis); and, for the younger group, pregnancy.   
  
62 
 
3.3.2. Study design and procedure 
This was a cross-sectional single session study with participants completing a 
questionnaire pack, and providing a blood sample in order to determine neutrophil 
function and levels of cortisol, cortisone and DHEAS in their serum.    
3.3.3. Questionnaires 
Health behaviours 
A questionnaire adapted from the Whitehall II study (Marmot et al. 1991) was used to 
assess health behaviours.  Subjective sleep disturbances were reported by participants 
through the Pittsburgh Sleep Quality Index (Buysse et al. 1989), where higher overall 
score indicates poorer sleep quality.  Adequate internal consistency (Cronbach’s α =.69) 
has been demonstrated previously (Spira et al., 2011) and in the present sample, α = .68. 
Depression and anxiety 
HADS (Zigmond and Snaith 1983) was used to measure current anxiety and depressive 
symptomatology in participants.  The HADS has acceptable internal consistency (.80 to 
.93 for anxiety and .81 to .90 for depression) (Herrmann, 1997; White & Hastings, 
2004), and in the present study, .86 and .81, respectively. 
Perceived stress 
PSS was used to assess how unpredictable and overwhelming daily life was during the 
previous month (Cohen et al. 1983a).  The scale shows good internal reliability 
(Cronbach’s α = .75); in the present study.86.   
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Caregiver burden 
In order to assess the stress caused by a caregiving role, a short form version of BI was 
used (Bédard et al., 2001).  This version has a Cronbach's alpha of .88.  For younger 
group, the questions were amended replacing ‘your relative’ with ‘your child’, while 
'spouse/partner' was used in older caregivers' questionnaire pack.  Examples of items 
include ‘Do you feel that because of the time you spend with your child/young 
spouse/partner that you don’t have enough time for yourself?’ Internal consistency in 
the current sample was .91. 
Time spent caregiving 
The amount of time spent caregiving was assessed using a modified version of the CAS 
(Davis et al. 1997).  Hours for each caring role (e.g., dressing, eating, transport) were 
summed together to yield a total daily score for time spent caregiving.  
Social Support  
The 12-item SFS (Dunst et al. 1988) was used to assess types of support available to 
participants in both younger and older group.  In the present study the internal 
consistency was .89.   
In the older group only, perceived social support was measured using The Medical 
Outcomes Study Social Support Survey (MOS) (Sherbourne and Stewart 1991).  Overall 
functional support was assessed as a summary of four different categories of support:  
emotional/informal (e.g 'someone to confide in or talk about problems'), tangible 
('someone to help you if confined to bed'), affectionate (e.g. 'someone who hugs you'), 
and positive social interactions (e.g. 'someone to do something enjoyable with').  The 
questions were assessed using 5-poing Likert-type scale ranging from 1-none of the time 
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to 5-all of the time.  High internal consistency of .91 has been reported previously, as 
well as test-retest variability from .72 to .78 for all four categories (Goodman 1997, 
Sherbourne and Stewart 1991).  The scale has been used previously in chronic stress 
research (Phillips et al. 2005, Phillips et al. 2006a).  Internal consistency in the current 
sample was .97. 
Care-recipient problem behaviour 
SDQ (Goodman 1997) was used to screen for child behaviour difficulties.  In the current 
sample the internal consistency for problem behaviour was .86.   
In the older adults, the Pearlin Problematic Behaviour (PPB) subscale was used which is 
a part of longer model developed to assess the stress of the caregivers of people with 
dementia (Pearlin et al. 1990).  The subscale focuses on frequency certain behaviours 
occur in a patient and demand caregiver's attention.  Participants were asked to mark the 
number of days they had to deal with certain situations weekly from 1- '0 days' to 4 - '5 
or more days'.  Total score was calculated by adding the scores from the individual 
questions. This subscale alone has been previously used in the dementia research 
(Gaugler et al. 2000, Teel and Press 1999) and has a good internal consistency 
(Cronbach's α=.88) (Teel and Press 1999).  Internal consistency in the current sample 
was .78. 
3.3.4. Blood sampling and assays 
Venous blood sample were collected in the morning, into one heparin tube and one plain tube 
(BD Vacutainer, Oxford, UK).  The heparin tube was used to assess neutrophil function in 
whole blood, in particular bacteria-induced phagocytosis and ROS production.  The samples 
in the plain tubes were allowed to clot for one hour, after which they were centrifuged at 
65 
 
1600xg (Eppendorf Ltd Centrifuge 5804/5804R, Stevenage, UK) for 10 min, and the 
separated serum was frozen at −20 °C until assayed.   
Neutrophil functional assays 
Phagocytosis of E.coli was measured using a fluorescence-based kit (Phagotest, Orpegen 
Pharma GmvH, Heilderberg, Germany) following the manufacturer's protocol.  100µl of the 
whole blood at the 0°C was incubated with 20µl of fluorescein isothiocyanate (FITC)-labelled 
bacteria, and then incubated at 37°C for 10 minutes with the negative control left on ice.  
After the incubation period, the test tube was transferred on ice to stop the reaction and FITC-
quenching solution was added to the both tubes to extinguish the fluorescence of all the 
bacteria that were left un-phagocytosed.  After two washing steps in PBS, the lysing solution 
was added to the tubes and left for 20min at the room temperature to allow lysing of 
erythrocytes and fixation of lymphocytes.  The cells were then washed twice and dsDNA was 
stained with a nuclear counter-stain for 10min on ice. The assays were analysed using a three-
laser Dako Cyan High Performance flow cytometer (Dako, Carpinteria, California), with 
Summit v 4.3 software.  Neutrophils were distinguished from other leukocytes by gating on 
forward scatter and side scatter and any remaining bacterial aggregates were excluded using 
red fluorescence staining to identify cells having diploid DNA content. 10-15000 leucocytes 
per sample were collected and the phagocytosis was presented as phagocytic index (PI), 
which is number of bacteria ingested per cell, seen as mean fluorescence intensity (MFI) 
multiplied by the percentage of neutrophils that had phagocytosed E.coli. 
Neutrophil oxidative burst in response to E.coli was measured using a commercial kit 
(Phagotest, Orpegen Pharma GmbH), the assays were performed according to the 
manufacturer's protocol. In summary, 100µl of the whole blood was mixed with 20µl of 
opsonised E.coli, and incubated at 37°C for 10 minutes together with another tube without 
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stimulus that served as a negative background control.  Formation of ROS was monitored by 
addition and oxidation of dihydrorhodamine (DHR) 123 that served as a fluorogenic 
substrate.  The reaction was stopped by adding lysing solution in order to remove erythrocytes 
and achieve partial fixation of leukocyte in the samples.  The samples were then washed in 
PBS, and DNA staining solution was added.  ROS generation was evaluated using flow 
cytometry using the same gating technique as described above, with MFI used as a measure of 
the oxidative burst activity of neutrophils. 
Serum steroid hormone analysis  
Steroid hormone analysis in serum was conducted by liquid chromatography/tandem mass 
spectrometry (LC-MS/MS).  Briefly, 200 µl of serum was mixed with internal standard 
cortisol-d4, and after protein denaturation at 55°C, samples were extracted using methyl t-
butyl ether (MTBE) as a solvent.  The mixture was then vortex-mixed, centrifuged at 
1200rpm (MSE, Centaur 2, DJB Labcare, England) for 5 minutes and the MTBE layer was 
removed and evaporated under nitrogen at 40-55°C.  The dried residues were resolved in 
100µl 50/50 mixture of methanol and water, and transferred into a 96-well plate for analysis 
by LC-MS/MS.  
For DHEAS, a protein crash method was used for extraction following the protocol described 
previously (Haring et al. 2013).  Briefly, 20µl serum, internal standard DHEAS-d2, and 
ZnSO4 each and 100µl of acetonitrile were combined, vortex mixed for 1 minute, and then 
centrifuged for 5 minute at 14000rpm (MSE, Centaur 2, DJB Labcare, England).  Supernatant 
(100µl) was then transferred into a clean glass test tube, evaporated to dryness and 
reconstituted in 50/50 MeOH/H2O for analysis. 
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A Waters Xevo mass spectrometer with Acquity UPLC local console was used.  An 
electrospray ionisation source was used in a positive mode.  Steroids were quantified by 
comparison to a calibration series with respect to the internal standard used, and 
quantification was completed using TargetLynx software version 4.1 (MassLynx 4.1).  Intra-
assay reproducibility was <10%.  The calibration range was 1.38 - 1380 nmol/l for cortisol 
and cortisone, and 0.026 - 26 µmol/l for DHEAS.  
3.5. Statistical analyses  
Comparisons between the caregivers and control groups on socio-demographics and 
questionnaire scores were conducted by ANOVA and chi-square.  Tests of the main 
effects of age and caregiving status as well as caregiving * age interaction effects were 
examined using 2x2 ANOVA; with effect sizes reported as η2.  Significantly different 
demographic or health behaviour variables between the groups were controlled for in 
further ANCOVAs.  Correlations were used within the caregiver participants to 
determine whether or not psychosocial and caregiving variables were associated with 
neutrophil function.  Where they were, hierarchical linear regression was conducted to 
further examine this association with age entered at step 1 and any significantly 
associated caregiving/psychosocial variable at step 2.   
 
3.4. RESULTS 
3.4.1. Demographic characteristics and health behaviours  
The demographic and health behaviour variables for each group are summarised in Table 
1.  In the younger sample, caregiver and control parents did not differ in their 
demographic characteristics.  Health behaviours were also similar, with the exception of 
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caregivers being more likely to drink alcohol daily (p=.005).  In both caregivers and 
controls, a few participants reported that they suffered from chronic illness (mainly 
asthma and high/low blood pressure).  Consequently, some of the parents in both groups 
reported taking medication, mainly non-steroidal asthma treatments and anti-
hypertensives.  In the older group, caregivers and controls were comparable on all of the 
demographic and health behaviour variables except for exercise scores where controls 
were more active than caregivers.  Similar numbers of participants reported suffering 
from chronic disease, mainly from those typical for older age such as high blood pressure 
and mild arthritis.    
3.4.2. Caregiving and psychosocial characteristics of each group 
Caregiving parents reported spending more time caring for their child than control 
parents (Table 2).  Other psychosocial characteristics were also significantly different 
between the groups and in the expected direction; caregivers reported higher depression 
and anxiety, perceived stress and child problem behaviours.  They also reported poorer 
sleep quality, higher caregiving burden and poorer quality of social support.  Table 2 
shows that depression and anxiety symptomatology, perceived stress scores, sleep 
quality, and general social support were significantly worse in the older caregiver group 
compared to older controls.  Caregiving burden reported by older caregivers was in the 
high range, according to the previously reported cut off of 17 (Bedard et al. 2001). 
Problematic behaviour on the Pearlin scale was higher than previously reported for samples of 
caregivers (Roepke et al. 2008).  Interestingly, younger caregivers reported higher depression 
and anxiety symptoms, perceived stress and caregiving burden than the older caregivers 
(Table 2).   
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     Table 1.  Demographic characteristics and health behaviours of young and old, caregivers and controls.  
 Young Older 
 Caregivers  
(N = 53) 
Controls  
(N = 33) 
 
 
Caregivers  
(N =40) 
Controls  
(N =42) 
 
 
 N (%) / Mean (SD) p N (%) / Mean (SD) p 
Age (years) 38.3 (4.78)a 40.1 (5.44) .10 69.3 (5.81) 72.4 (5.42) .06 
Age of child/spouse (years) 7.4 (3.70) 7.2 (4.54) .85 72.3 (8.06) 73.1 (6.04) .63 
Gender (Female) 38 (69) 21 (62) .55 26 (65) 19 (45) .07 
Marital status (Partnered) 47 (89)a 30 (88) .95 40(100) 42(100) - 
Ethnicity (Caucasian) 50 (93) 27 (79) .07 38 (97) 39 (93) .33 
Occupational status (non-manual) 40 (85)a 31 (94) .22 22(63) 32 (80) .10 
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In full time work   21 (47)a 19 (63) .16 3 (8) 1 (4) .53 
Taking medications 5 (9)a 7 (21) .14 33 (80) 29 (74) .51 
Alcohol intake (daily or more) 14 (26) 1 (3) .005 10 (28) 12 (30) .83 
Smokers 10 (19)a 2 (6) .10 1 (3) 3 (7) .36 
Body Mass Index  26.4 (4.89) 24.5 (3.58) .06 26.3 (3.08) 26.1 (4.37) .82 
Exercise score  5.5 (4.99)a 6.4 (5.44) .45 3.5 (3.16) 5.2 (3.71) .04 
Fruit and vegetable consumption score  8.2 (2.83)a 8.8 (2.36) .25 9.7 (2.46) 10.3 (2.85) .31 
Fat consumption score  11.1 (3.31)a 10.9 (3.72) .76 9.5 (3.62) 10.2 (3.91) .46 
  ap < .05 between younger caregivers and older caregivers 
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    Table 2.  Caregiving and psychosocial characteristics of young and old, caregivers and controls. 
 Young Older 
 Caregivers  
(N = 53) 
Controls  
(N = 33) 
 Caregivers  
(N = 40) 
Controls  
(N = 42) 
 
 
 Mean (SD) p Mean (SD) p 
Hours spent caregiving per day 
minus supervision 
4.8 (4.15) 2.9 (3.23) .03 3.6 (3.28) - - 
Sleep quality score  8.4 (3.13) 6.7 (3.15) .02 8.1 (3.47) 6.2 (3.80) .02 
HADS anxiety score  10.4 (3.52)a 6.4 (2.85) <.001 7.7 (4.96) 4.1 (3.93) <.001 
HADS depression score  8.6 (3.04)a 4.2 (3.67) <.001 6.0 (3.94) 2.8 (2.61) <.001 
Perceived stress score (PSS)  30.8 (5.56)a 23.5 (6.59) <.001 24.0 (8.21) 16.4 (7.83) <.001 
72 
 
Social support score (SFS)  31.9 (7.99) 38.6 (9.62) .001 33.6 (11.18) - - 
Caregiver burden score (BI)  26.3 (7.67)a 13.7 (6.69) <.001 21.0 (8.62) - - 
Child behaviour problems (SDQ) 18.8 (4.64) 7.2 (3.99) <.001 - - - 
Pearlin problematic behaviour (PPB) - - - 22.9 (5.89) - - 
Social support score (MOS) - - - 63.1 (18.66) 86.0 (11.34) <.001 
     
ap < .05 between younger caregivers and older caregivers 
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3.4.3 Neutrophil function across all groups 
For neutrophil phagocytic ability, there was a main effect of age, F(1,167) = 49.81, p < 
.001, η2 = .230, such that older adults had a higher PI , but no main effect of caregiving, 
F(1,167) = 3.62, p  = .06, η2 = .021, and no caregiving * age interaction effect, F(1,167) 
= .53, p  = .47, η2 = .003.  These data are shown in Figure 1A.  Repeated analyses with 
adjustment for health behaviours that differed between the groups (alcohol intake in 
young; exercise level in the older group) revealed the same significant main effect of age, 
p < .001.  
For neutrophil superoxide production, there was a main effect of age, F(1,164) = 12.23, p 
= .001, η2 = .069, and caregiving, F(1,164) = 4.98, p  = .03, η2 = .029, such that older 
participants and caregivers had significantly higher superoxide production.  However, 
there was no caregiving * age interaction effect, F(1,164) = 0.18, p  = .67, η2 = .001, see 
Figure 1B.  Repeated analyses with adjustment for covariates revealed only a main effect 
of age, p = .001.
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Figure 1. Neutrophil function in response to bacteria E.coli in young and 
old, caregivers and controls.  A. Neutrophil phagocytosis of E.coli 
presented as phagocytic index (PI, number of bacteria ingested per 
neutrophil). B. Neutrophil reactive oxygen species (ROS) production 
presented as mean fluorescence intensity (MFI).  Error bars are standard 
errors of the mean (SEM) and * indicates p < .05.  
B 
             * 
              * 
A 
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3.4.4. Serum steroid hormone concentrations 
Due to the skew of the data for serum hormones and their ratios, these were log 
transformed for the analyses, but their raw values are presented in the figures.  For 
cortisol, there was a main effect of age, F(1,160) = 5.65, p = .02, η2 =.034, such that 
participants in the older group had higher concentrations of this hormone.  However, 
there was no main effect of caregiving, F(1,160)=.021, p = .88, η2 = .000, nor a 
caregiving * age interaction effect, F(1,160) = .516, p = .47, η2 = .003, as shown in 
Figure 2A.  Repeated analyses with covariate adjustment also revealed an age effect, p = 
.03.  For DHEAS, as expected, there was a main effect of age, F(1,156) = 109.52, p < 
.001, η2 =.412, with older adults showing lower levels.  There was no main effect of 
caregiving, F(1,156) = 1.15, p = .28, η2 = .007, nor  caregiving * age interaction, F(1,156) 
= 3.14, p = .08, η2 = .020 (Figure 2B). After covariate adjustment the main effect of age 
remained significant, p < .001.  The cortisol:DHEAS ratio showed a significant effect of 
age, F(1,154) = 120.44, p < .001,  η2 =  .440, with older adults having a higher ratio, but 
no main effect of caregiving, F(1,153) = .16, p = .25, η2 = .009, nor a caregiving * age 
effect, F(1,153) = .181, p = .21, η2 = .010, as presented in Figure 2C.  Repeated 
subsequent analyses including the covariates for both young and old showed a similar 
main effect of age, p < .001.  For the cortisol:cortisone ratio, there was no age effect, 
F(1,160) = 1.51, p = .22, η2 = .009, but both a main effect of caregiving, and a significant 
caregiving * age interaction effect were present, F(1,160) = 15.48, p < .001, η2 = .088, 
and F(1,160) = 19.88, p < .001, η2 = .111, respectively, Figure 2D.  Pairwise 
comparisons revealed significant differences between caregivers and controls in the 
younger group, p < .001, with higher ratio present in younger caregivers, but no 
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difference between older caregivers and controls, p = .34.  Covariate analyses revealed 
analogous main, p < .001, and interaction effects, p =.001.   
3.4.5. Psychological factors and immunity and hormones within caregivers 
Analysis within all caregiving participants showed that caregivers with higher anxiety, 
r(87) = -.34, p  = .001, depression, r(87) = -.31, p  = .003, perceived stress, r(87) = -.34, p  
= .001, and caregiving burden, r(87) = -.37 p  < .001, exhibited significantly lower 
neutrophil phagocytic ability.  No such relationships emerged for neutrophil superoxide 
production, but caregivers with poorer sleep quality had lower oxidative burst activity, 
r(85) = -.23, p  = .03.  Correlations between questionnaire scores and hormones within 
the caregiving participants revealed that among older caregivers lower DHEAS was 
recorded in those with higher anxiety symptomatology (r(35) = -.42, p = .01) and 
perceived stress (r(35) = -.33, p = .05), while higher cortisol:DHEAS ratio was seen in 
those who reported higher anxiety symptoms (r(35) = .34, p = .04).
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Figure 2. Serum stress hormone concentrations in young and old, caregivers 
and controls.  A. Serum cortisol concentrations in nmol/l. B. Serum DHEAS 
concentration in µmol/l. C. Cortisol:DHEAS ratio. D. Cortisol:cortisone 
ratio.  Error bars are SEM and * indicated p < .05.  
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3.4.5. Sensitivity analysis 
Given the lack of effects of caregiving status per se, but the correlations with several of 
the psychological variables, regression analyses were conducted within the caregivers 
alone, predicting neutrophil functions from the significant psychological variables that 
emerged in the correlation analyses with adjustment for chronological age to use the full 
range of age data.  For phagocytic ability, anxiety, β = -.21, p = .036, ∆R2 = .038, and 
caregiver burden, β = -.24, p = .014, ∆R2 = .052, were significant predictors, whereas 
depression, β = -.14, p = .16, ∆R2 = .017, and perceived stress, β = -.15, p = .14, ∆R2 = 
.019, were not, following adjustment for age.  For oxidative burst activity, sleep quality 
adjusted for age significantly predicted neutrophil oxidative burst activity, β = -.24, p = 
.025, ∆R2 = .055. 
 
3.5. DISCUSSION 
In the present study, caregivers and controls differed, as expected, on the majority of 
psychosocial and caregiving variables.  Despite this, neutrophil function of caregivers 
was comparable to that of the controls.  The significant effects observed were for age; 
unexpectedly, older adults had higher phagocytosis and oxidative burst activity than the 
participants from the younger groups.  This ageing effect was contrary to what might be 
expected, as previous research including from our own group, mainly reports a decrease 
in neutrophil function due to immunosenescence (Butcher et al. 2001, Panda et al. 2009, 
Wenisch et al. 2000).  However, it is consistent with the previously reported increase in 
oxidative burst activity associated with ageing in other studies (Cannizzo et al. 2011, 
Tortorella et al. 2001).  It is possible, that the present older sample, in particular older 
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caregivers, was predominantly comprised of the participants who have very effective 
immune function which provides resilience and increased likelihood of survival into 
older age, despite the additional stress of their caregiving role.  In other words, what we 
are observing here could be a robustness of innate immunity with healthy ageing, and a 
continuing capacity to resist illnesses in general with the caregiving role.  This has 
previously been observed in reductions in cancer incidence in the oldest old, where 
phenotypic changes in NK and T cells as well as age-related changes in the production of 
pro-and anti-inflammatory cytokines, such as IFN-γ and IL-4, create unsuitable 
surroundings for neoplastic transformations  (Bonafe et al. 2001).  Thus, our older 
sample may have comprised individuals whose genetic and epigenetic predisposition 
have provided them with a robust immune response, giving them a chance to live to old 
age (Davey Smith 2011).  In addition, if we are observing a robustness of neutrophil 
function in the current older sample, then this is accompanied by a similar psychological 
resilience, as the overall scores for perceived stress, depression and anxiety 
symptomatology reported by the older adults were lower than those of the younger 
sample who were perhaps exhibiting a worse psychological response to their caregiving 
role (see Table 2).  Such psychological robustness in individuals aged over 64 years 
compared to younger groups has previously been reported (Gooding et al. 2012).   
Alternatively, the present results could also be interpreted as a support for the hypothesis 
that the innate immune system dominates in older age, and that immunosenescence is 
more evident in adaptive immunity (Franceschi et al. 2000).  However, caution is 
warranted here, as the observation that innate immunity is predominant in older age was 
observed among the oldest old and centenarians, whereas the mean age in the present 
older sample overall was 71 years.   
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The absence of a caregiving status effect on neutrophil function was not anticipated, but 
it is possible that this aspect of innate immunity, unlike adaptive immune function such 
as the response to vaccination (Gallagher et al. 2009a, Gallagher et al. 2009b), is not 
diminished by the chronic stress of caregiving.  It is also possible that the general 
immune integrity observed in the current caregiving sample is due to the method of 
assessing immunity.  Previous studies showing caregiving effects have used in vivo 
challenge of the immune response, e.g., vaccination (Gallagher et al. 2009a, Gallagher et 
al. 2009b, Glaser et al. 2000), and wound healing (Kiecolt-Glaser et al. 1995).  These in 
vivo methods demand an integrated immune response.  The present study, on the other 
hand, examined in vitro stimulation, without a systemic pathogenic challenge.  The 
negative impact of caregiving may be more readily observed in models where the 
immune system is challenged with pathogens in vivo.   
Interestingly, analysis within the caregiving participants indicated that those individuals 
with anxiety and caregiver burden had poorer neutrophil function, specific to 
phagocytosis.  For superoxide production, poorer sleep quality predicted poorer function.  
A negative association between chronic stress and neutrophil superoxide generation has 
been reported previously in the bereaved (Khanfer et al. 2011), who also showed high 
levels of depression and anxiety.  Among elderly hip fracture patients, only those who 
reported high levels of depression showed poorer neutrophil function, though again this 
was restricted to superoxide generation (Duggal et al. 2013a).  Similarly, poor sleep has 
been associated with alterations in immunity in a number of studies (Besedovsky et al. 
2012).  This suggests that while no overall detrimental effect of caregiving was seen in 
this study, individuals reporting higher psychological distress and suffering poorer sleep 
have poorer innate immune function.   
81 
 
Serum steroid hormone analyses revealed higher cortisol, lower DHEAS and higher 
cortisol:DHEAS ratio in the older sample overall, which is consistent with previously 
reported changes in hormone status with increasing age (Buford and Willoughby 2008).  
Comparable cortisol and DHEAS levels between caregivers and controls are perhaps 
surprising, as it is commonly accepted that chronic stress leads to the increase and 
decrease in these hormones, respectively (Epel et al. 2007).  However, exception to these 
findings, such as those that showed increased DHEA levels in depressed patients (Heuser 
et al. 1998), as well as those that suggested differential effects of stress on DHEAS 
dependent on the level of anxiety (Boudarene et al. 2002), suggest greater caution when 
studying the relationship between stress response and these hormones.  Further, the lack 
of increase in cortisol levels in caregivers could be the consequence of allostatic load, 
when due to a higher frequency of chronic stress exposure the body is shutting of 
endocrine parameters and preventing expected responses (McEwen 1998), increase in 
cortisol levels due to chronic stress of caregiving in this particular case.   
Younger caregivers also had a relatively high cortisol:cortisone ratio.  This ratio is an 
indicator of systemic 11β-HSD1 activity which in turn can be increased if pro-
inflammatory status is raised (Tomlinson and Stewart 2005). An increased serum 
cortisol:cortisone ratio has also been reported in surgical patients, probably as a 
consequence of the continuous HPA axis stimulation during the stress response (Vogeser 
et al. 2003).    
The study has a number of limitations.  First, sample size in each group can be regarded 
as small, but is of a similar magnitude to other caregiving studies (Gallagher et al. 2009a, 
Gallagher et al. 2009b, Vedhara et al. 2002).  Second, it could be argued that due to the 
high burden of the caregiving role, those worst affected by this type of chronic stress 
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would be less likely to participate in the study, making the current sample biased towards 
those that are healthier and cope better.  However, the attempt to minimise such bias was 
through organising home visits and accommodating the testing session to best suit 
individual caregivers’ needs even when they had high caregiver burden.  Further, the 
scores on the psychological measures suggested that our sample did have high caregiver 
stress and burden similar to previous caregiver studies where immune effects were seen.  
Third, steroid hormones are known to show diurnal variations in secretion and therefore 
it could be argued that single time point blood collections will not give the accurate 
representation of their concentration.  However, an attempt was made to overcome this 
issue by taking fasted morning blood samples.  Finally, inclusion of a further measure of 
innate immunity, such as NK cell function, might have strengthened the study although 
effects of stress on this have already been demonstrated in older caregivers.   
In conclusion, the neutrophil function in caregivers compared to controls overall was 
preserved, with the main differences emerging between young and old participants.  
Nevertheless, it should be noted that those caregivers who reported higher anxiety and 
burden levels, as well as poorer sleep quality, demonstrated poorer neutrophil function.  
Implications for future research are that studies should focus less on caregiving status in 
general, and more on individual differences among caregivers, specifically those with 
high levels of psychological morbidity.    
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CHAPTER 4 
 
T CELL IMMUNITY AND CAREGIVING STRESS 
IN YOUNGER AND OLDER CAREGIVERS 
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4.1. ABSTRACT    
Caregiving stress is a well established model for examining the impact of chronic stress on 
immunity.  The present study aimed to examine the impact of stress and ageing on parameters 
of T cell immunity and anti-CMV antibody titre using caregivers and controls across two age 
cohorts.  79 young and older caregivers (parents mean age 38 years of children with 
developmental disabilities and spousal dementia caregivers, mean age 70 years, respectively) 
were compared to 76 age- and sex-matched non-caregiving controls.  Participants completed 
questionnaires on a range of socio-demographic, health behaviour, psychosocial and 
caregiving variables, and provided a blood sample.  PBMCs were stored for assessment of T 
cell senescence and exhaustion markers and thymic output, and serum was used to measure 
anti-CMV antibody titre.  Despite greater psychological morbidity, seen as the greater 
depression, anxiety, and perceived stress than controls, caregivers showed robust immunity 
for most T cell parameters with the exception of the KLRG1+ (marker of T cell senescence) T 
cell pool, where caregivers and older participants showed higher numbers of T cells 
expressing this molecule.  In addition, amongst older caregivers, those who reported higher 
behavioural problems in care-recipients showed a greater senescent profile.  A higher 
percentage of KLRG1+ T cells in caregivers could explain their previously reported poorer 
immune response.  These data also suggest that the impact of caregiving per se on immunity 
is not uniform and greater attention should be paid to those with greater psychological 
morbidity.  
  
85 
 
4.2. INTRODUCTION 
Numerous adverse effects of chronic stress (e.g., caregiving or bereavement) on 
adaptive immunity have been reported in the past decades, see e.g. (Gouin et al. 2008, 
Glaser and Kiecolt-Glaser 2005, Powell et al. 2011, Cohen et al. 1991).  The immune 
system correlates of the negative effects of stress include reduced vaccination response 
(Vedhara et al. 1999, Glaser et al. 2000, Phillips et al. 2006a, Gallagher et al. 2009a, 
Gallagher et al. 2009b), poorer latent virus control (Pariante et al. 1997, Glaser and 
Kiecolt-Glaser 1997), thymic involution indicated by reduced output of naive T cells 
(Selye 1956), the shift from a cellular Th1 to a humoral Th2 phenotype by changes in 
cytokine expression (Marshall et al. 1998), and increased blood leukocytosis 
(Franchimont 2004).   
 
The adaptive immune system undergoes dramatic changes during the physiological 
ageing process.  These changes, termed immunosenescence, have been well 
documented, for reviews see (Gruver et al. 2007, Miller 1999, Weng 2006), and include 
both a decrease in the number of newly produced naive T cells (Fagnoni et al. 2000, 
Hale et al. 2006, Gruver and Sempowski 2008), as well as a shift from naive T cells 
towards a higher number of longer lived memory T cells, in particular CD8+ T cells as 
the peripheral memory T cell pool expands to maintain homeostasis (Pawelec 2007).  
The established means of quantifying thymic output and naive T cell production is 
through the number of cells expressing TREC, stable extrachromosomal DNA 
fragments created during T cell receptor (TCR) formation (Kong et al. 1998) in the 
process of somatic rearrangement during T cell maturation (Abbas and Janeway 2000, 
Janeway et al. 2001).  In addition, ageing is accompanied by many phenotypic and 
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functional alterations in T cell subsets.  For example, expression of CD28 antigen, a co-
stimulatory molecule necessary for T cell activation (Lenschow et al. 1996), is 
decreased during ageing (Boucher et al. 1998), with implications for longevity of 
vaccination responses and maintained resistance to latent infection such as Varicella 
zoster.  Further, an increase in the subsets of senescent CD28-CD57+ lymphocytes with 
normal ageing has been noted (McNerlan et al. 1998, Merino et al. 1998, Onyema et al. 
2012).  CD57 is present on terminally differentiated T lymphocytes and is considered as 
a marker contributing to T cell senescence (Brenchley et al. 2003) and indicative of the 
increase in activation-induced apoptosis (Focosi et al. 2010).  It has been shown that 
oligoclonally expanded CD8+ T lymphocytes are predominantly enriched with the 
CD28-CD57+ subset (Wood et al. 2009, Morley et al. 1995).  PD-1, a receptor that plays 
an inhibitory role during T cell activation (Jin et al. 2011), and is important in T cell 
exhaustion (Wherry 2011) is also present more frequently on aged T lymphocytes 
(Lages et al. 2010).  Finally, another inhibitory receptor that is commonly considered a 
marker contributing to T cell senescence, co-inhibitory cadherin KLRG1 (Grundemann 
et al. 2006, Henson and Akbar 2009) also shows increased expression in T cells from 
older donors (Vasto et al. 2007).  Interestingly, it has been shown that blockade of 
KLRG1 leads to restoration of proliferative function by a mechanism that involves the 
phosporylation and activation of Akt protein kinase (Henson et al. 2009), suggesting 
KLRG1 as a regulator involved in both exhaustion and senescence-related pathways 
(Akbar and Henson 2011).  The implications of these changes in both cell senescence 
and cell exhaustion are a negative impact on the functional capacity of memory T cells, 
weakening at the same time the integrity of the immune response overall and thus 
resistance to infection (Akbar and Henson 2011).    
87 
 
 
Another important contributor to immunosenescence is CMV (Pawelec et al. 2005).  
CMV is a latent virus belonging to the Herpesviridae family with the ability to remain 
silent until inflammatory factors and weakened immune surveillance trigger its 
activation (Hahn et al. 1998).  This virus is believed to direct the restructuring of the 
lymphoid subsets in the periphery, seen as the increase in the effector memory T cell 
pool and the reduction in the naive T cells in those who are CMV-seropositive 
(Chidrawar et al. 2009).  As a result, the presence of chronic viral infections such CMV 
leads to the accumulation of T cells with a senescent and exhausted profile namely a 
CD28−CD57+KLRG1+ phenotype (Weng et al. 2009, Derhovanessian et al. 2009). 
 
Until recently, there has been a consensus that caregivers, regardless of their age, 
experience poorer immunity than non-caregiving age-matched controls (Kiecolt-Glaser 
et al. 1991b, Esterling et al. 1994, Kiecolt-Glaser et al. 1996, Glaser and Kiecolt-Glaser 
1997, Vedhara et al. 1999, Gallagher et al. 2009a, Gallagher et al. 2009b).  In the 
previous chapter, however, it was demonstrated that caregivers, both young and older, 
displayed robust neutrophil function, compared to matched controls, observed as the 
ability to phagocytose bacteria and produce ROS.  Indeed, these functions of the innate 
immune system were only diminished in those caregivers with higher psychological 
morbidity, as reported in chapter 3. The present analysis extends our previous 
observations in innate immunity by examining associations between caregiving stress, 
ageing, and T cell immunity using four different participant groups: younger parental 
caregivers of children with developmental disabilities and age- and sex-matched 
parental controls of typically developing children; older spousal dementia caregivers, 
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and age- and sex-matched healthy non-caregiving older adults.  This four-group 
comparison allows us to examine the effects of caregiving stress on T cell immunity 
with and without the effect of ageing.   
 
Focussing on adaptive immunity and specifically T cell immunity, this study examined 
TREC expression as a marker of thymic output and expression of markers that 
contribute to the senescent and exhaustion profile of T cells. It also aimed to determine 
whether any of the previously described psychological or caregiving-specific variables, 
such as depression, anxiety, caregiving burden, social support or behaviour of care-
recipients were related to a more immunosenescent profile within the caregiver group.  
It was expected that caregivers, and particularly older caregivers would show the 
greatest evidence of immunosenescence, and that those with worse psychological 
morbidity would have greater expression of the molecules that are part of the T cell 
senescence and exhaustion pathways as well as reduced TREC frequency.  Finally, by 
measuring CMV serostatus and anti-CMV antibody titre, the study aimed to ascertain if 
any group differences were driven by the presence of this chronic latent viral infection. 
 
4.3. METHODS 
4.3.1. Participants  
The data presented here are from 39 young parental caregivers and 34 age- and sex-
matched control parents, and of 40 older spousal caregivers and 42 matched controls.  
Inclusion criteria for the younger parental group were to have a child aged between 3 
and 18 years, living at home.  The young caregiver group consisted of 11 parents of a 
child with Smith-Magenis syndrome (28%), 21 parents with at least one child with 
89 
 
Fragile X syndrome (54%), and seven parents of a child with Cornelia de Lange 
syndrome (18%).  Parents of children with a developmental disability were mainly 
recruited via syndrome group events.  Control parents of typically developing children 
were recruited via local advertisements.  Older caregivers were aged 60+ years and full 
time carers of a spouse/partner with a diagnosis of dementia, recruited via NHS trusts 
across England; older controls were recruited through the Birmingham 1000 Elders 
group of healthy older adults 
(http://www.birmingham.ac.uk/research/activity/mds/centres/healthy-
ageing/elders.aspx).  Exclusion criteria were: taking immunosuppressive drugs, 
suffering from an ongoing chronic immune-related disease (e.g. cancer, diabetes, 
rheumatoid arthritis); and pregnancy in the younger group.   
4.3.2. Study design and procedure 
This was a cross-sectional study where participants attended a one off session at which 
they completed a questionnaire pack, and provided a blood sample to determine markers 
of T cell exhaustion and senescence, and thymic output, as well as serum CMV antibody 
titre.  Informed written consent was obtained prior to study participation, and the study 
was approved by the local NHS ethics committee. 
4.3.3. Questionnaires 
Health behaviours were assessed using a questionnaire adapted from the Whitehall II 
study (Marmot et al. 1991), as described in chapter 2.  HADS (Zigmond and Snaith 
1983), PSS (Cohen et al. 1983b), and BI (Bedard et al. 2001), were used to determine 
psychological morbidity while social support availability was examined using the SFS 
(Dunst et al. 1988).  Finally, children’s challenging behaviour was assessed through SDQ 
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(Goodman 1997) in the younger group, while the PPB (Pearlin et al. 1990) subscale was 
administered to older caregivers to report on the frequency of dementia-related 
behaviours in their spouse/partner. 
4.3.4. Blood sampling and assays 
Blood sampling 
Venous blood was collected between 9-11 a.m. pre-prandially, from an ante-cubital vein into 
two 6ml heparin tubes.  PBMCs were isolated by the standard density gradient centrifugation 
using Ficoll-PaqueTM PLUS (GE Healthcare, Upsala Sweden), following the supplier's 
protocol, aliquoted and stored in a freezing medium consisting of heat inactivated foetal calf 
serum (Sera Laboratories International, Sussex, UK) and 10% (v/v) dimethyl sulfoxide 
(DMSO), to allow recovery of frozen PBMCs that are functional.   
Immunostaining for senescent and exhausted profile of T cells 
Immunostaining was conducted by staining isolated PBMCs with a combination of 
fluorochrome-conjugated anti-human antibodies and consequent multicolour flow cytometry 
analysis, using CyAnADPTM cytometer (Dako, Cambridgeshire, UK).  Optical alignment, 
sensitivity and linearity of the instrument were performed once per week.  Appropriate 
isotope controls were used for setting the gates and compensation was conducted before each 
experiment electronically by Summit software using single stained cells.  Anti-human 
antibodies used for staining were as follows: CD3 PE-Cyanine7 (clone UCHT1, ebiosciences, 
Hatfield, UK), CD4 eFluor® 450 (clone OKT4, ebiosciences, Hatfield, UK), CD8 PE (clone 
UCHT-4, ImmunoTools GmbH, Friesoythe, Germany), for defining CD3+CD4+ and 
CD3+CD8+ cells as appropriate; and CD28 APC (clone CD28.2, BD Pharmingen, UK), CD57 
FITC (clone HCD57, BioLegend, Cambridge BioScience, UK), PD-1 APC (clone eBioJ105 
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(J105), ebiosciences, Hatfield, UK), and KLRG1 FITC (clone 2F1/KLRG1, BioLegend, 
Cambridge BioScience, UK) for further characterisation of senescence/exhaustion-related 
markers.  Cells were then washed and re-suspended in PBS/BSA for flow cytometric analysis.  
At least 15000 events were acquired within the lymphocyte gate for each sample and 
appropriate gating was used to distinguish between live and dead cells.  Further phenotyping 
was conducted on CD3+CD4+ and CD3+CD8+ cells.  T cell senescent profiles were 
characterised by the absence of CD28 and/or presence of CD57 marker, and exhaustion profile 
was assessed by PD-1 expression, in CD4+ and CD8+ T-cells separately.   In addition, 
KLRG1+ T cells were separately examined as potentially involved in both senescence- and 
exhaustion-related pathways.  Data are presented as the percentage of antigen positive cells.  
Data analyses were conducted using Summit v4.3 software (Dako, Fort Collins, CO, USA).   
Thymic output analysis 
Thymic output was assessed through the TREC analysis, where low TREC expression 
ratio indicates lower thymic output of naïve T-cells (Douek et al. 1998, Hazenberg et al. 
2001).  DNA was isolated from PBMCs using a QIAamp DNA Blood Mini Kit 
(Quiagen) following the supplier’s protocol and eluted in 50µl of DNA elution buffer.  
DNA concentration and purity was subsequently measured using a NanoDrop™ 
spectrophotometer and only those samples with 260/280 and 260/230 ratio above 1.8 
were used.  Aliquots of 200ng of DNA were used for quantitative (q)PCR analysis.  
QPCR was performed on a Real Time PCR Roche LC480 sw1.5 light cycler using 
TaqMan probes.  Reaction volume consisted of forward and reverse primers in final 
concentration of 0.5 µM and probes in final concentration of 0.2 µM for both TREC and 
control gene, 2xTaqMan Master Mix from LightCycler 480 Probes Master Mix (Roche, 
UK) in final reaction volume of 20 µl per sample made using nuclease-free water 
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(Roche, UK).  The primer sequences for TREC were 5′-
CACATCCCTTTCAACCATGCT′ for forward and 5′-GCCAGCTGCAGGGTTTAGG-
3′ for reverse primer (Mitchell et al. 2010), and 
ACACCTCTGGTTTTTGTAAAGGTGCCCACT for fluorescent sequence-specific 
probe.  Primers were dissolved in the quantity of provided buffer to yield 100pmol/µl, 
then aliquoted and stored at -20°C.  For normalisation, a referent gene was used which 
represent the constant region of the T cell receptor with 5'-
CCTGATCCTCTTGTCCCACAG-3' forward and 5'-
GGATTTAGAGTCTCTCAGCTGGTACA-3' reverse primer as well as 5'-
ATCCAGAACCCTGACCCTGCCG-3' probe.  Samples were run in triplicate and 
average Ct value was calculated for both TREC and reference gene.  Rather than 
calculating exact number of copies of TREC per number of T cells for every sample, the 
method for relative quantification of TREC was developed which determines TREC 
status comparing to the calibrator (a 23 year old male) using the formula for the Pfafl 
method: Ratio = (Etarget gene = TREC)∆Ct, TREC (calibrator – sample of interest)/(Ereferent gene=gene for a constant T 
cell receptor region )∆Ct, referent gene (calibrator – sample of interest), where E is amplification efficiency of 
particular DNA fragment, and Ct is the threshold cycle or cycle number at which enough 
amplified product accumulates to produce measurable fluorescence signal (Pfaffl 2001).  
The lower the expression ratio, the higher the decrease of the TREC gene in the test 
sample when compared to the calibrator. 
CMV serum antibody titre 
For the evaluation of CMV antibody titre, a standardised CMV ELISA developed by the 
Antiviral Immunology lab, Cancer Sciences, University of Birmingham was used as 
previously reported (Savva et al. 2013, Wall et al. 2013), and described in detail in 
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chapter 2.  As before, the standard curve measured up to 1000 arbitrary units of IgG and 
those with more than 10 units were considered CMV positive. 
4.3.5. Statistical analyses  
Where data for the absolute numbers, percentage of T cells and TREC expression ratio 
used in the analyses were skewed, these values were log transformed.  Tests of the main 
effects of age and caregiving status as well as caregiving * age interaction effects on T 
cell markers related to the senescence (CD28, CD57 and KLRG1) and exhaustion (PD-
1), TREC and serum CMV antibody titre were examined using ANOVA, with partial eta-
squared as the measure of effect size throughout.  Demographic, health behaviour 
variables, and in the case of absolute numbers and percentage of T cells used in the 
analyses, a number of CD3+ cells that were significantly different between the groups 
(determined by chi-square and ANOVA), were controlled for in further ANCOVAs run 
for each immune outcome.  In addition, analyses were re-run using CMV status as a 
covariate to ascertain if any of the effect that emerged was driven by the presence of 
CMV infection.  CMV seropositive subset of participants was then divided into two 
groups using median split of anti-CMV antibody titre to examine the relation to the 
parameters of T cell immunity.  Finally, correlations were used within the caregiver 
group to ascertain whether or not psychosocial and caregiving variables were associated 
with immune outcomes. 
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4.4. RESULTS 
4.4.1. Demographic, health behaviour and psychosocial characteristics 
Descriptive statistics for demographic and health behaviour variables for each group are 
presented in Table 1.  Briefly, caregivers and controls in the younger and sample were 
comparable on all demographics and health behaviours, with the exception of the 
ethnicity (p = .02), and the frequency of the alcohol consumption (p=.01) in young, with 
caregivers more likely to be White and to drink alcohol on a daily basis than control 
parents (p = .03).  The only difference between the older groups was the exercise score (p 
= .04), with controls being more active than caregivers.   
Psychosocial characteristics between caregivers and controls in both groups were 
significantly different in the expected direction; caregivers reported higher depression, 
anxiety, perceived stress, and lower social support.  Caregiving burden was also higher in 
younger caregivers than controls, while older caregivers scored high on this scale 
according to the reported cut off of 17 (Bedard et al. 2001).  This questionnaire was not 
administered to older controls as they were not caregiving for their spouse/partner.  For 
problematic behaviour of care-recipients, younger parental caregivers reported more 
problems than control parents while older spousal dementia caregivers reported high 
scores on the Pearlin scale higher than those previously reported in caregivers (Roepke et 
al. 2008). 
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Table 1.  Demographic characteristics, health behaviours and psychosocial variables of each group.  
 Young Older 
 Caregivers  
(N = 39) 
Controls  
(N = 34) 
 
 
Caregivers  
(N =40) 
Controls  
(N =42) 
 
 
 N (%) / Mean (SD) p N (%) / Mean (SD) p 
Age (years) 38.7 (4.78) 40.1 (5.44) .26 69.3 (5.81) 72.4 (5.42) .06 
Age of child/spouse (years) 7.6 (3.63) 7.2 (4.54) .66 72.3 (8.06) 73.1 (6.04) .63 
Gender (Female) 25 (64) 21 (62) .84 26 (65) 19 (45) .07 
Marital status (Partnered) 33 (89) 30 (88) .90 40(100) 42(100) - 
Ethnicity (Caucasian) 36 (97) 27 (79) .02 38 (97) 39 (93) .33 
Occupational status (non-manual) 30 (88) 31 (94) .41 22(63) 32 (80) .10 
In full time work   15 (48) 19 (63) .24 3 (8) 1 (4) .53 
Chronic illness (no) 35 (95) 29 (85) .19 21 (55) 17 (42) .26 
Taking medications 2 (6) 7 (21) .06 33 (80) 29 (74) .51 
Alcohol intake (daily or more) 10 (27) 1 (3) .01 10 (28) 12 (30) .83 
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Smokers 5 (14) 2 (6) .30 1 (3) 3 (7) .36 
Hours of sleep (> 7 hours) 6 (17) 3 (9) .38 7 (19) 8 (21) .86 
Body Mass Index  25.8 (4.65) 24.5 (3.58) .21 26.3 (3.08) 26.1 (4.37) .82 
Exercise score  5.2 (4.30) 6.4 (5.44) .29 3.5 (3.16) 5.2 (3.71) .04 
Fruit/vegetable consumption score  8.6 (2.75) 8.8 (2.36) .70 9.7 (2.46) 10.3 (2.85) .31 
Fat consumption score  11.5 (2.94) 10.9 (3.72) .44 9.5 (3.62) 10.2 (3.91) .46 
HADS anxiety score  10.4 (3.85) 6.4 (2.85) <.001 7.7 (4.96) 4.1 (3.93) <.001 
HADS depression score  8.5 (3.18) 4.2 (3.67) <.001 6.0 (3.94) 2.8 (2.61) <.001 
Perceived stress score  30.2 (5.68) 23.5 (6.59) <.001 24.0 (8.21) 16.4 (7.83) <.001 
Social support score (SFS)  31.6 (7.17) 38.6 (9.62) .001 33.6 (11.18) - - 
Caregiver burden score (BI)  26.0 (7.82) 13.7 (6.69) <.001 21.0 (8.62) - - 
Child behaviour problems (SDQ) 19.6 (4.62) 7.2 (3.99) <.001 - - - 
Pearlin problematic behaviour - - - 22.9 (5.89) - - 
CMV seropositive 13(34) 19 (59) .04 24 (63) 27 (64) .92 
CMV antibody titre     82.2 (178.75) 158.7 (223.34) .63 200.2 (261.08) 169.9 (190.07) .45 
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4.4.2. Immunostaining for exhausted and senescent profile of T cells 
For CD3+ cell numbers, there was no main effect of age, F(1,140) = 3.08, p = .08, η2 = 
.022, no caregiving * age interaction effect, F(1,140) = 0.325, p = .57, η2 = .002, but 
there was a main effect of caregiving, F(1,140) = 7.97, p = .005, η2 = .054, such that 
caregivers had higher numbers (Figure 1B).  Subsequent analyses with the covariate 
adjustment (ethnicity, alcohol intake, and exercise) confirmed this main effect of 
caregiving (p = .005).  Therefore, CD3+ cell number was treated as a covariate in 
subsequent analyses.  
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Figure 1. CD3+ cell count.  A) Representative flow cytometry scatter plot 
of CD3+ cells. B) CD3+ cell count in old (n = 35) and young (n = 38) 
caregivers, and old (n = 40) and young (n = 31) controls. 
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CD3+T cells that do not express/express the CD28 co-stimulatory molecule  
For CD4+CD28- T cell count there was no main effect of age, F(1,140) = 1.37, p = .24, η2 = 
.010, or caregiving, F(1,140) = 1.16, p = .28, η2 = .008, nor a caregiving * age interaction 
effect, F(1,140) = 0.56, p = .46, η2 = .004 (Figure 2C).  Repeated subsequent analyses with the 
covariate adjustment (CD3+ cell count, ethnicity, alcohol intake and exercise) confirmed this.  
For the percentage of CD4+CD28- T cells, there was no main effect of age, F(1,140) = 1.05, p 
= .31, η2 = .007, no main effect of caregiving, F(1,140) = 2.07, p = .15, η2 = .015, nor a 
caregiving * age interaction effect, F(1,140) = 0.16, p = .75, η2 = .001 (Figure 2D).  Repeated 
analyses with the adjustment for covariates did not alter these results.   
For CD8+CD28- T cell counts there was a main effect of age, F(1,140) = 12.69, p = .001, η2 = 
.083, such that older participants had higher numbers of these cells, but no main effect of 
caregiving, F(1,140) = 1.80, p = .18, η2 = .013, nor caregiving * age interaction effect, 
F(1,140) = 0.72, p = .79, η2 = .001, see Figure 2E.  Repeated analyses with adjustment for 
covariates confirmed the main effect of age (p < .001), but revealed the main effect of 
caregiving, such that caregivers unexpectedly had lower numbers of these cells than controls 
(p = .03).  For CD8+CD28- T cell frequency there was a main effect of age, F(1,140) = 22.94, 
p < .001, η2 = .141, and caregiving, F(1,140) = 5.27, p = .02, η2 = .036, such that participants 
in the older group and controls had a higher percentage of CD8+CD28-  cells.  However, there 
was no caregiving * age interaction effect, F(1,140) = 0.36, p = .55, η2 = .003.  Pairwise 
comparisons revealed that the difference within the younger group was the main driver of the 
caregiving effect, Figure 2F.  Repeated analyses with adjustment for covariates revealed the 
same significant main effect of age (p < .001), and caregiving (p = .02).
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For the numbers of CD3+ CD4+ cells that express the CD28 co-stimulatory molecule, there 
was no main effect of age, F(1,140) = 0.29, p = .59, η2 = .002, but there was a main effect of 
caregiving, F(1,140) = 11.55, p = .001, η2 = .076, and caregiving * age interaction effect, 
F(1,140) = 4.63, p = .03, η2 = .032 (Figure 3A).  Repeated subsequent analyses with the 
covariate adjustment revealed only a significant caregiving * age interaction effect (p = .001), 
such that older caregivers had highest numbers.  For the percentage of these cells, there was 
no main effect of age or caregiving, nor caregiving * age interaction effect, F(1,140) = 0.87, p 
= .35, η2 = .006, F(1,140) = 1.99, p = .16, η2 = .014, F(1,140) = 1.73, p = .19, η2 = .012, 
respectively, and this was further confirmed after covariate adjustment analyses (Figure 3B). 
For CD8+ CD28+ cell numbers, there was a main effect of age, F(1,140) = 49.79, p < .001, η2 
= .262, and caregiving, F(1,140) = 6.61, p = .01, η2 = .045, such that younger participants and 
caregivers had more of these cells, but no caregiving * age interaction effect, F(1,140) = 0.17, 
p = .90, η2 = .000 (Figure 3C).  Repeated subsequent analyses with the covariate adjustment 
revealed only the main effect of age (p < .001).  For the percentage of these cells, again main 
effects of age, F(1,140) = 35.35, p < .001, η2 = .202, and caregiving, F(1,140) = 10.68, p = 
.001, η2 = .071 were observed, such that younger adults and caregivers had higher percentage 
of these cells, but no caregiving * age interaction effect, F(1,140) = 0.74, p = .39, η2 = .005 
(Figure 3D). Repeated subsequent covariate analyses confirmed both main effects of age and 
caregiving (p < .001 and .03, respectively). 
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  Figure 3. CD3+ cells that express CD28 marker.  CD4+CD28+ T cells in 
old (n = 35) and young (n = 38) caregivers, and old (n = 40) and young (n 
= 31) controls presented in A) Absolute numbers (103/ml) and B) 
percentages.  CD8+CD28- T cells in old (n = 35) and young (n = 38) 
caregivers, and old (n = 40) and young (n = 31) controls presented as C) 
Absolute numbers (103/ml) and D) percentages. Data are presented as mean 
and SEM, and * indicated p < .05. 
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CD3+ cells that express the CD57 marker of T cell senescence  
For the CD4+CD57+ T cell count, there was a main effect of age, F(1,140) = 11.86, p = .001, 
η
2
 = .078, such that older adults had higher numbers of these cells, but no main effect of 
caregiving, F(1,140) = 0.09, p = .92, η2 = .000, nor caregiving * age interaction effect, 
F(1,140) = 0.168, p = .68, η2 = .001, as shown in Figure 4C.  Repeated ANCOVAs confirmed 
the main effect of age (p = .001).  For the CD4+CD57+ T cell percentage, there was a main 
effect of age, F(1,140) = 13.56, p < .001, η2 = .088, and caregiving, F(1,140) = 5.50, p = .02, 
η
2
 = .038, such that older participants and controls had a higher frequency of CD4+CD57+ 
cells, but there was no caregiving * age interaction effect, F(1,140) = 0.55, p = .46, η2 = .004, 
as shown in Figure 4D.  Repeated analyses with adjustment for covariates (CD3+ cell count, 
alcohol intake, ethnicity and exercise) confirmed only the main effect of age (p = .003).   
For CD8+CD57+ T cell numbers, there was a main effect of age, F(1,140) = 12.69, p = .001, η2 
= .083, such that participants from the older cohort had higher numbers of these cells, but no 
main effect of caregiving, F(1,140) = 1.80, p < .18, η2 = .013, nor caregiving * age interaction 
effect, F(1,140) = 0.72, p = .79, η2 = .001.  Repeated covariate analyses confirmed the main 
effect of age, and revealed a main effect of caregiving (p <.001 and .03, respectively), see 
Figure 4E.  For the percentage of these cells, there was a main effect of age, F(1,140) = 38.70, 
p < .001, η2 = .2815, such that older participants had higher percentage of CD8+CD57+  cells, 
but no main effect of caregiving, F(1,140) = 0.94, p = .34, η2 = .007, nor caregiving * age 
interaction effect, F(1,140) = 0.91, p = .34, η2 = .006 (Figure 4F).  Repeated analyses with the 
adjustment for covariates revealed the same main effect of age (p < .001). 
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Figure 4. CD3+ cells that express CD57 marker of T cell senescence.  
Representative flow cytometric plots demonstrating gating pattern for 
identification of CD3+ A) CD4+ and B) CD8+ CD57+ cells.   CD4+ CD57+ T cells 
in old (n = 35) and young (n = 38) caregivers, and old (n = 41) and young (n = 31) 
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KLRG1+T cells 
For CD4+KLRG1+ T cell numbers, there was no main effect of age, F(1,140) = 0.14, p = .71, 
η
2
 = .001, nor caregiving * age interaction effect, F(1,140) = 0.06, p = .81, η2 = .000, but there 
was a main effect of caregiving, F(1,140) = 6.69, p = .01, η2 = .047, such that caregivers 
overall had higher percentage of cells expressing this marker (Figure 5C).  Subsequent 
covariate analyses confirmed these findings (p = .04). For the percentage of CD4+KLRG1+ T 
cells there was no main effect of age, F(1,140) = 1.04, p = .31, η2 = .007, no effect of 
caregiving, F(1,140) = 3.15, p = .08, η2 = .022, and no caregiving * age interaction effect, 
F(1,140) = 0.94, p = .33, η2 = .007 (Figure 5D).  After covariate adjustment a main effect of 
caregiving emerged (p = .03) such that caregivers had a higher percentage of these T cells.   
For CD8+KLRG1+ T cell numbers, there was no main effect of age, F(1,140) = 3.02, p = .08, 
η
2
 = .021, nor caregiving * age interaction effect, but there was a main effect of caregiving, 
F(1,140) = 6.07, p = .02, η2 = .042, such that caregivers overall had a higher numbers of these 
cells.  After repeated analyses with covariate adjustment, the main effect of age emerged (p = 
.03), and the main effect of caregiving was confirmed (p = .04).  These details are presented 
in Figure 5E.  For the percentages of these cells, there was a main effect of age, F(1,140) = 
5.93, p = .02, η2 = .041, and caregiving, F(1,140) = 5.36, p = .02, η2 = .037, with older adults 
and caregivers having the higher percentage of CD8+KLRG1+ T cells, but no caregiving * age 
interaction effect, F(1,140) = 0.02, p = .87, η2 = 0.000.  These data are presented in Figure 5F.  
Covariate adjustment confirmed both main effects of age and caregiving (p = .01 and p = .02, 
respectively).   
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Figure 5. CD3+ cells expressing KLRG1 marker.  Representative flow cytometry 
describing gating method for detecting A) CD4+ and B) CD8+KLRG1+ within the 
CD3+ population. CD4+ KLRG1+ T cells in old (n = 35) and young (n = 38) 
caregivers, and old (n = 40) and young (n = 31) controls, presented in C) Absolute 
numbers (103/ml) and D) percentages. Under E and F are respective presentations 
of CD8+KLRG1+ T cells.  Data are mean ± SEM and * indicates p < .05. 
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T cells expressing PD-1 marker of exhaustion 
For CD4+PD1+ T cell count, there was a main effect of age, F(1,140) = 16.01, p < .001, 
η
2
 = .103, such that the older group had more of these cells, and a caregiving * age 
interaction effect, F(1,140) = 6.30, p = .01, η2 = .043, such that older caregivers had the 
highest number of these cells, but no main effect of caregiving, F(1,140) = 0.05, p = .83, 
η
2
 = .000.  Subsequent covariate analyses confirmed both main effects of age and 
caregiving * age interaction effect (p < .001 and .04, respectively), see Figure 6C.  For 
the percentage, there was a main effect of age, F(1,140) = 22.45, p < .001, η2 = .138, 
such that younger participants had lower percentage of T cells expressing this marker of 
exhaustion, but no main effect of caregiving, F(1,140) = 1.93, p = .17, η2 = .014, nor a 
caregiving * age interaction effect, F(1,140) = 0.38, p = .54, η2 = .003, as shown in 
Figure 6D.  Repeated analysis after adjusting for covariates revealed the same age effect 
(p < .001).   
For the number of CD8+PD1+ T cells, there was no main effect of age, F(1,140) = 2.79, p 
= .10, η2 = .020, no main effect of  caregiving, F(1,140) = 0.32, p = .57, η2 = .002, nor 
caregiving * age interaction effect, F(1,140) = 0.004, p = .95, η2 = .000, but after 
subsequent covariate analyses the main effect of age emerged (p = .02).  These data are 
presented in Figure 6E.  For the frequency of these cells, there was a main effect of age, 
F(1,140) = 17.72, p < .001, η2 = .112, such that older adults had higher percentage of T 
cells expressing this marker of exhaustion, but no main effect of caregiving, F(1,140) = 
0.05, p = .83, η2 = .000, nor caregiving * age interaction effect, F(1,140)= 0.68, p= .41, 
η
2
 = .005.  These effects are shown in Figure 6F.  Subsequent covariate analyses revealed 
the same age effect (p < .001).
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Figure 6. CD3+ cells expressing PD-1 marker of exhaustion. Percentage of T cells 
showing the expression of PD-1 marker of exhaustion.  Representative flow cytometry 
plot showing gating strategy for detection of A) CD4+PD-1+ and B) CD8+PD-1+ cells 
within CD3+ lymphocyte subset.  CD4+ PD1+ T cells in old (n = 35) and young (n = 
38) caregivers, and old (n = 40) and young (n = 31) controls, presented as C) Absolute 
numbers (103/ml) and D) percentages. E and F present corresponding values for 
CD8+PD-1+ T cells. Data are mean ± SEM, and * indicates p < .05. 
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              *             * 
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TREC levels 
There was a main effect of age on TREC levels, F(1,139) = 109.82, p < .001, η2 = 
.441, such that older participants had greater fold decrease of TREC when 
compared to the calibrator.  There was no main effect of caregiving, F(1,139) = 
3.25, p = .07, η2 = .023, nor was there caregiving * age interaction effect, F(1,139) 
= 1.48, p = .23, η2 = .011 (Figure 7).  Repeated analyses with covariate adjustment 
revealed the main effect of age (p <.001), but the trend for a caregiving effect 
disappeared completely (p = .30). 
 
 
 
 
 
 
 
 
 
 
Figure 7.  Thymic output presented as TREC expression ratio.  
Percentage of TREC expression ratio in old (n = 35) and young (n = 
39) caregivers, and old (n = 37) and young (n = 32) controls. Data are 
mean ± SEM and * indicates p < .05. 
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CMV seropositivity and serum antibody titre 
Overall, 83 (55%) of subjects were CMV positive, with the number of CMV positive 
being higher in the younger group, χ2(1) = 4.91, p = .03.  In the younger group, 32 (86%) 
were seropositive overall, with caregivers being less likely to be CMV positive, χ2(1) = 
4.43, p = .04.  In the older group 51 (64%) participants were CMV positive, and the 
presence of the CMV infection was similar between older caregivers and controls, χ2(1) 
= .01, p = .92.  Within the CMV positive subset (N = 82), for CMV antibody titre, there 
was no main effect of age, F(1,78) = 2.00, p = .16, η2 = .025, caregiving, F(1,78) = 0.66, 
p = .42, η2 = .008, nor caregiving * age interaction, F(1,78) = 0.21, p = .65, η2 = .003.  
Covariate analysis did not alter these results.  
Further, the analyses regarding T cell subsets expressing markers of senescence and 
exhaustion were re-run controlling for CMV serostatus as a covariate to determine if any 
of the effects were driven by CMV infection.  All main effects of age reported previously 
remained the same, while the caregiving effect for CD8+CD28- (p = .20), CD8+CD28+ (p 
= .17), as well as CD8+CD57+ (p = .20), disappeared.  On the other hand, the main effect 
of caregiving for T cells expressing the KLRG1 marker remained significant for both 
CD4+ (p = .01) and CD8+ (p = .02) T cells. 
Finally, median CMV titre was used for splitting CMV seropositive subjects into two 
groups with high versus low serological responses, and the comparison of T cell 
immunity parameters between the groups are presented in Table 2.  Interestingly, the 
groups were significantly different on almost all immune parameters with the exclusion 
of CD8+ T cells expressing the PD-1 marker of exhaustion. 
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Table 2.  T cell immunity parameters between CMV seropositive participants with high 
and low CMV titre, created using median split of CMV titre. 
 
High CMV titre Low CMV titre  
 
Mean (SD) p 
CD3+CD4+CD28- cells (number x 103/ml) 1.3 (1.23) 1.1 (0.73)  .07 
CD3+CD4+CD28- cells (%) 13.5 (12.52) 6.1 (7.39) < .001 
CD3+CD8+CD28- cells (number x 103/ml) 2.5 (1.56) 1.0 (0.76) < .001 
CD3+CD8+CD28- cells (%) 57.6 (18.39) 35.9 (18.23) < .001 
CD3+CD4+CD28+cells (number x 103/ml) 6.2 (2.67) 7.7 (2.52)  .001 
CD3+CD4+CD28+ cells (%) 80.1 (15.56) 88.3 (8.04) .001 
CD3+CD8+CD28+ cells (number x 103/ml) 1.9 (1.37) 2.1 (1.2) .12 
CD3+CD8+CD28+ cells (%) 42.3 (19.07) 61.5 (17.26) < .001 
CD3+CD4+CD57+cells (number x 103/ml) 1.0 (0.71) 0.5 (0.47) < .001 
CD3+CD4+CD57+ cells (%) 15.8 (12.11) 6.5 (6.48) < .001 
CD3+CD8+CD57+ cells (number x 103/ml) 2.5 (1.56) 1.0 (0.76) < .001 
CD3+CD8+CD57+ cells (%) 53.5 (20.76) 29.9 (18.00) < .001 
CD3+CD4+KLRG1+cells (number x 103/ml) 0.6 (0.59) 0.5 (0.83) .01 
CD3+CD4+KLRG1+ cells (%) 8.5 (8.61) 5.7 (9.95) < .001 
CD3+CD8+KLRG1+ cells (number x 103/ml) 1.0 (1.14) 0.6 (0.56) .03 
CD3+CD8+KLRG1+ cells (%) 23.5 (21.59) 18.4 (16.12) .43 
CD3+CD4+PD1+cells (number x 103/ml) 1.2 (0.81) 0.9 (0.39) .01 
CD3+CD4+PD1+ cells (%) 16.1 (9.51) 10.3 (5.17) < .001 
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CD3+CD8+PD1+ cells (number x 103/ml) 1.0 (0.72) 0.8 (0.43) .25 
CD3+CD8+PD1+ cells (%) 20.0 (11.27) 21.9 (9.4) .10 
TREC expression ratio 0.3 (0.34) .4 (.41) .03 
 
Psychological factors and immune parameters within caregivers in each group 
Within the caregiving group overall, analyses showed that caregivers who reported 
higher anxiety, depression, and stress levels, had lower percentage of CD57+ for both 
CD4+ and CD8+, and CD4+PD-1+ T cells, as well as higher expression ratio of TREC, see 
Table 3.  In addition, those with a higher burden index had a lower percentage of CD4+ T 
cells expressing PD-1 marker of exhaustion, as well as higher TREC expression ratio, 
Table 3.  Analysis within the caregiving participants in the younger group showed that 
caregivers who reported higher depression, anxiety, perceived stress, and burden levels, 
as well as more problematic behaviour in their child(ren), had a higher TREC expression 
ratio, detailed in Table 4.  In the older group, caregivers who reported higher problematic 
behaviour in their spouses/partners had higher percentage of CD8+CD57+ T cells, see 
Table 4. 
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Table 3.  Correlations between the T cell immunity and caregivers' psychosocial 
characteristics. 
 Caregivers overall (N=73) 
 
CD4+CD57+ (%)  CD8+CD57+ (%) CD4+PD-1+ (%) TREC 
HADS anxiety r(68) = -.25, 
p = .04 
ns r(68) = -.24, 
p = .05 
r(69) = .31, 
p = .01 
HADS depression r(68) = -.26, 
p = .03 
r(68) = -.24, 
p = .04 
r(68) = -.30, 
p = .01 
r(69) = .38, 
p = .001 
Perceived stress (PSS) r(68) = -.30, 
p = .01 
r(68) = -.31, 
p = .01 
r(68) = -.35, 
p = .003 
r(69) = .35, 
p = .003 
Caregiver burden score (BI) ns ns r(68) = -.25, 
p = .03 
r(69) = .32, 
p = .01 
*ns = non-significant correlation 
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Table 4.  Correlations between the T cell immunity and young/old caregivers' psychosocial 
characteristics. 
 Young  
(N=38) 
Old 
(N=35) 
 
TREC CD8+CD57+ 
   
HADS anxiety r(34) = -.34, p = .04 ns 
HADS depression r(35) = -.53, p = .001 ns 
Perceived stress r(35) = -.52, p = .001 ns 
Caregiver burden score (BI) r(35) = .44, p = .01 ns 
Child behaviour problems (SDQ) r(35) = .35, p = .03 - 
Pearlin problematic behaviour - r(32) = .42, p = .02 
*ns = non-significant correlation 
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4.5. DISCUSSION 
Psychosocial measures were significantly different and in the expected direction between 
the caregivers and controls in both young and old participants.  There was an age-related 
increase in the absolute number and frequency of the CD8+ CD28- subset but caregivers 
unexpectedly showed lower numbers of these cells than age- and sex-matched controls, 
with younger caregivers also having a lower frequency of these cells than controls.  
CD8+CD28+ T cells predictably showed age-related changes in the opposite direction 
than CD8+CD28- T cells, and a caregiving effect in favour of caregivers.  While age 
related differences were in agreement with previous reports (Fagnoni et al. 1996, Vallejo 
et al. 1999, Boucher et al. 1998), the apparent beneficial effect of caregiving effect is 
unexpected and novel.  The negative impact of CD28- CD8+ T cells on immunity is 
related to their loss of proliferative capacity due to the loss of the co-stimulatory signal 
from CD28 (Vallejo 2005) and resulting decreased tolerance (Bour-Jordan et al. 2011). 
The high percentages of CMV and EBV specific CD8+CD28- T cells in older adults 
(Weng et al. 2009) are also thought to compromise immunity by occupying 
immunological space leaving limited room for other T cell subsets to expand when new 
pathogens are encountered (Pawelec et al. 2005).  Accumulation of CD28- T cells with 
age has been attributed to repeated antigen stimulation, as T cell activation induces 
decreases in CD28 expression, through lifelong exposure to pathogens and the constant 
stimulation by chronic viral infections such as CMV, reviewed in (Vallejo 2005).  This is 
further confirmed by the increase in CD8+CD28- T cells with poor proliferative capacity 
in advanced HIV infection (Effros et al. 1996).  The present findings confirmed 
significantly higher numbers of these cells in the CMV positive participants with high 
CMV antibody titres, but with caregivers having lower incidence of CMV infection. 
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Therefore, a possible explanation for the lower levels of CD8+CD28- T cells in young 
caregivers is the significantly lower incidence of chronic CMV infection when compared 
to the young controls, which would reduce the overall infectious burden responsible for 
expansion of the CD8+CD28- T cell subset (Weng et al. 2009, Kern et al. 1996) .  
Additional confirmation for this was gained in the repeated analyses using CMV status as 
covariate where the caregiving effect disappeared, while age remained significant.  
CD57+ cells in both CD4+ and CD8+ subset of T cells were more abundant in the older 
sample, as previously reported (Merino et al. 1998, Bandres et al. 2000), and this has 
been related to limited proliferative capacity and 'clonal exhaustion' (Wood et al. 2009, 
Brenchley et al. 2003).  On the other hand, the preserved T cell profile in case of 
CD8+CD57+ cells, and lower percentages of CD4+CD57+ cells, shown among older 
caregivers was unexpected.  However, increased CD57+ cells in the elderly have 
previously been related to CMV infection (Pourgheysari et al. 2007).  Although there 
was no difference in serum CMV antibody titre between caregivers and controls amongst 
older adults in the present study, the percentage of CD4+CD57+ T cells significantly 
positively correlated with levels of anti-CMV antibodies (data presented in Appendix, 
Additional findings from chapter 4), which could explain the unexpected increase in the 
percentage of these cells amongst older controls.  This is further confirmed by the 
significantly higher numbers of these cells in CMV seropositive participants who had a 
relatively higher CMV antibody titre.  In addition, repeated analyses adjusting for CMV 
status eliminated this caregiving effect.  On the other hand, the increase in CD57+ cells in 
both CD4+ and CD8+ subsets, although more prominent in the latter, has been shown to 
occur after acute exercise which mobilised these terminally differentiated highly 
cytotoxic cells in both young and old (Campbell et al. 2012, Simpson et al. 2007, 
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Simpson et al. 2008).  Thus, perhaps the low percentages of these cells in caregivers in 
the current sample are a dampening of the numbers of cells with high killing potential 
due to the chronic stress of caregiving.  This decrease in CD57+ cells has been previously 
reported in some chronic diseases, such as chronic Lyme’s disease, where the increase in 
CD57+ levels relate to improved symptoms (Stricker and Winger 2001).  Finally, it has 
been argued that cells expressing the CD57 marker and/or lacking CD28 represent only 
terminally differentiated effector T cells with high cytotoxic potential, which then 
apoptose as a result of their activation, and are therefore not a marker of immune 
deficiency (Kern et al. 1996). 
KLRG1 was increasingly expressed on CD8+ T cells from the present older participants, 
confirming previous findings (Henson et al. 2009).  This is not surprising, as this marker 
of terminally differentiated T cells is associated with replicative senescence and inhibits 
cell proliferation (Henson et al. 2009, Henson and Akbar 2009).  In addition, KLRG1 is 
known to down-regulate CD95-mediated cell lysis and, in certain cases, inhibit T cell 
activation (Rosshart et al. 2008).  Interestingly, blockade of this inhibitory marker can 
restore proliferative function, which indicates the potential involvement of KLRG1 in 
exhaustion-related pathways (Henson et al. 2009, Akbar and Henson 2011).  KLRG1 was 
also shown to be increasingly expressed on both CD4+ and CD8+ T cells in caregivers 
when compared to controls, indicating the possibility that chronic caregiving stress can 
affect the functionality of the T cell immunity.  This higher percentage of functionally 
impaired T cells rich in inhibitory receptors such as KLRG1 is what may explain the 
poorer vaccination response observed in caregivers (Kiecolt-Glaser et al. 1996, Gallagher 
et al. 2009a, Vedhara et al. 1999).  This is likely as it has been shown that KLRG1 
prevents the response of CD4+ T cells to novel antigens (Shi et al. 2014) necessary for 
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achieving adequate immune protection following vaccination.  Further support for this 
target specific effect of caregiving stress that could explain the higher percentage of T 
cells expressing this senescence marker in caregivers regardless of their age comes from 
studies that suggest changes in the methylation profile of DNA, the epigenome, due to 
stressful life experiences.  There is now a growing body of evidence that stress, from 
prenatal to adult social stress, through epigenetic changes influences not only behaviour 
and stress responses (Gudsnuk and Champagne 2012), but also, via the HPA axis, has an 
impact on immune-related genes (Uddin et al. 2010).  A recent study compared people 
with and without posttraumatic stress disorder associated with changes in DNA 
methylation profiles and gene expression including KLRG1 (Uddin et al. 2010), 
potentially compromising the individual's immunity (Uddin et al. 2010). 
Significant age effects were observed for both CD4+PD-1+ and CD8+PD-1+ T cells, with 
older adults having a higher percentage of both of these subsets, consistent with some 
previous research (Lages et al. 2010, Dolfi et al. 2013), reviewed in (Lefebvre and 
Haynes 2012), but not all (Canaday et al. 2013).  Chronic caregiving stress did not 
appear to affect PD-1 expression as caregivers in the current sample showed a T cell 
exhaustion profile comparable to that of the controls.  Therefore, it seems that although 
physical stress, such as laparoscopic-assisted surgery, can induce an increase in PD-1 
expression on both CD4+ and CD8+ T lymphocytes (Arai et al. 2012), caregiving stress 
may not affect this aspect of immunity.   
The significant age effect on TREC expression was in agreement with previous research 
indicating a decrease in thymic output and production of naive T cells with age (Naylor 
et al. 2005, Betjes et al. 2011, Mitchell et al. 2010).  However, there was no negative 
effect of caregiving stress observed for this immune parameter; if anything, caregivers 
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showed a trend towards higher thymic output than controls, largely influenced by the 
younger group.   
A higher percentage of CMV positive individuals in the younger group was not expected, 
and is higher than previously reported for an equivalent age group (Dowd et al. 2009, 
Staras et al. 2006).  However, this could be due to specifically targeting parents, rather 
than younger adults per se, who may have more exposure to CMV through contact with 
their children whose infection rates can be high due to  day-care centre attendance (Adler 
1988).  Interestingly, comparison between CMV seropositive participants with high and 
low serological profiles revealed group differences in almost all T cell immunity 
parameters with the exception of CD8+ T cells expressing the PD-1 marker of 
exhaustion.  This is in agreement with previously reported data that suggest the role of 
CMV in driving T cells towards senescent or exhaustion profiles through repeated 
stimulation of T cells in an attempt to control the infection (Almanzar et al. 2005, Chou 
and Effros 2013). 
Higher psychological morbidity was related to lower levels of some immunesenescence 
markers and higher TREC, which seems counterintuitive.  However, it appears that this 
overall effect results from the higher psychological morbidity scores in the younger 
caregivers group, that, due to their age, also exhibit the expected lower or absent 
immunosenescence shown in terms of T cell marker expression and output of naïve T 
cells.  This is further confirmed by the direct relationship between higher problem 
behaviours in care-recipients and higher percentage CD8+CD57+ T cells amongst the 
older caregivers, which suggests that, for older caregivers at least, future research into 
caregiving should focus on those with higher psychological morbidity. 
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Overall, the results presented in this chapter provide a support for a mixed picture of the 
effect of caregiving stress on T cell phenotype in young and old, with the KLRG1 marker 
of cell senescence being the main responder to caregiving stress.  These data also 
indicate that the contribution of caregiving stress to immunesenescence is not uniform 
across T cell functional markers. The KLRG1 result may indicate that a prominent 
negative effect of caregiving stress in both young and old would be seen during active 
immune stimulation/challenge in vivo of the adaptive immune system such as vaccination 
(Gallagher et al. 2009a, Gallagher et al. 2009b, Glaser et al. 2000, Kiecolt-Glaser et al. 
1995, Vedhara et al. 1999). Caregiving stress in these situations may prevent the immune 
response from a competent reaction and adequate protection, namely a clinically relevant 
increase in antibody titre.  Thus, the higher percentage of KLRG1- T cells in caregivers 
and controls presents a potential mechanism for the poorer vaccination response 
previously reported in this stressed group (Shi et al. 2014). 
The study has a number of limitations.  First, the sample size could be regarded as small, 
yet it is of the same magnitude as in previously reported caregiving studies (Gallagher et 
al. 2009a, Gallagher et al. 2009b, Vedhara et al. 1999, Vedhara et al. 2002), and therefore 
large enough to determine medium effect size reported by the previous studies.  Second, 
one could argue that requirements for the participation in the study biased the sample 
towards those caregivers with lower burden and stress levels overall and therefore 
immune integrity.  However, attempts were made to avoid this by providing the 
opportunity of home visits for participants.  In addition, scores on psychosocial scales 
were comparable if not higher to those previously reported by other caregiving research, 
suggesting that the present caregivers did have high burden and stress levels.  Finally, 
conducting staining on frozen and then thawed PBMCs might give different results to 
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those that arise from the work on fresh PBMCs, but as all the samples were treated in the 
same way from the moment of blood sampling until the acquisition of the data on flow 
cytometer, the comparison between groups would not be affected by this.   
In conclusion, caregivers showed poorer KLRG1 T cell profiles compared to controls, but 
other markers of T cell-related immunesenescence and exhaustion did not differ between the 
groups.  This KLRG1 effect could explain previous caregiving effects on vaccination 
response and suggest KLRG1 as a target for future intervention.  Further, among older 
caregivers, those who reported higher behavioural problems in care recipients showed a 
greater senescent profile.  These findings underline the importance of considering individual 
differences in the impact of caregiving stress on immunity, and that future research should 
focus on those who report higher psychological morbidity.    
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CHAPTER 5 
 
 
BEREAVEMENT STRESS AND NEUTROPHIL 
FUNCTION IN YOUNG AND OLDER ADULTS: 
ROLE OF THE HPA AXIS AND 
IMMUNESENESCENCE 
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5.1. ABSTRACT    
The effect of the chronic stress of bereavement on immunity is poorly understood.  Previous 
studies have demonstrated negative effects on immunity in older adults, and those who report 
higher depressive symptoms.  The aim of the present study was to compare the effect of 
bereavement on neutrophil function in healthy young and old adults, also assessing serum 
levels of the stress hormones, cortisol and DHEAS.  41 young (mean age 32 years) and 52 
older adults (mean age 72 years), bereaved and non-bereaved, took part in the study.  They 
completed questionnaires on socio-demographic and health behaviour characteristics, as well 
as psychosocial variables, and provided a blood sample for analysis of neutrophil function 
(phagocytosis and ROS production) and stress hormone analysis.  Bereaved participants in 
both age groups reported more symptoms of depression and anxiety than controls and scored 
moderately highly on bereavement-specific questionnaires for these symptoms.  Despite this, 
young bereaved participants showed robust neutrophil function when compared to age-
matched non-bereaved controls, and comparable stress hormone levels, while reduced 
neutrophil ROS production and raised stress hormone levels (cortisol:DHEAS ratio) were 
seen in the older bereaved group compared to their age-matched controls.  Reduced neutrophil 
function among older bereaved participants may be the result of the inability to maintain 
stress hormone balance, specifically the cortisol:DHEAS ratio.  
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5.2. INTRODUCTION 
Bereavement is a stressful life event often accompanied by grief after the loss of someone 
close (Stroebe and Stroebe 1987) and, as such, has numerous consequences for physical and 
mental health (Parkes 1964).  In addition to the increase in morbidity and mortality associated 
with bereavement in older adults (Biondi and Picardi 1996, Kaprio et al. 1987, Stroebe et al. 
2007), particularly in the case of the unexpected death (Shah et al. 2013), bereavement has 
been shown to have a number of adverse effects on immunity (Adrianopoulos and Flaherty 
1991).  For example, bereavement in the year prior to vaccination related to lower antibody 
responses to two different influenza strains in older adults (mean age 75 years) (Phillips et al. 
2006a), and decreased lymphocyte response to PHA (Bartrop et al. 1977).  On the molecular 
level, the expression of the genes specifically involved in B cell immunity was down-
regulated in bereaved older adults (aged 61-83 years) when compared to age- and sex-
matched controls (O'Connor et al. 2014).   Bereaved parents aged 38-61 years experienced a 
decrease and increase in the number of regulatory and helper T cells, respectively, compared 
to matched controls after the sudden and unexpected death of their child (Spratt and Denney 
1991).  In terms of the innate immune response, bereaved middle aged female spouses aged 
57.1 ± 7.9 years (mean ± SD) had a poorer NK cell cytotoxic activity when compared to 
gender matched controls (Irwin et al. 1987), and neutrophil ROS production was lower in 
bereaved older adults (mean age 72 years) when compared to the age- and sex-matched non-
bereaved participants (Khanfer et al. 2011).  In contrast, a group of middle aged widows 
(mean age 56 years) showed preserved immune response compared to non-bereaved controls 
(Zisook et al. 1994).  However, within the bereaved group, those with depressive symptoms 
had lower NK cell activity and response to mitogen stimulation than those without (Zisook et 
al. 1994).    
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Previous studies of the impact of physical stress (e.g. hip fracture) have shown that impaired 
immune function, specifically neutrophil ROS production was only seen among older adults 
with concomitant immunosenescence and did not occur in young patients with a similar level 
of trauma (Butcher et al. 2003).  Importantly in this study HPA axis activity, specifically a 
raised cortisol:DHEAs ratio was highest in those patients with the lowest neutrophil ROS 
production and also lower in patients who developed infection.  Further, a subsequent study 
revealed that reduced ROS production and a higher cortisol:DHEAS was observed only in 
those hip fracture patients with depressive symptoms when compared to both those patients 
without depression and healthy age-matched controls (Duggal et al. 2013a).  These data 
suggest that the effects of some types of stress on immunity may only be observed among 
older adults, or among those with poorer psychological status, e.g., high depressive 
symptoms. 
Stress activates the HPA axis and subsequently induces the secretion of cortisol, a hormone 
with immune suppressive effects (Charmandari et al. 2005).  DHEAS, also secreted by the 
adrenal gland in response to stress, is considered to be immune-enhancing (Phillips et al. 
2007).  Whilst cortisol has been shown to decrease the adhesion and increase mobility of the 
neutrophils (Davis et al. 1991, Zak-Nejmark et al. 1998), DHEAS increased neutrophil ROS 
production in vitro (Radford et al. 2010).  An imbalance between these two hormones, i.e., a 
high cortisol:DHEAS ratio can arise in response to stress (Boudarene et al. 2002, McCraty et 
al. 1998) and have negative implications for immunity including increase risk of bacterial 
infection (Butcher et al. 2005).  Further, our previous research in older adults showed a higher 
cortisol:DHEAS ratio in bereaved participants when compared to age- and sex-matched 
controls (Khanfer et al. 2011).  Indeed, with ageing, levels of DHEAS decline whereas 
cortisol continues to be produced, termed adrenopause (Orentreich et al. 1984), thus resulting 
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in a higher cortisol:DHEAS ratio.  Whether the same increased stress hormone ratio and 
associated reduction in neutrophil function would be observed in younger adults suffering the 
stress of bereavement is not known. 
Consequently, the present study sought to extend our previous research which showed 
reduced neutrophil function in older bereaved adults (Khanfer et al. 2011).  Specifically, it 
compared neutrophil function and the cortisol:DHEAS ratio in four groups of participants: 
younger bereaved adults; non-bereaved young participants; older bereaved adults and non-
bereaved age-matched controls.     
 
5.3. METHODS 
5.3.1. Participants  
21 young bereaved adults and 20 age- and sex-matched non-bereaved controls, as well 
as 26 older bereaved adults and 26 controls participated in the study.  Recruitment was 
conducted mainly via local advertisements and the Bereavement Care Centre, Queen 
Elizabeth Hospital, Birmingham.  The bereaved group comprised participants who 
suffered bereavement in the past two months.  None of the participants suffered from a 
chronic immune disorder or acute infection, and none were taking immunosuppressive 
medication.   
5.3.2. Study design and procedure 
Participants attended a morning testing session where they completed a questionnaire 
pack and provided a blood sample.  Informed written consent was obtained, and the 
study was approved by the local Ethics Committee. 
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5.3.3. Questionnaires 
Groups were compared on general socio-demographic variables, as well as health 
behaviours.  The latter were assessed using an adaptation of the Whitehall II study 
questionnaire (Marmot et al. 1991).  HADS (Zigmond and Snaith 1983), was used to 
determine depression and anxiety symptoms in all participants, and the Cronbach's alpha 
in the present study was .86 for anxiety and .80 for depression.  The availability of social 
support was examined using the MOS Social Support Survey (Sherbourne and Stewart 
1991).  The Cronbach's alpha in the current sample was .96.   
Bereaved participants were asked about their recent bereavement using the Core 
Bereavement Items questionnaire (CBI, (Burnett et al. 1997)), and the Impact of Event 
Scale (IES, (Horowitz et al. 1979)). The CBI assesses the feelings of the bereaved on a 4-
point scale from 0 - never, to 3 - continuously happening.  An example of a typical item 
is 'Do reminders of this person such as photos, situations etc. cause you to feel 
loneliness'.  Previously used in bereavement research (Tolstikova et al. 2005, Holland et 
al. 2013), the scale showed good internal consistency at .91; and .94 in the present study.  
The IES asks about frequency of feelings about the bereavement (e.g. how frequently 
'you had dreams about it'), with higher scores meaning higher negative impact.   The 
scale shows good internal consistency (.79-.92) (Corcoran and Fischer 1994); and .89 in 
the current sample.  They were also asked who the deceased person was in relation to 
them, and whether the death was expected or not. 
5.3.4. Blood sampling and assays 
Venous blood was collected in the morning, between 9-11a.m., from the ante-cubital vein into 
two 6ml tubes (BD Diagnostics, Oxford, UK), one with heparin for neutrophil functional 
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assessment, and one plain for serum cortisol/DHEAS analyses.  The blood samples in the 
plain tube were left for 30 minutes to coagulate, after which they were centrifuged at 1600xg 
for 10 minutes and serum from the supernatant layer was stored at -20°C for future analysis.  
Neutrophil phagocytosis of FITC labelled E coli and oxidative burst activity in response 
to unlabelled E coli were assessed using two commercial kits (Phagotest, Orpegen 
Pharma, Heilderberg, Germany), following the suppliers protocol.  Both aspects of 
neutrophil function were assessed using a three-laser Dako Cyan High Performance flow 
cytometer (Dako, Carpinteria, California), with Summit v 4.3 software.  Phagocytic 
ability was expressed as phagocytic index which was calculated as: Phagocytic index = 
% phagocytic neutrophils x MFI, where MFI is mean fluorescence intensity measured by 
flow cytometry.  The difference between MFI in the test sample (which is the sample 
with E.coli) and control sample (sample with wash buffer) was used to measure the 
oxidative burst activity of neutrophils. 
Concentrations of cortisol and DHEAS in the stored serum samples were analysed using 
corresponding ELISA commercial kits (IBL international, Hamburg, Germany), 
following the suppliers protocol.  The optical density (OD) was measured at 450nm 
within 15 minutes of stop solution addition.   Standard curves were then constructed 
using GraphPad Prism 6 software by plotting the OD of the standards against their 
concentrations on semi-logarithmic graph.  The unknown concentrations of the samples 
(in nmol/l for cortisol and µmol/l for DHEAS) were calculated from the standard curve 
using the cubic spline fit.   
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5.3.5. Statistical analyses  
Comparison between the bereaved and non-bereaved on socio-demographics, and 
questionnaire scores were conducted by ANOVA and chi-square as appropriate; with 
effect sizes reported as η2.  Further, 2x2 bereavement group * age group ANOVAs were 
used to compare immune and hormone measures in the young and old, bereaved and 
controls.   Neutrophil function and hormone levels were skewed and therefore subjected 
to log transformation.  Significantly different demographic or health behaviour variables 
between groups were controlled for in further ANCOVAs.  Correlations were used 
within younger bereaved group only to examine whether the cortisol:DHEAS ratio or 
any other questionnaire variables were related to neutrophil function.  Further, bereaved 
participants were divided into two groups (those who lost spouse or parent versus those 
who lost more distant relative), and differences between them on neutrophil function and 
hormone status were examined using ANOVAs.   
 
5.4. RESULTS 
5.4.1. Demographic, health behaviour and psychosocial characteristics 
Table 1 shows that bereaved participants and controls were reasonably well matched on 
most socio-demographic and health behaviour variables in both young and old groups, 
with the exception of occupational status (p = .02), and the medication (p=.04) in the 
young.  Young bereaved were more likely to hold manual occupations, and to take 
medication, mainly anti-hypertensives and non-steroidal asthma treatments.  The 
bereaved in both groups reported more symptoms of depression and anxiety than 
controls.  Social support availability did not differ between groups in either of the age 
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cohorts.  Bereaved participants scored moderately highly on both the CBI and IES, albeit 
slightly lower than bereaved participants in previous research (Walsh et al. 2002, Burnett 
et al. 1997, Horowitz et al. 1979, Corcoran and Fischer 1994).  In the younger group, two 
bereaved participants had lost a spouse (9.5%), eight had lost a parent (38.1%), nine a 
grandparent (42.9%), and two a distant relative, e.g. parent-in-law (9.5%).  For the older 
group, the respective values were 17 (65%), 3 (12%) and 6 (23).  The death was expected 
in 86% of cases in the younger group, and in 84% in the older group.   
5.4.2. Neutrophil function 
For neutrophil phagocytosis, a 2x2 age group versus bereavement group ANOVA 
comparing neutrophil phagocytosis in young bereaved and matched controls with older 
bereaved and controls revealed the significant main effect of age, F(1,87) = 31.45, p < 
.001, η2 = .265, such that younger participants showed higher phagocytosis overall than 
older adults, but there was no overall main effect of bereavement, F(1,87) = 0.26, p = .61, 
η
2
 = .003, nor bereavement * age interaction effect, F(1,87) = 1.94, p = .17, η2 = .022 
(Figure 1A).  Repeated analyses with adjustment for occupational status and medication 
usage revealed the same significant main effect of age, p < .001.  
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Table 1.  Socio-demographic, health behaviour and psychosocial characteristics of bereaved and non-bereaved participants. 
Young Older  
 Bereaved  
(N = 21) 
Non-bereaved  
(N = 20) 
 
 
Bereaved 
(N = 26) 
Non-bereaved 
(N = 26) 
 
 N (%) / Mean (SD) p N (%) / Mean (SD) p 
Age (years) 31.8 (9.03) 31.7 (8.41) .97 71.3 (5.79) 72.6 (5.72) .42 
Gender (Female) 9 (43) 10 (50) .65 18 (69) 17 (65) .77 
Ethnicity (Caucasian) 21 (100) 17 (85) .07 26 (100) 25 (96) .31 
Occupational status (non-
manual) 
16 (76) 20 (100) .02 19 (76) 21 (81) .68 
Taking medications 4 (19) 0 (0) .04 15 (60) 15 (58) .87 
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Alcohol intake (daily or more) 5 (25) 2 (10) .21 10 (38) 7 (27) .38 
Smokers 5 (25) 4 (20) .71 2 (1) 3 (12) .64 
Body Mass Index  24.3 (4.20) 23.0 (2.70) .27 26.2 (3.93) 25.5 (3.36) .52 
Exercise score  7.8 (5.95) 9.6 (4.83) .30 5.5 (1.35) 8.0 (1.35) .21 
Fruit and vegetable 
consumption score  
9.8 (2.96) 8.9 (2.27) .28 9.3 (2.03) 9.9 (2.04) .27 
Fat consumption score  10.6 (3.53) 11.3 (2.65) .49 10.6 (3.66) 10.0 (3.21) .56 
HADS anxiety scorea  8.0 (4.63) 5.2 (3.08) .03 8.6 (4.90) 4.2 (2.95) <.001 
HADS depression scorea  4.7 (3.15) 2.5 (2.50) .02 6.1 (5.54) 2.42 (2.32) .003 
Social support score (MOS)a  73.8 (17.68) 80.4 (12.65 ) .18 70.4 (19.61) 80.2 (16.26) .06 
Core bereavement items (CBI)  23.2 (10.93) - - 29.8 (13.28) - - 
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The Impact Event Scale (IES) 33.1 (15.52) - - 33.2 (15.6) - - 
Death expected - yes 18 (86) - - 21 (84) - - 
Bereavement type                       
Spousal 
 
2(10) 
 
- 
 
- 
 
17 (65) 
 
- 
 
- 
              Close relative (parent) 8 (38) - - 3 (12) - - 
              Distant relative/friend 11 (52) - - 6 (23) - - 
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For neutrophil ROS generation 2x2 ANOVA comparing neutrophil ROS production 
between young and old, bereaved and control revealed a significant main effect of age, 
F(1,87) = 34.4, p < .001, η2 = .284, such that older participants had higher neutrophil 
superoxide burst than younger subjects.  There was, however, no main effect of 
bereavement overall, F(1,87) = 1.02, p = .31, η2 = .012, nor bereavement * age 
interaction effect, F(1,87) = 2.63, p = .11, η2 = .029.  Pairwise comparison revealed that 
the lack of the effect between bereaved subjects and controls was driven by the 
comparable ROS production in the younger group (p = .69), while there was a significant 
effect of bereavement in the older group (p = .05), such that older bereaved subjects had 
lower ROS production than older controls (Figure 1B).  Repeated analysis with covariate 
adjustment also revealed a main effect of age (p < .001). 
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Figure 1. Neutrophil function in response to bacteria E.coli in young and old, 
bereaved and non-bereaved. A: Neutrophil phagocytosis of FITC labelled E.coli 
presented as phagocytic index (bacteria ingested (MFI) x % neutrophils uptaking 
bacteria) between young and old, bereaved and non-bereaved subjects. B: 
Neutrophil superoxide production in response to E.coli presented as MFI, 
between young and old, bereaved and non-bereaved. Error bars are SEM and * 
indicates p < .05.  
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5.4.3. Stress hormone concentrations 
For cortisol,  2x2 ANOVA between young and old bereaved and controls showed a 
significant main effect of age, F(1,84) = 8.80, p = .004, η2 = .095, such that younger 
participants had higher serum cortisol levels, but no main effect of bereavement, F(1,84) 
= 3.28, p = .07, η2 = .038, nor bereavement * age interaction effect, , F(1,84) = 1.42, p = 
.24, η2 = .017.  Pairwise comparison revealed a significant effect of bereavement in the 
older group (p = .03), such that older bereaved subjects had higher cortisol levels than 
controls, while there was no difference in the young (p = .68) (Figure 2A).  Repeated 
analyses with covariates adjustment showed a similar main effect of age (p = .03). 
For DHEAS, 2x2 ANOVA using young and old, bereaved and non-bereaved showed a 
significant main effect of age, F(1,84) =62.08, p < .001, η2 = .425, such that younger 
subjects had higher serum DHEAS, but no main effect of bereavement, F(1,84) = 1.95, p 
= .17, η2 = .023, nor bereavement * age interaction effect, F(1,84) = 1.77, p = .19, η2 = 
.021, was seen (Figure 2B).  Pairwise comparison revealed a significant bereavement 
effect in the older group (p = .04), such that older bereaved had lower DHEAS than non-
bereaved older controls, while the levels of this hormone were comparable between the 
groups in the young (p = .97).  Repeated subsequent analyses including the covariates 
showed a similar main effect of age, p < .001. 
For the cortisol:DHEAS ratio, 2x2 ANOVA revealed a significant main effect of age, 
F(1,84) = 14.35, p < .001, η2 = .146, and the trend towards an effect of bereavement, 
F(1,84) = 3.59, p = .06, η2 = .041, such that younger participants and control participants 
had a lower cortisol:DHEAS ratio, respectively.  There was, however, no bereavement * 
age interaction effect, F(1,84) = 2.33, p = .13, η2 = .027.  Pairwise comparison revealed 
that the trend towards a bereavement effect was driven by the differences in older group 
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(p = .01), while the ratio was comparable between the young (p = .80) (Figure 2C).  
Covariate analyses confirmed a main effect of age, p =.002.  
 Figure 2. Serum stress hormone levels in young and old, bereaved and non-
bereaved.  Serum A. cortisol, B. DHEAS or C. cortisol:DHEAS ratio for young 
and old, bereaved and non-bereaved subjects. Error bars are SEM and * indicates 
p < .05.  
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5.4.4. Psychological factors and immune and hormone measures   
Correlations within the bereaved groups revealed no association between neutrophil 
function and any of the psychosocial and socio-demographic variables.  There was also 
no significant difference in neutrophil function between those bereaved participants who 
had lost a spouse or parent and those who had lost a more distant relative.  Correlation 
analysis within the bereaved group revealed that those with higher CBI scores, indicative 
of greater grief had a higher cortisol:DHEAS ratio, r(42) = .34, p = .03, and those who 
reported higher social support had lower cortisol:DHEAS ratio, r(42) = - .31, p = .04.  
When bereaved participants were separated into two groups based on who they had lost, 
there was a difference between the groups in their cortisol:DHEAS ratio, F(1,42) = 9.04, 
p = .004, η2 = .177, such that those who had lost someone more distant had a lower 
cortisol:DHEAS ratio.  
 
5.5. DISCUSSION 
The results presented in this chapter showed that there was no difference in neutrophil 
function and serum hormone levels between bereaved and controls overall, with the main 
differences emerging between the two age groups.  This was despite the differences in 
psychosocial variables that showed higher depressive and anxiety symptoms in the 
bereaved.  Closer analyses revealed the younger group as responsible for these null 
findings, since neutrophil function and stress hormone levels were comparable between 
the groups in the young.  On the other hand, older bereaved subjects had poorer ROS 
production, and higher cortisol:DHEAS ratios when compared to the matched non-
bereaved older adults, consistent with the previous studies of bereavement and immune 
function in older adults (Khanfer et al. 2011, Phillips et al. 2006a).  The absence of an 
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effect of bereavement on neutrophil function in the younger sample is perhaps surprising 
given the high levels of depression and anxiety symptoms among the bereaved, similar to 
those recorded for the older bereaved sample (Table 1).  In addition, responses to 
questionnaires measuring grief, and impact of the bereavement indicated significant 
feelings of loss in the present study in both groups.  However, only a limited number of 
studies have examined the effect of bereavement on immune function in younger adults.  
Lower numbers of regulatory T cell and helper T cells (Spratt and Denney 1991), and 
lower NK cell cytotoxicity (Gerra et al. 2003) were reported for individuals who had 
experienced sudden/unexpected death of a close friend or family member.  Further, no 
group differences in NK cell activity were observed between middle aged widows and 
married controls (Zisook et al. 1994), although NK cell activity and the response to 
mitogens was poorer in a small sample of widows with symptoms of major depression.  
In the present study, although depressive symptomatology was higher among the 
bereaved, only one bereaved participant met the criteria for severe depression or higher 
(HADS > 11).  There are several potential explanations for the present null findings for 
neutrophil function in the young bereaved.  It is possible that the intact neutrophil 
function was attributable to losses in the present study being of less close relationships 
than those of older adults, only 10% of the bereavements were spousal in the younger 
sample, the comparable figure for the older participants was 65% (Table 1).  However, 
there was no difference in neutrophil function in the present study between those who 
have lost a close relation (spouse, parent) and those who have lost a more distant relative 
(grandparent, parent-in-law).    Further, social support is an unlikely explanation for 
preserved immunity in the present study as the support scores of the young bereaved 
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were virtually identical to those found in older bereaved participants, who showed 
reduced neutrophil ROS production. 
A plausible explanation for the preservation of neutrophil function in young but not older 
bereaved subjects is the difference in the HPA axis response between the two groups, 
superimposed upon the aged neutrophil.  Previous research indicates that stress may 
affect immune function more readily in the context of concomitant immune ageing.  For 
example, lower sIgA, (Gallagher et al. 2008), and higher antibody titres against CMV 
(Pariante et al. 1997) were specifically characteristic of older caregivers.  In general, 
there is consistent evidence of compromised immune function in older spousal caregivers 
for partners with dementia (Glaser et al. 2000, Vedhara et al. 1999), whereas the results 
from the studies of younger caregivers are more variable (Gallagher et al. 2009a, 
Vedhara et al. 2002).  Here the cortisol:DHEAS ratio was only raised in the older 
bereaved subjects compared to their controls and not in the younger bereaved group. 
With the well documented and opposing effects of cortisol (Bekesi et al. 2000) and 
DHEAS (Butcher et al. 2005, Radford et al. 2010) on neutrophil ROS production, this 
proposal had biological validity.  
The present study is not without limitations.  First, the sample size can be regarded as 
small; however, bereaved participants are notoriously difficult to recruit and the sample 
size is comparable to that recruited to previous studies of immunity and bereavement 
(Gerra et al. 2003, Khanfer et al. 2011).  Second, it could be argued that the preserved 
immune function in the present sample was due to bias such that those who are less 
stressed by or coping better with bereavement might be more likely to take part.  
However, the scores on CBI and IES suggested that the bereavements were significantly 
stressful.   
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In conclusion, unlike older bereaved adults, younger bereaved participants showed no 
detrimental effect of bereavement on neutrophil function and stress hormone 
concentrations when compared to the matched non-bereaved controls.  This is most 
likely attributable to the absence of immunosenescence and adrenopause in the younger 
aged bereaved group.
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CHAPTER 6 
 
 
OVERALL DISCUSSION 
  
142 
 
6.1. SUMMARY OF THE MAIN THESIS FINDINGS 
The research in this thesis was concerned with the relationship between chronic stress 
(caregiving and bereavement), ageing and different aspects of immune and endocrine 
function, in particular neutrophil function, serum anti-CMV antibody titre, the predominance 
of T cell exhausted and senescent phenotypes and stress hormone (cortisol, cortisone and 
DHEAS) levels. 
Chapters two, three and four focused on the chronic stress of caregiving, examining its effect 
on aspects of both innate and adaptive immunity, as well as stress hormone levels; while 
chapter five compared the effect of the chronic stress of bereavement on neutrophil function 
and the HPA axis in younger adults, and compared it to the results obtained from older 
participants.   
 
Chapter two examined the effect of caregiving stress in parents of children with 
developmental disabilities on CMV seropositivity and serum CMV antibody titre by 
comparing them to age- and sex-matched control parents of typically developing children.  
The aim was to determine whether caring for a child with a developmental disability 
negatively influenced caregiving parents' immunity, responsible for keeping latent virus 
infection under control.  This would be evidenced through an increased titre to the 
corresponding virus in younger caregivers' serum when compared to the controls.  The study 
showed that caregiving parents were no more likely to be CMV seropositive than parents of 
typically developing children.  It also did not find any differences between the groups in 
serum antibody titres against CMV.  However, in focusing on the caregiving group alone, the 
study also aimed to elucidate whether CMV titre in seropositive caregiving parents was 
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associated with any health behaviours and/or psychological/caregiving variables.  An 
association emerged between CMV antibody titre and negative health behaviour variables in 
CMV seropositive caregivers, such that those with a higher BMI, lower exercise level, 
smokers and those eating less well overall had higher CMV antibody titres.  Overall, this 
study confirmed a lack of negative effect of caregiving stress on latent virus control in a 
younger population, but suggested a possible negative influence of detrimental health 
behaviours practiced by some stressed caregivers on this aspect of immunity. 
 
Chapter three focused on the effect of caregiving stress and/or age on neutrophil function 
(phagocytosis and ROS production), outcomes previously not investigated in the caregiving 
research, as well as stress hormone (cortisol, cortisone and DHEAS) levels using the 
previously described four groups of participants.  Despite the differences in 
psychosocial/caregiving variables, such that caregivers in both age groups reported higher 
psychological morbidity than controls, no difference was found in neutrophil function 
between caregivers and controls, and cortisol, DHEAS and their ratio was comparable 
between the groups.  Younger caregivers exhibited, however, an increased cortisol:cortisone 
ratio, which is an accepted indicator of systemic generation of cortisol via the enzyme 11β-
HSD1, a novel finding in caregiving research.  Finally, focusing on caregivers alone, those 
with higher anxiety symptoms and caregiving burden had lower neutrophil phagocytosis and 
poorer ROS production was seen in those reporting poorer sleep quality.  This suggests that 
the focus of future caregiving research should perhaps be less on caregiving status in general 
and more on the individuals who demonstrate higher psychological morbidity.   
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Chapter 4 focused primarily on the parameters of T cell immunity, examining, in particular, 
the effect of caregiving stress with and without ageing on T cell senescent and exhaustion 
profile and thymic output, immune parameters not previously examined in this group of 
chronically stressed individuals, as well as serum CMV antibody titre.  Caregivers overall 
demonstrated a generally robust T cell profile, with the main differences emerging between 
young and old, with older adults showing greater cell senescence as might be expected.  The 
exception was an increased percentage of T cells expressing the KLRG1 senescent profile in 
caregivers overall when compared to controls, an effect that supports previous findings of a 
poorer vaccination response in old and young caregivers, and that could be used in future 
interventions.  In addition, amongst older caregivers, those who reported higher problematic 
behaviour in their spouses with dementia showed poorer CD57+ T cell senescent profile.  This 
suggests, once again, that the focus of the future caregiving research should be more on 
caregiving individuals with a higher caregiving burden.   
Chapter five examined the effect of a different type of chronic stress, suffering bereavement, 
on neutrophil function, and serum stress hormone (cortisol and DHEAS) levels in the younger 
and old adults.  Due to the difficult nature of recruiting bereaved participants, the effect of the 
stress of bereavement is largely under-researched and frequently suffers from small research 
sample sizes.  This is the first study to examine the effect of bereavement on neutrophil 
function in young adults and compare it to an older sample, in order to examine possible 
reasons for the different patterns of findings in the different age groups.  Despite scoring 
higher on depression and anxiety questionnaires than controls, as well as reporting high levels 
of grief and feelings of loss, younger bereaved participants showed neutrophil function 
comparable to that of the young controls.  In addition, serum stress hormone (cortisol and 
DHEAS) levels were similar between the groups.  Comparison with results of the effect of 
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bereavement on older adults, who showed poorer ROS production and higher 
cortisol:DHEAS, revealed a significant age effect for all the variables measured.  This 
suggests that the presence of immunosenescence is necessary for a negative effect of 
bereavement on neutrophil function and stress hormone levels to be observed, and that 
younger adults are protected against the negative immune impact of bereavement due to their 
younger immune systems.  
 
6.2. CAREGIVING STRESS, IMMUNE FUNCTION, CORTISOL, CORTISONE AND 
DHEAS 
The model of stress of caregiving in young used was parents of children with developmental 
disabilities.  This way an attempt was made to replicate the caregiver burden due to 
behavioural problems seen in dementia patients, and find the equivalent model in a younger 
group to compare the effect of caregiving stress in younger adults to the frequently examined 
older spousal dementia caregivers.  The findings presented imply robust immune and 
endocrine responses in young caregiving parents, comparable to that of the age- and sex-
matched control parents of typically developing children.  CMV positivity, anti-CMV 
antibody titre, neutrophil function, and cortisol and DHEAS levels did not significantly differ 
from those measured in the control group.  These findings are consistent with some previous 
studies examining caregiving stress in a younger population.  For example, spousal caregivers 
of multiple sclerosis patients had similar levels of IgG and hemagglutination-inhibition 
antibodies, and cytokines IFN-γ and IL-4, as matched controls (Vedhara et al. 2002).  On the 
other hand, the concentration of salivary stress hormones (cortisol and DHEAS) was higher in 
non-caregivers than in caregivers, while their ratio remained the same (Vedhara et al. 2002), 
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which is comparable to the present findings.  Another study showed no difference in salivary 
sIgA levels between caregivers and matched controls in younger aged cohorts from the West 
of Scotland Twenty-07 study (Gallagher et al. 2008).  No difference was also observed for 
serum anti-CMV antibody titres between younger female caregivers of handicapped people 
and non-caregiving controls (Pariante et al. 1997).     
However, chapter 3 demonstrated a significant difference in the serum cortisol:cortisone ratio 
between younger parental caregivers and age- and sex-matched controls, a marker of systemic 
generation of cortisol.  A raised cortisol:cortisone ration has been previously reported in the 
surgical patients, during the acute-phase response and after Synacthen stimulation and, as 
such, is considered an indicator of systemic 11β-HSD1 activity (Vogeser et al. 2001, Vogeser 
et al. 2002, Vogeser et al. 2003).  The 11β-HSD1 enzyme is responsible for converting 
inactive glucocorticoids, such as cortisone, into their active forms, cortisol in humans 
(Chapman et al. 2013).  An increase in the cortisol:cortisone ratio in younger caregivers 
could, therefore, indicate an increase in 11β-HSD1 activity caused, for example by pro-
inflammatory factors, such as cytokines TNF-α and IL-1 (Escher et al. 1997, Cai et al. 2001).  
It is important to note here, however, that serum cytokine concentrations of caregiving parents 
were similar to those of the controls (see Appendix with the Additional findings from chapter 
3).  On the other hand, this does not eliminate the possibility of 11β-HSD1 being influenced 
by pro-inflammatory cytokines from other sources, such as autocrine signals (Cooper et al. 
2001, Ignatova et al. 2009, Yang et al. 2009).  However, it was beyond the scope of the 
present study to measure this, or any impact of this increased inflammatory marker in our 
sample.  A longitudinal study with more inflammatory markers included, such as CRP, would 
be necessary to examine the potential implications of the increased cortisol:cortisone ratio in 
younger caregivers.  In summary, an increased cortisol:cortisone ratio in younger parental 
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caregivers could be seen as further support for a negative effect of caregiving stress on certain 
parameters in younger adults, such as those previously reported for vaccination response 
(Gallagher et al. 2009a, Gallagher et al. 2009b).  
Chapter 4 reported comparable T cell immunity between caregivers and controls in both older 
and younger adults, with the exception of the CD28- T cell subset, where paradoxically 
caregivers had lower numbers of senescent CD28- T cells.  In addition, the percentage of 
CMV positive individuals among young caregivers was lower than those in controls.  
Therefore, one possible explanation for the unexpectedly robust immune response in younger 
caregivers could be the lower incidence of chronic CMV infection which is known to be an 
important predictor of CD8+ CD28- T cell subset expansion (Kern et al. 1996, Weng et al. 
2009).  This is further confirmed by the positive association between the CD8 +CD28- T cell 
subset and CMV antibody titre in the younger group (r (41) = .48, p = .001, see Appendix, 
Additional findings from chapter 4), and subsequent ANCOVAs using CMV status as a 
covariate that eliminate this difference between T cells expressing CD28 marker in caregivers 
and controls.   
Overall, the results from chapters 2, 3 and 4 that refer to the differences in immune and 
hormone status between younger caregivers and controls add to the mixed findings reported 
by a number of studies that aimed to elucidate the effect of caregiving stress on health in the 
young, suggesting that this effect might not be straightforward, but instead has differential 
effects on different immune and endocrine parameters.   
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6.3. AGEING, IMMUNE FUNCTION, CORTISOL, CORTISONE AND DHEAS 
Chapters 3 and 4 also attempted to examine the differences in immune and hormone 
parameters that are a consequence of the different ages of our mixed caregiver and controls 
sample.  The results from chapter 3 showed consistent differences between young and older 
adults on neutrophil function and most of the hormone measures, with the exception of the 
cortisol:cortisone ratio.  Older adults unexpectedly had higher neutrophil function (both 
phagocytosis and ROS production), but also an expected higher cortisol, lower DHEAS and a 
higher cortisol:DHEAS ratio.  Increased neutrophil function in the older group is surprising 
considering the overall consensus about decreasing immune function with age (Franceschi et 
al. 2007, Panda et al. 2009, Shaw et al. 2010).  However, increased superoxide production has 
been previously reported (Cannizzo et al. 2011), and it was further supported by higher ROS 
production seen in older age cohort in our bereavement study.  In addition, this is not the first 
study to indicate the possible perseverance and potential dominance of innate immunity in 
older age, suggesting that perhaps the negative effect of immunosenescence is more clearly 
marked in the adaptive branch of immune response (Franceschi et al. 2000).  Age-related 
differences in the stress hormone status, in particular increased serum cortisol and lower 
serum DHEAS, and subsequently higher cortisol:DHEAS ratio among older adults, confirms 
previously reported and well established findings (Buford and Willoughby 2008).  The 
imbalance between these hormones with age is considered to be a contributing factor to 
immunosenescence, and its negative effects on different immune parameters.  
For T cell immunity in chapter 4, there was a main effect of age for most of the parameters 
measured, with the exception of CD4+ both CD28- and KLRG1+ T cells, indicating an overall 
greater senescent and exhausted T cell profile in older group.   This is consistent with the 
previously reported data (Fagnoni et al. 1996, Henson and Akbar 2009, Weng 2006, Wherry 
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2011), and is related to the increase in the replicative senescence of T cells and their inhibition 
of the proliferation as well as the loss of functionality (Akbar and Henson 2011).  One of the 
main drivers of this increase in senescence and exhaustion in T cells is thought to be repeated 
antigen stimulation as a consequence of chronic latent viral infection present over the years 
(Boucher et al. 1998, Chidrawar et al. 2009, Kern et al. 1996).  A higher TREC expression 
ratio in the younger compared to the older adults is again in concordance with previously 
reported research on thymic atrophy with age (Mitchell et al. 2010, Naylor et al. 2005).  
TREC represent extra-chromosomal DNA segments that are transported from thymus in so 
called recent thymic emigrants, mature CD4+ and CD8+ thymocytes that emigrate from 
thymus (Jamieson et al. 1999).  As such, TREC is directly associated with thymic output for 
CD4+ T cells, and with thymic output when peripheral T cell division and death are taken into 
account, for CD8+ T cells (Ye and Kirschner 2002).  Therefore, a decrease in TREC 
expression ratio in older adults indicates a decreasing ability to produce novel naive T cells in 
later life, leaving the organism potentially less able to fight off the infections that the body is 
exposed to for the first time.  This is likely to underlie, at least in part, the reduced vaccination 
response to new antigens exhibited by older adults (Goodwin et al. 2006). 
 
6.4. CAREGIVING STRESS AND AGEING, IMMUNE FUNCTION, CORTISOL, 
CORTISONE AND DHEAS 
Chapters 3 and 4 also aimed to elucidate the potential additive effects of caregiving stress and 
ageing on immune function and serum stress hormone levels.  They presented the findings of 
the studies that used four groups of participants as models of caregiving stress with and 
without ageing, as well as age-matched controls.  To our knowledge, these are the first studies 
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to simultaneously examine the effect of caregiving stress in the cross-sectional experimental 
set up, using two distinct age groups (23-50 and >60 years).  This enabled direct examination 
of individual and synergistic effect of chronic stress and ageing on person's health.  However, 
the hypothesised additive impact of caregiving and ageing on immunity was, on the whole, 
not observed.  With the exception of serum cortisol:cortisone ratio, there was no caregiving * 
age interaction effect for any of the measured variables, suggesting that, at least in the present 
sample, caregiving stress and ageing did not act synergistically to result in reduced immunity. 
   
In terms of the effect of caregiving stress on immune function between older spousal 
caregivers of dementia patients and age- and sex-matched controls,  chapter 3 reported no 
difference in neutrophil function, cortisol, DHEAS, cortisol:DHEAS and cortisol:cortisone 
ratio between the groups.  This was opposite to expectations based on the previous extensive 
research that showed a detrimental effect of caregiving stress on spousal dementia caregivers 
(Esterling et al. 1994, Glaser et al. 2000, Kiecolt-Glaser et al. 1991a, Vedhara et al. 1999).  
The most parsimonious explanation for this discrepancy between the present study findings 
and the previously reported research would be lower psychological morbidity in the current 
sample and selection bias towards those caregivers who are less stressed and are therefore 
much more likely to take part in the study.  However, from the scores on the range of 
psychological and caregiving-specific questionnaires used in the study it was clear that on the 
basis of the perceived stress, caregiving burden and problematic behaviour of the care-
recipient, the present group of caregivers was comparable in terms of stress levels to those 
used previously in caregiving research (Bauer et al. 2000, Bedard et al. 2001, Li et al. 2007, 
Roepke et al. 2008).  Another possible explanation emerged after closer analysis of the nature 
of the immunological assays used in the previous research when compared to those in the 
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present studies.  For example, caregivers of dementia patients showed poorer NK cell 
response only after stimulation with recombinant cytokines IFN-γ and IL-2 (Esterling et al. 
1994, Esterling et al. 1996).  In contrast, measure of the innate immunity in the study 
presented in chapter 3 was neutrophil function after in vitro stimulation with bacteria E.coli 
only, and therefore more resembling the studies that looked at the NK cytotoxicity without 
cytokine induction (Esterling et al. 1996, Irwin et al. 1991), which, on the contrary, did not 
observe any significant differences between older dementia caregivers and matched controls.  
Further, in previous studies, older caregivers showed a poorer immune response to influenza 
vaccination (Glaser et al. 1998, Kiecolt-Glaser et al. 1996, Vedhara et al. 1999), lower 
antibody titre against pneumococcal pneumonia antigen after 6 months follow up (Glaser et 
al. 2000), and slower wound healing (Kiecolt-Glaser et al. 1995) than age-matched controls.  
This further confirms the inability of the immune response to respond adequately in the 
presence of caregiving stress when actively challenged.  In other words, perhaps the strongest 
negative effect of caregiving stress is exerted once the organism is confronted with the 
pathogenic challenge or injury, such as in the case of administering a vaccination antigen, or 
causing a small biopsy wound, while the effect of stress on immunity in the resting state, such 
was the case in the present studies, was not clearly visible.  This is perhaps further confirmed 
by a study that reported no difference in the incidence of the upper respiratory infection 
between older caregivers and controls, but instead showed that caregivers who succumbed to 
the infection, took significantly more days to heal then the controls in which the same illness 
has occurred (Kiecolt-Glaser et al. 1991a).  This however, cannot be the case for all 
components of the immune response, since a different study found shorter telomere length in 
PBMCs of caregivers of Alzheimer's dementia patients than in controls at the basal 
(unstimulated) level (Damjanovic et al. 2007). 
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There was no difference in serum hormone levels (cortisol, cortisone and DHEAS) between 
the older caregivers and controls in the present study, despite the high perceived stress 
reported by older caregivers comparable to the levels of stress reported in previous studies 
(Bauer et al. 2000).  This contrasts with the higher cortisol levels reported in previous 
research in dementia caregivers when compared to controls (Bauer et al. 2000, Vedhara et al. 
1999), but is in concordance with others (Jeckel et al. 2010).  It is important to note, however, 
that the 2010 study that showed comparable salivary cortisol levels between the groups, still 
found lower salivary DHEAS levels and higher cortisol:DHEAS ratio in caregivers (Jeckel et 
al. 2010), contrary to the present findings.   
The results from chapter 4 showed a comparable T cell exhaustion profile in caregivers 
overall when compared to the controls.  In terms of the T cell senescence, there was no 
difference between caregivers and controls in T cells expressing CD57 marker, and controls 
showed higher expression of CD28 than caregivers only in young, while the expression of this 
marker was comparable between older caregivers and controls. The present findings are the 
first to examine exhaustion and senescent profiles of T cells in detail between caregivers and 
controls, both young and old, and to demonstrate a difference in KLRG1+ T cell senescent 
profile in both caregivers and older participants.  The only other study that examined the 
percentage of CD28- T cells found no difference between older dementia caregivers and 
matched controls (Damjanovic et al. 2007), consistent with the results presented in chapter 4.   
Caregivers in both age groups demonstrated a higher percentage of CD4+ and CD8+ KLRG1+ 
T cells than controls.  This marker is associated with replicative senescence and inhibition of 
T cell proliferation (Henson and Akbar 2009), but it is also involved in the exhaustion-
specific pathways (Henson and Akbar 2009).  KLRG1 is an inhibitory marker increasingly 
expressed on highly differentiated T cells with ageing.  It has been shown that blockage of 
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KLRG1 can induce proliferative activity of these T cells (Henson et al. 2009), which suggests 
the potential for targeting pathogen-specific, highly differentiated T cells by blocking KLRG1 
receptor in order to increase the poor vaccination response seen in older adults (Henson et al. 
2009, Henson and Akbar 2009).  This is further confirmed by a study that reported the 
inhibitory role of KLRG1 in CD4+ T cells response to novel antigens (Shi et al. 2014).  In 
addition, the increase in KLRG1 expression in caregivers presented in chapter 4 could explain 
consistently poorer vaccination response in caregivers when compared to the matched 
controls (Gallagher et al. 2009a, Kiecolt-Glaser et al. 1996, Vedhara et al. 1999).  Thus, this 
chapter gives further support to the notion that some but not all aspects of immunity are 
influenced by caregiving stress, but also contributes a potential mechanism by which some 
aspects of immunity are impaired in both young and older caregivers.  
 
6.5. PSYCHOSOCIAL AND CAREGIVING FACTORS, IMMUNE RESPONSE AND 
HORMONES 
Various studies have previously examined the relationship between self-reported 
psychological distress and impaired immune response in caregivers.  For instance, spouses 
and children of Alzheimer's dementia patients who reported higher depression 
symptomatology and perceived stress on the day of the vaccination against tetanus exhibited a 
lower antibody response (Li et al. 2007).  Also, those caregivers who reported more negative 
thoughts such as worry and rumination, had poorer antibody response than those whose 
thoughts were more positive (Segerstrom et al. 2008).  Further, higher stress levels and 
anxiety symptoms were correlated with PHA proliferation, but not in vitro IL-2 production 
(Bauer et al. 2000).  In younger caregivers, those parental caregivers who reported more child 
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behavioural problems had also poorer antibody response to vaccination against pneumonia 
(Gallagher et al. 2009b).  The findings in chapter 3 build on this previous literature by 
comparing neutrophil function (phagocytosis and ROS production) with all psychosocial and 
caregiving variables measured.  The results showed that caregivers with higher depression and 
anxiety symptomatology, perceived stress and caregiving burden had poorer neutrophil 
phagocytosis.  In addition, those with poorer sleep quality had lower neutrophil ROS 
production.  Subsequent sensitivity analysis further confirmed this for anxiety, caregiving 
burden and poorer sleep quality.   
 
The results in chapter 4 also relate higher psychological morbidity to lower levels of some 
aspects of immunity, specifically immunosenescence markers and higher TREC expression 
ratio, which at first appears counterintuitive.  However, the explanation for this discrepancy 
lies in the overall better senescent and exhausted profile in the younger caregivers, who, in 
addition, reported higher psychological morbidity than older caregivers (see Table 1, chapter 
3).  This is further confirmed with the findings that more problematic behaviour by care-
recipients is reported by older caregivers whose T cells express more CD57 senescent 
markers.   Overall, the results of chapters 3 and 4 add to the mixed picture of a differential 
effect of caregiving stress on various immune parameters.  In addition, they emphasise the 
importance of future research to focus not on caregiving status per se, but in particular on 
those individuals who show higher psychological morbidity, and highlight this sub-sample of 
caregivers as those most in need of intervention to address both psychological distress and its 
associated immune impairment. 
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6.6. BEREAVEMENT STRESS, NEUTROPHIL FUNCTION, CORTISOL AND 
DHEAS IN YOUNG AND OLDER ADULTS 
Chapter 5 examined the effect of chronic stress after suffering bereavement on neutrophil 
function and serum cortisol and DHEAS levels in younger and older adults.  Bereaved 
participants reported higher depression and anxiety symptomatology than age- and sex 
matched controls, and significant levels of feelings of loss and grief.  Despite this, there was 
no difference in neutrophil function (both phagocytosis and ROS production), nor serum 
stress hormone levels between the younger caregiver and control groups.   
To our knowledge, this is the first study to simultaneously examine the effect on neutrophil 
function and stress hormone levels after recent bereavement in young and older adults.  The 
present findings of no difference in immune and endocrine parameters are perhaps surprising 
considering previously reported study by our laboratory that found significantly lower 
oxidative burst activity in older bereaved adults when compared to the matched controls 
(Khanfer et al. 2011).  However, closer analyses revealed the younger group as the main 
driver of this null finding, and that the older bereaved adults did show impaired immunity.  
The levels of depression and anxiety symptoms, as well as feelings of loss and grief reported 
by the young bereaved in the present study were high, and similar to those recorded for older 
bereaved adults (see Table 1, chapter 5) but did not extend to an impact upon immunity in the 
older group. 
Previous findings from bereavement research showed poorer NK cell function (Irwin et al. 
1987), vaccination response (Phillips et al. 2006a) and neutrophil ROS production (Khanfer et 
al. 2011) in older bereaved adults when compared to the matched controls.  For younger 
adults, however, poorer immune function was reported only if accompanied by symptoms of 
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major depression (Zisook et al. 1994), or in the case of the sudden and unexpected death of 
the loved one (Gerra et al. 2003, Spratt and Denney 1991).  In the study presented in chapter 
5, only one bereaved participant met the criteria for severe depression or higher (HADS ≥ 11), 
and only 14% of losses were unexpected.  Therefore, in the absence of severe psychological 
morbidity, one could conclude that presence of immunosenesence, the deterioration of the 
immune system that occurs with age, is necessary for the bereavement to exert its full 
negative effect on the immune function.   
In terms of serum hormone levels, cortisol and DHEAS, as well as their ratio were similar in 
young bereaved to those of the control group.  This is again in contrast with the data from 
older group where, consistent with the previously reported data (Khanfer et al. 2011), 
bereaved had higher cortisol:DHEAS ratio, further confirming seeming ability of the young to 
resist the negative immune effect of chronic bereavement stress.  Interestingly, however, 
DHEAS was lower and ratio between the two hormones was higher in those young bereaved 
who lost closer relative (parent/spouse) when compared to those who lost more distant 
relative (grandparent, parent-in-law), and this ratio was higher in those who reported higher 
grief on CBI scale, and lower in those with higher social support, suggesting that those worst 
affected by bereavement did show some physiological decrements.  This was, however, not 
the case with the neutrophil function which was comparable between the groups, suggesting 
that perhaps specific nature of the loss might affect hormonal status, but not extend to an 
impact on immune parameters such as neutrophil phagocytosis and ROS production.  It is not 
known what the longer term effects of the raised cortisol:DHEAS ratio in the most distressed 
younger caregivers might be, which would need longitudinal study.  These findings also do 
not minimise the need to address the high levels of psychological distress in younger bereaved 
adults, despite their seeming protection against immune system down-regulation.  
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6.7. CHRONIC STRESS, IMMUNE RESPONSE AND THE HPA AXIS 
Based on the findings presented in this thesis as well as previously reported results it appears 
that the effect of chronic stress on immune function and stress hormones is dependent upon 
the type of chronic stress, specific parameters of immunity, and the circumstances in which 
the effect in question is measured.  With this in mind, it could be argued that caregiving 
stress, in both young and old, is most likely to exhibit its negative effect on an already 
stimulated immune response, such as during vaccination and wound healing (Esterling et al. 
1994, Gallagher et al. 2009b, Gallagher et al. 2009a, Vedhara et al. 1999), or in case of NK 
cell function when stimulated by cytokines (Esterling et al. 1994).  Similarly, a higher number 
of T cells expressing senescent KLRG1 marker in caregivers regardless of their age links to, 
and offers a possible explanation for the poorer vaccination response in those affected by 
caregiving stress, suggesting a negative effect of stress even in the absence of 
immunosenescence, at least for some parts of immune response.  On the other hand, 
measuring immune system function at rest, so in the absence of the prior immune challenge, 
may not show the expected negative effect, as seen for neutrophil function and some aspects 
of T cell immunity, presented in chapters 3 and 4, respectively, as well as in case of NK cell 
function without prior cytokine stimulation (Irwin et al. 1991).  In addition, the mechanisms 
by which caregiving stress demonstrates its effect might be more complex than HPA axis and 
stress hormone levels alone.  Another type of chronic stress, that of suffering with 
bereavement, appears to differently affect young and old individuals, with the HPA axis 
appearing to have an important role in exerting the negative effect of bereavement on the 
immune response in the old.  A proposed model of the relationship between chronic stress, 
immune and hormone parameters based on the data in the present thesis is presented in Figure 
1.  
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Figure 1. Proposed model of the relationship between chronic stress, immune response and stress hormones. 
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6.8. LIMITATIONS 
The studies presented in chapters 2 to 5 of this thesis suffer from several limitations.  One 
problem present throughout is the small sample sizes used.  This is a common problem for 
caregiving and bereavement research, mainly due to the challenges regarding the difficult 
recruitment of these groups of participants.  Therefore, one could assume that the limited 
power of these studies is the reason for the lack of the significant effects.  However, the 
studies used G-power analysis programme to determine the required number of participants 
for a medium effect size.  For example, the studies described in chapters 3 and 4, for the 
medium effect size, with power at .80, and alpha at .05 with 4 groups, required a sample size 
on the basis of power calculation of 134.  The aim was to recruit at least 35 participants in 
each group to allow for some small amount of missing data.  Further, the sample size in the 
present studies is of the similar magnitude and in some cases even greater than in previous 
research that reported significant effects on immunity (Gallagher et al. 2009a, Glaser et al. 
2000, Vedhara et al. 1999).   
Another limitation that applies to studies in chapters 2 through to 5 is the method of 
recruitment.  Since the target of all the studies were hard-to-reach groups of participants, 
parents of children with developmental disabilities, spouses of dementia patients or bereaved 
younger adults, it could be argued that there is the bias in these studies towards those that 
cope better and are therefore more likely to take part in the studies, but may not be 
representative of the caregiving/bereaved population.  However, in all cases attempt was 
made to minimise this bias by giving the option of the home visits to participants and overall 
organising the testing session so that they best suit individual's needs, and the participants 
reported similar high levels of psychological morbidity i.e., stress and burden to previously 
reported samples.  Further, most of the younger caregivers from chapters 2, 3 and 4 were 
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recruited via syndrome groups, and from our experience, those were the parents that indicated 
these support days as one of the very few qualitative support mechanisms available to them, 
where they could gain the relief from their very stressful daily life.   
A third limitation relevant to all the studies was that they were all cross-sectional, and 
therefore unable to determine changes in certain aspects of immune function in the stressed 
groups over time.  This was particularly relevant for the CMV studies presented in chapter 2 
and a part of chapter 4 where comparing the antibody titre against CMV with the control 
group could not determine if comparable antibody levels were indeed the consequence of the 
adequate immune control over the virus or there were other factors involved such as time 
since initial infection.  In that respect, future longitudinal studies that measure immune 
function over the several time points using the same sample subset will be able to shed light 
on this question, although it is envisaged that this would be particularly challenging in these 
difficult to reach groups. 
A potential limitation which applies to the studies presented in chapters 3 and 5 is related to 
the diurnal variations of stress hormone levels such as cortisol and cortisone (Nomura et al. 
1997).  Therefore, measuring the serum levels of these hormones in a single time point could 
be interpreted as inaccurate.  However, attempts were made to overcome this limitation by, 
where possible, conducting the blood sampling in the narrow time window, between 9-11a.m.   
In addition, our initial aim for the study presented in chapter 3 was to collect and analyse 24-
hour urine samples, as a more accurate measure of the steroid hormone levels.  However, the 
analysis of these samples was not possible due to the costs of the assay required. 
Finally, studies in chapters 2 and 3 would benefit from introducing another measure of 
immune response.  In chapter 2, measuring CMV-specific T cell response would provide a 
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better understanding of adequate control of CMV infection.  In chapter 3, in addition to 
neutrophil function, measuring another component of innate immunity, such as NK cell 
function, would increase the power of analyses.  However, in both cases, additional analyses 
would require a large amount of the whole blood, unavailable in the present studies.  In 
addition, for the study in chapter 3, analyses of NK cell function have already been conducted 
and measured in the older spousal dementia caregivers (Esterling et al. 1996, Esterling et al. 
1994).   
 
6.9. FUTURE DIRECTIONS 
The findings from this thesis can be used as a basis for several directions of future research.   
A common path for all the studies would be replicating it using the larger sample in order to 
either confirm or refute the present findings.  In addition to this, the research in each of the 
chapters can be taken forward in different ways. 
The lack of differences in serum anti-CMV antibody titre between younger parental 
caregivers and controls should be further examined by conducting a longitudinal study that 
will monitor serum CMV seropositivity and corresponding titre over several time points using 
the same group of participants.  Only then the conclusion can be made if the comparable 
levels between these two groups are indeed the consequence of preserved latent virus control 
in younger caregivers or present results are the artefact of, for example, different infection 
times.  Further, other parameters of the immune system directed against CMV should be 
measured.  This includes CMV-specific T cell immunity, as the main effector system 
responsible of controlling CMV infection, as well as IgM antibody titre, that, in addition to 
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IgG would provide a clearer picture about the time of the infection and if re-infection of the 
virus has occurred. 
The findings of the study presented in chapter 3 suggested that those caregivers with higher 
psychological morbidity show poorer neutrophil functioning.  Therefore, they emphasise the 
importance of extending the future research focus from caregivers in general, towards those 
with greater stress, depression, anxiety and burden.  In other words, rather than generalising 
the effect of caregiving stress across the population it is perhaps more important to focus on 
detecting individual feelings, needs and ability to function under particular circumstances.  
This will not only enable early detection of those individuals that need greater psychosocial 
support, but will also provide the insight to the method of the intervention that might be the 
most helpful in order to preserve effective immune function.  For example, this particular 
group of caregivers showed poorer neutrophil phagocytosis associated with higher anxiety 
and burden and poorer neutrophil ROS production with poorer sleep, suggesting therefore, 
that those individuals would most benefit from the interventions targeting lowering anxiety 
and providing more respite time.  The need for individualisation of treatment is further 
supported by the findings in chapter 4 that identified problematic behaviour in care-recipient 
as the driver of the higher senescent profile amongst older caregivers, but no association 
between other psychosocial variables and immune functioning, again suggesting a need for 
respite care and possibly interventions to help cope with dementia patients’ challenging 
behaviours. 
Higher expression of the KLRG1 marker in caregivers despite comparable senescent and 
exhausted profiles assessed through CD28, CD57 and PD-1 marker presented in chapter 4 is 
perhaps the most relevant for the future studies focussing on immunity.  First, it complements 
the previously reported studies that found a poorer vaccination response in both younger and 
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older caregivers when compared to the age- and sex-matched controls.  Second, KLRG1 is 
starting to emerge as the safest target for the reversion of the early senescence and exhaustion 
(Akbar and Henson 2011), and therefore potentially the best pathway for the future 
interventions.  One direction would be to further explore KLRG1 as a potential mechanism 
for increasing the function of specific T cells.  This could then be used in future medical 
interventions to boost vaccination response in older and stressed adults.   
The final study in chapter 5 showed no difference in neutrophil function and stress hormone 
levels between bereaved and controls, which was driven by the lack of the effect in younger 
group.  There was also no indication of an association between psychological morbidity in 
bereaved and immune or endocrine parameters, with the exclusion of those losing closer 
relative and reporting higher grief having higher cortisol:DHEAS ratio, while those with 
higher social support having lower ratio.  This suggests that in the case of bereavement, 
immunosenescence is perhaps necessary for exerting negative effect on neutrophil and 
endocrine function.  However, these findings are only preliminary and need to be further 
confirmed in larger studies.  Further, additional measures of immune function would help in 
understanding if the preservation of neutrophil function in young bereaved adults is in fact 
representative of the immune response in general.  Interventions that address grief in younger 
caregivers could also be a useful model for the study of the potential to improve immune 
function in those at risk due to high psychological morbidity.  Finally, additional decrease in 
DHEAS in those caregivers and bereaved from the older cohort who report higher anxiety 
symptomatology, perceived stress, and for bereaved participants, higher feelings of grief point 
to, and further support the idea of an randomised controlled trial of DHEA replacement 
therapy to the stressed older adults. 
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6.10. CONCLUSIONS 
In conclusion, the present studies demonstrated that the effect of chronic stress on immune 
and endocrine function, be it caregiving or bereavement, is not straightforward, but depends 
on many factors.  These factors include the specific immune parameters or hormones 
measured; the age of stressed person; and, at least in the case of caregiving stress, the 
psychological resilience or burden of the individual.  There was no evidence that immune 
control over CMV virus is compromised in younger parental caregivers, and similarly for 
neutrophil function and serum cortisol and DHEAS in young bereaved, suggesting that 
previously reported decrements in these immune parameters for older populations were most 
likely a consequence of the synergistic effect of chronic stress and immunosenescence.  On 
the other hand, neutrophil function, as well as some of the markers of T cell-related 
exhaustion and senescence, were preserved in both young and older caregivers when 
compared to the age-matched controls.  Similarly, serum cortisol and DHEAS as well as their 
ratio were comparable between the groups, with the main differences emerging between 
young and old.  However, the differences between caregivers and controls emerged for the 
KLRG1 T cell profile, confirming previously the reported decrease in the vaccination 
response in both young and old caregivers when compared to controls, and emphasising the 
potential for manipulating KLRG1 related pathways in future immunotherapeutic measures 
for boosting the immunity in the aged and stressed.  In addition, caregivers had a higher 
serum cortisol:cortisone ratio, which could indicate a raised 11β-HSD1 activity in this 
stressed group.  Finally, the caregiving studies indicated the differential effects of caregiving 
stress-influenced behaviours or emotions on different immune parameters.  In the case of 
CMV antibody titre, it was unhealthy behaviours such as poorer diet and exercise levels and 
higher BMI that was associated with the higher CMV antibody titre.  Further, caregivers with 
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higher anxiety and burden levels as well as poorer sleep showed poorer neutrophil function, 
while older caregivers who reported more problem behaviours in their spouses with dementia 
had higher senescent profile.  Finally, although there was no association between 
psychological morbidity and neutrophil function in the young bereaved adults, those who lost 
closer relative had lower serum DHEAS, and higher cortisol:DHEAS ratio.  These findings 
implicate the importance of measuring individual differences in chronically stressed groups 
more closely rather than simply focusing on stress exposure per se, as a better way of 
examining mechanisms linking stress and health, and targets for potential intervention.   
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APPENDIX 
 
ADDITIONAL FINDINGS FROM CHAPTER 3 
The Table below presents the raw serum cytokine values (in pg/ml) collected from the 
older and young, caregiving and control participants presented in the chapter 3.  Symbol a 
presents significant age effect; symbol b significant difference between caregivers and 
controls; and symbol c significant age * caregiving interaction effect.  Serum levels of the 
cytokines: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-15, IFN-γ, TNF-α, and GM_CSF 
were simultaneously detected using a Human Cytokine 10-Plex Panel for 96-well plate 
(Invitrogen). The assay was performed following suppliers instructions (Invitrogen, Cat. 
no.LHC0001).  Briefly, the polystyrene beads internally dyed with red and infrared 
fluorophores of different intensities are conjugated to cytokine-specific capture 
antibodies.  The wells were coated with 50µl of mixed beads, aspirated and washed 
twice, after which 100µl of and 100µl of previously diluted standards were added to the 
each well and incubated on the shaker for 2 hours at 250rpm. After washing, cytokine-
specific biotinylated detector antibodies were added and incubated for 1 hour allowing 
binding to the corresponding immobilized cytokines. Washing step was preformed to 
remove the excess of biotinylated antibody, after which PE-streptavidin was added and 
incubated for 30 minutes to allow the formation of a four-member solid phase sandwich. 
The excess PE-streptavidin was washed and the beads were analysed using a Luminex 
detection system (Luminex 100). The specific cytokines and their concentrations were 
determined by monitoring the bead colour (analyte) and the signal strength of the assay 
(PE fluorescence).  
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 Mean (SD) 
 Young Older 
  
Caregivers  
(N = 52) 
 
Controls  
(N = 32) 
 
Caregivers  
(N =37) 
 
Controls  
(N =40) 
IL-1β a 13.4 (24.63) 9.7 (9.16) 12.2 (28.24) 8.7 (37.56) 
IL-6 6.8 (11.07) 4.0 (4.87) 14.0 (27.02) 5.1 (8.17) 
GM-CSF c 20.1 (28.0) 27.6 (36.92) 35.7 (52.99) 24.1 (41.41) 
IL-5 32.6 (101.19) 5.3 (9.09) 13.3 (40.12) 13.1 (36.20) 
IFN-γ 6.6 (21.75) 2.4 (1.95) 6.8 (13.01) 2.7 (2.68) 
TNF-α   44.0 (100.46) 10.7 (14.78) 43.4 (100.47) 22.9 (47.84) 
IL-2 a 6.5 (10.11) 6.5 (7.74) 6.8 (15.36) 5.8 (13.67) 
IL-4 b 24.93 (55.44) 8.6 (7.68) 29.8 (65.24) 16.8 (39.52) 
IL-8 a, b, c 21.7 (33.42) 16.8 (24.50) 58.9 (156.38) 0.2 (1.37) 
IL-10 c 66.5 (98.49) 81.2 (126.28) 103.4 (146.27) 70.2 (122.39) 
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ADDITIONAL FINDINGS FROM CHAPTER 4 
The Table below presents correlations between CMV titres and the T cell senescent (CD28- and 
CD57+) profiles split between young and older adults. 
Young 
 r df p 
    
CD4+CD28- T cells .32 41 .04 
CD8+CD28- T cells .48 41 .001 
CD4+CD57+ T cells .43 41 .001 
CD8+CD57+ T cells .32 41 .04 
Older 
CD4+CD28- T cells .45 53 .001 
CD8+CD28- T cells .43 53 .001 
CD4+CD57+ T cells .39 53 .004 
CD8+CD57+ T cells .22 54 .11 
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HEALTH BEHAVIOUR QUESTIONNAIRE 
Please circle the appropriate answer 
 
1. Over the last year, 
how many 
cigarettes, on 
average, did you 
smoke per day? 
None 
 
1-5 
 
6-10 
 
11-20 
 
21+ 
 
40+ 
 
2. Over the last year, 
on average, how 
often have you 
taken an alcoholic 
drink? 
Never Special 
Occasions 
only 
1-2 
per 
month 
 
1-2 
per 
week 
 
Almost 
daily 
 
2 per 
day or 
more 
 
 
For the following question, please base your answers on the following: 
1 unit = ½ pint of beer, 1 small glass of wine, 1 measure of spirit 
Remember that home poured measures are likely to be larger 
1 bottle of wine = 6 glasses, 1 average bottle of spirits = 27 measures 
 
3. Over the last year, 
on average, how 
many units did you 
drink per week? 
 
 
None 
 
1-5 
 
 
6-10 
 
11-20 
 
 
20-40 
 
 
41+ 
 
4. Over the last year, 
how many hours, 
on average did you 
sleep per night? 
 
 
0-3 
 
 
4-5 
 
 
6-7 
 
 
8-9 
 
 
10-11 
 
 
 
12+ 
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5. Over the last year, 
how often have you 
taken 
vitamin/mineral 
supplements? 
Never 
 
Special 
Occasions 
only 
1-2 
per 
month 
 
1-2 
per 
week 
 
Almost 
daily 
 
2 per 
day or 
more 
 Over the last year, how many hours per week on average, have you spent participating in 
activities which are:        
6. Mildly energetic e.g. 
walking? 
0 1-2 
 
3-5 
 
6-8 
 
9-10 
 
11+ 
 
7. Moderately energetic 
e.g. leisurely 
swimming, golf 
0 
 
1-2 
 
3-5 
 
6-8 
 
9-10 
 
11+ 
 
8. Vigorously energetic 
e.g. running, squash 
 
0 
 
1-2 
 
3-5 
 
6-8 
 
9-10 
 
11+ 
 
 
Please answer the following questions with reference to your diet over the last year.  Answer 
as honestly and accurately as possible.  
9. Are you on a special 
diet of any sort? 
No 
 
Vegetarian 
 
Vegan 
 
Weight-loss 
 
Other 
 
 
If other, please state…………………………………………………………………. 
10. How often do 
you eat 
breakfast? 
Every  
day 
 
Most days 
(3-6) 
 
Once or 
twice a 
week 
Less than 
once a 
week 
 
Never 
 
171 
 
Please indicate how often you have eaten each of the following foods over the past year.  
 Never Less 
than 
once a 
week 
1 or 2  
a 
week 
Most 
days 
(3-6) 
Once  
a  
day 
2-3 
times 
a day 
4 or 
more 
times 
a day 
Fresh fruit/salad/raw veg. 
 
      
Cooked veg. (not potatoes)        
Chips/fried food        
Potatoes/pasta/rice        
Bread (2 slices=one 
portion) 
       
Crisps/similar        
Tea        
Sweets/Chocolate        
Breakfast cereal        
Biscuits/cakes/puddings        
Low fat snack bars        
Full fat dairy products        
Reduced fat dairy products        
Fish/seafood (not fried)        
Poultry (not fried)        
  
11. Apart from breakfast, how many 
main/cooked meals do you usually have 
during the day? 
 
 
......... 
  
 12. How many cups/cans of caffeinated 
drink (coffee/tea/cola) do you usually 
drink in a day? 
 
......... 
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Processed meat (e.g. 
pasties, pies, burgers) 
       
Beef/lamb/pork/ham/ 
bacon 
       
Soft drinks (non-
caffeinated) 
       
Pure fruit juice        
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PITTSBURGH'S SLEEP QUALITY INDEX (PSQI) 
1. During the past year, what time have you usually laid down to go to sleep? 
  Usual Bed time: ______________  
      
2. During the past year, how long (in minutes) has it taken you to fall asleep at night?   
Number of minutes: __________________ 
 
 3. During the past year what time have you usually gotten up in the morning? 
Getting up time: _______________________ 
 
4. During the past year how many hours of actual sleep did you get a night? (This may       
be different than the number of hours you spent in bed)        
Hours of sleep per night:________________ 
 
For each of the remaining questions, mark the one best response. Please answer all 
questions.  
 
5. During the past year, how often have you had trouble sleeping because you…….. 
 Not during 
the past 
month  
Less than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
times a 
week 
Could not get to sleep within 30 min….. 
 
    
Woke up in the middle of the night or 
early in the morning….. 
    
Had to get up to use the bathroom… 
 
    
Could not breathe comfortably… 
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Felt too hot… 
 
    
Felt too cold ….. 
 
    
Had bad dreams…. 
 
    
Had pain …… 
 
    
 
6. During the past year, how would you rate your sleeping quality overall? 
Very bad       Fairly bad      Fairly good  Very good 
 
7. During the past year, how often have you taken medicine (prescribed or ‘over the counter’) 
to help you sleep? 
              Not during the       Less than               Once or twice                Three or more  
                past month           once a week             a week                          times a week 
 
8. During the past year, how often have you had trouble staying awake while driving, eating 
meals, or engaging in social activity? 
              Never                      Less than               Once or twice                Three or more  
                                              once a week           a week                           times a week 
 
9. During the past year, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? 
                 Not problem             Only a very              Somewhat of                    A very big 
                 at all                        slight problem          a problem                         problem 
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HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) 
This questionnaire is about how you feel in general.  Read each item and circle the reply 
which comes closest to how you have been feeling in the past week.  Don't take too long over 
your replies: your immediate reaction to each item will probably be more accurate than a long 
thought-out response.     
1. I feel tense or wound up  
 
Most of the 
time  
 A lot of the 
time  
Time to time Not at all 
2. I still enjoy the things I 
used to enjoy  
 
Definitely 
as much 
Not quite so 
much 
  Only a little  
 
Hardly at 
all 
3. I get a sort of frightened 
feeling as if something 
awful is about to happen  
 
Very 
definitely 
and quite 
badly 
Yes, but not 
too badly  
 
A little, but it 
doesn't worry 
me 
Not at all 
4. I can laugh and see the 
funny side of things 
As much as I 
always could  
Not quite as 
much now 
Definitely not 
so much now 
Not at all 
5. Worrying thoughts go 
through          my mind 
A great 
deal of the 
time  
A lot of the 
time 
From time to 
time but not 
too often 
Only 
occasionall
y 
6. I feel cheerful Not at all  Not often Sometimes  Most of 
the time 
7. I can sit at ease and feel 
relaxed 
 
Definitely  Usually  Not often Not at all 
8. I feel as if I am slowed 
down 
Nearly all 
the time   
  Very often Sometimes  Not at all   
9. I get a sort of frightened 
feeling like butterflies in 
the stomach 
 
Not at all  
 
Occasionally  
 
  Quite often  
 
Very often 
10. I have lost interest in my 
appearance 
Definitely I don't take 
so much care 
as I should  
I may not take 
quite as much 
care 
I take as 
much care 
as ever 
11. I feel restless as if I have 
to be on the move 
Very much 
indeed  
Quite a lot  Not very 
much  
Not at all 
12. I look forward with 
enjoyment to things 
As much as 
ever I did 
Rather less 
than  used to  
Definitely less 
than I used to 
Hardly at 
all 
13. I get sudden feelings of 
panic 
Very often 
indeed 
Quite often Not very often  Not at all 
14. I can enjoy a good book 
or radio or TV 
programme 
 
Often  
 
  Sometimes  
 
  Not often  
 
Very 
seldom 
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CAREGIVING ACTIVITY SURVEY (CAS) 
These questions ask about your caregiving time. 
On average, for any given day or night, how many hours do you spend doing the following 
for your children......? 
 
1. Taking them to various places (other than shopping) by car or public transport (please 
include preparation time).  
________ Hours   ______Min  
 
2. Helping them to dress (undress, dress, reminding them what to wear etc)  
________ Hours   ______Min  
 
3. Helping them with their eating (cutting food, feeding, cleaning them after eating)  
________ Hours   ______Min  
 
4. Helping them to wash, brush their teeth, maintain their appearance over the day 
________ Hours   ______Min  
 
5. Watching and supervising them in case they get into difficulty 
________ Hours   ______Min  
 
6. On average, for any given week, how many hours do you feel you have lost either for     
work or leisure because of your caregiving role. 
________ Hours   ______Min 
 
7. On average, for any given month, how many hours respite (social services or friends 
and family) from your caregiving duties do you receive?  
________ Hours   ______Min 
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CAREGIVING BURDEN INDEX (BI) 
This questionnaire assesses your stress experience whilst caring for your child/children. There 
are no right or wrong answers. It is just your own personal feeling that count. For each item, 
please indicate how often you have felt that way. 
1. Do you feel that because of the 
time you spend with your child 
that you don’t have enough time 
for yourself? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
2. Do you feel stressed between 
caring for your child and trying to 
meet other responsibilities for 
your family or work? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
3. Do you feel angry when you are 
around your child? 
Never Rarely Sometimes Quite 
Frequently 
Nearly 
always  
4. Do you feel that your child 
currently affects your relationship 
with other family members or 
friends in a negative way? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
5. Do you feel that your health has 
suffered by your involvement 
with your child? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
6. Do you feel strained when you are 
around your child? 
 
Never Rarely Sometimes Quite 
frequently 
Nearly 
always  
7. Do you feel that you don’t have 
much privacy as you would like, 
because of your child? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
8. Do you feel that your social life 
has suffered because you are 
caring for your child? 
 
Never Rarely Sometimes Quite  
frequently 
Nearly 
always  
9. Do you feel you have lost control 
of your life because of your 
child’s disability? 
 
Never Rarely Sometimes Quite 
frequently 
Nearly 
always  
10. Do you feel uncertain about what 
to do about your child? 
 
Never Rarely Sometimes Quite 
frequently 
Nearly 
always  
11. Do you feel you should be doing 
more for your child? 
 
Never Rarely Sometimes Quite 
frequently 
Nearly 
always  
12. Do you feel you could be doing a 
better job of caring for your child? 
 
Never Rarely Sometimes Quite 
frequently 
Nearly 
always  
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STRENGHTS AND DIFFICULTIES QUESTIONNAIRE (SDQ) 
For each item, please mark the box on the basis of the child's behaviour over the last six 
months. It would help us if you answered all items as best you can, even if they seem daft!  
If you have more than one child with developmental disabilities, please complete the 
questionnaire regarding the child with what you consider to be the most difficult behaviour.                          
                                                                                                 Not    Somewhat  Certainly     
                                                                                                 True       True        True 
1. Considerate of other people’s feelings 
   
2. Restless, overactive, cannot stay still for long 
   
3. Often complains of headaches, stomach-aches 
or sickness 
   
4. Shares readily with other children (treats, 
toys, pencils etc) 
   
5. Often has temper tantrums or hot tempers 
   
6. Rather solitary, tends to play alone 
   
7. Generally obedient, usually does what adults 
request 
   
8. Many worries, often seems worried 
   
9. Helpful if someone is hurt, upset or feeling ill 
   
10. Constantly fidgeting or squirming 
   
11. Has at least one good friend 
   
12. Often fights with other children or bullies 
them 
   
13. Often unhappy, down-hearted or tearful 
   
14. Generally liked by other children 
   
15. Easily distracted, concentration wanders 
   
16. Nervous or clingy in new situations, easily 
loses confidence 
   
17. Kind to younger children 
   
179 
 
18. Often argumentative with adults 
   
19. Picked on or bullied by other children 
   
20. Often volunteers to help others (parents, 
teachers, etc) 
   
21. Can stop and think things out before acting 
   
22. Can be spiteful to others 
   
23. Gets on better with adults than with other 
children 
   
24. Many fears, easily scared 
   
25. Sees tasks through to the end, good attention 
span 
   
    
• Takes a long time to settle to sleep at night    
• Wakes in the night often for long periods    
• Is awake very early before anyone else in the 
family 
   
During the past year how many times did you awake per night on average? (This may be due  
to   young child(ren) waking and needing care)       Times awake per night:____________ 
During the past year, how often have 
you had trouble sleeping because 
your child(ren) is/are wakeful and 
need care 
Not during 
the past 
month  
Less than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
times a 
week 
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PERCEIVED STRESS (PSS) 
The questions in this scale ask you about your feelings and thoughts during the LAST 
MONTH. In each case, indicate by ticking in the appropriate space how often you felt or 
thought a certain way. Although some of the questions are similar, there are differences 
between them and you should treat each one as a separate question.   
 Never  Almost 
never  
Sometimes  Fairly 
often 
Very 
often 
1. In the past month, how 
often have you been upset 
because of something that 
happened unexpectedly?  
 
     
2. In the past month, how 
often have you felt that 
you were unable to control 
the important things in 
your life? 
 
     
3. In the past month, how 
often have you felt 
nervous or stressed? 
 
     
4. In the past month, how 
often have you dealt with 
irritating life hassles? 
 
     
5. In the past month, how 
often have you felt that 
you were effectively 
coping with important 
changes that were 
occurring in your life? 
 
     
6. In the past month, how 
often have you felt 
confident about your 
ability to handle personal 
problems? 
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7. In the past month, how 
often have you felt that 
things were going your 
way? 
 
     
8. In the past month, how 
often have you felt that 
you could not cope with 
all the things you had to 
do? 
 
     
9. In the past month, how 
often have you been able 
to control irritations in 
your life? 
 
     
10. In the past month, how 
often have you felt that 
you were on top of things? 
 
     
11. In the past month, how 
often have you been 
angered because of things 
that happened that were 
outside of your control? 
 
     
12. In the past month, how 
often have you found 
yourself thinking about 
things that you have to 
accomplish? 
 
     
13. In the past month, how 
often have you been able 
to control the way you 
spend your time? 
 
     
14. In the past month, how 
often have you felt 
difficulties were piling up 
so high that you could not 
overcome them? 
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SUPPORT FUNCTION SCALE - SHORT FORM (SFS-SF) 
Listed below are 12 different types of assistance which people sometimes find helpful. This 
questionnaire asks you to indicate how much help you need in these areas. Please circle the 
response that best describes your needs. Please answer all the questions.  
How often is each of the following kinds of support available to you if you need it? 
1. Someone to talk about 
things that worry you 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
2. Someone to help take care 
of your child  
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
3. Someone to talk to when 
you have questions about 
raising your child 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
4. Someone who loans you 
money when you need it 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
5. Someone to encourage or 
keep you going when 
things seems hard 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
6. Someone who accepts 
your child regardless of 
how (s)he acts 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
7. Someone to help with 
household chores 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
8. Someone to relax or joke 
with 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
9. Someone to do things with 
your child 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
10. Someone to provide you 
or your child with 
transportation 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
11. Someone to hassle with 
agencies or individuals 
when you can’t  
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
12. Someone who tells you 
about services for your 
child or family 
 
Never Once in 
a while 
Sometimes  Often  Quite 
Often 
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MEDICAL OUTCOMES STUDY: SOCIAL SUPPORT SURVEY (MOS-SSS) 
About how many close friends and close relatives do you have (people you feel at ease with 
and can talk to about what is on your mind)? 
People sometimes look to others for companionship, assistance, or other types of support.   
How often is each of the following kinds of support available to you if you need it? 
 None 
of the 
time 
A little 
of the 
time 
Some 
of the 
time 
Most 
of the 
time 
All of 
the 
time 
1. Someone to help you if you were 
confined to bed 
     
2. Someone you can count on to listen to 
you when you need to talk 
     
3. Someone to give you good advice 
about a crisis 
     
4. Someone to take you to the doctor if 
you needed it 
     
5. Someone who shows you love and 
affection 
     
6. Someone to have a good time with 
     
7. Someone to give you information to 
help you understand a situation 
     
8. Someone to confide in or talk to 
about yourself or your problems 
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9. Someone who hugs you 
     
10. Someone to get together with for 
relaxation 
     
11. Someone to prepare your meals if you 
were unable to do it yourself 
     
12. Someone whose advice you really 
want 
     
13. Someone to do things with to help 
you get your mind off things 
     
14. Someone to help with daily chores if 
you were sick 
     
15. Someone to share your most private 
worries and fears with 
     
16. Someone to turn to for suggestions 
about how to deal with a personal 
problem 
     
17. Someone to do something enjoyable 
with 
     
18. Someone who understands your 
problems 
     
19. Someone to love and make you feel 
wanted 
     
 
  
185 
 
(PEARLIN) PROBLEMATIC BEHAVIOUR 
In the past week, how many days did you personally have to deal with the following behaviour  
of your spouse/partner?  On how many days did she/he: 
1. Keep you up at night 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
2. Repeat questions/stories 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
3. Try to dress the wrong way 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
4. Have a bowel or bladder 
“accident” 
No days  1-2 days 
 
3-4 days 5/more 
days 
5. Hide belongings and forget 
about them 
No days  1-2 days 
 
3-4 days 5/more 
days 
6. Cry easily No days  1-2 days 
 
3-4 days 5/more 
days 
7. Act depressed or downhearted 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
8. Cling to you or follow you 
around 
No days  1-2 days 
 
3-4 days 5/more 
days 
9. Become restless or agitated 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
10. Become irritable or angry No days  1-2 days 
 
3-4 days 5/more 
days 
11. Swear or use foul language No days  1-2 days 
 
3-4 days 5/more 
days 
12. Becomes suspicious, or 
believe someone is going to 
harm him/her 
No days  1-2 days 
 
3-4 days 5/more 
days 
13. Threaten people No days  1-2 days 
 
3-4 days 5/more 
days 
14. Show sexual behaviour or 
interests at the wrong 
time/place 
 
No days  1-2 days 
 
3-4 days 5/more 
days 
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THE QUESTIONS ABOUT THE BEREAVEMENT 
These questions are about your recent bereavement. 
 
1. How long is it since you were bereaved?  (days/months – please delete one) 
 
2. How was the person who has died related to you (spouse/relative/friend)?  
 
3. How old was this person when they died? 
 
4. Was the death of this person expected/unexpected?  (please delete one) 
 
Please tick below if this event has happened to you. 
For each event that happened to you, please score how serious (stressful, worrying, 
disruptive) a problem was on a scale of 1 to 10, where 1 is something really small and 
unimportant and 10 is the worst thing that could ever happen to you.                          
                            
Spouse / partner 
died 
Happened to me   1 2 3 4 5 6 7 8 9 10 
Didn’t happen             
 
Other household 
member died 
Happened to me   1 2 3 4 5 6 7 8 9 10 
Didn’t happen             
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Other close family 
(parent, child, 
sibling) 
Happened to me   1 2 3 4 5 6 7 8 9 10 
Didn’t happen             
 
Other more distant 
family died 
Happened to me   1 2 3 4 5 6 7 8 9 10 
Didn’t happen             
 
Friend died Happened to me   1 2 3 4 5 6 7 8 9 10 
Didn’t happen             
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CORE BEREAVEMENT ITEMS (CBI) 
These questions ask you about your feelings since your recent bereavement.  Please circle the 
appropriate answer.      
1. Do you experience images of 
the events surrounding this 
person’s death? 
Continuously Quite a bit of 
the time 
A little bit 
of the time 
Never 
2. Do thoughts of this person 
come into your mind whether 
you wish it or not? 
Continuously Quite a bit of 
the time 
A little bit 
of the time 
Never 
3. Do thoughts of this person 
make you feel distressed? 
Always Quite a bit of 
the time 
A little bit 
of the time 
Never 
4. Do you think about this 
person? 
Continuously Quite a bit of 
the time 
A little bit 
of the time 
Never 
5. Do images of this person 
make you feel distressed? 
Always Quite a bit of 
the time 
A little bit 
of the time 
Never 
6. Do you find yourself 
preoccupied with images or 
memories of this person? 
Continuously Quite a bit of 
the time 
A little bit 
of the time 
Never 
7. Do you find yourself thinking 
of reunion with this person? 
Always Quite a bit of 
the time 
A little bit 
of the time 
Never 
8. Do you find yourself missing 
this person? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
9. Are you reminded by familiar 
objects (photos, possessions, 
rooms etc.) of this person? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
10. Do you find yourself pining 
for/yearning for this person? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
11. Do you find yourself looking 
for X in familiar places? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
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12. Do you feel distress/pain if 
for any reason you are 
confronted with the reality 
that this person is not 
present/not coming back? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
13. Do reminders of this person 
such as photos, situations, 
music, places etc. cause you 
to feel longing for this 
person? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
14. Do reminders of this person 
such as photos, situations, 
music, places etc. cause you 
to feel loneliness? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
15. Do reminders of this person 
such as photos, situations, 
music places etc. cause you to 
cry about this person? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
16. Do reminders of this person 
such as photos, situations, 
music places etc. cause you to 
feel sadness? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
17. Do reminders of this person 
such as photos, situations, 
music places etc. cause you to 
feel loss of enjoyment? 
A lot of the 
time 
Quite a bit of 
the time 
A little bit 
of the time 
Never 
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THE IMPACT OF EVENT SCALE (IES) 
Below is a list of comments made by people after stressful life events like bereavement.  
Using the following scale, please indicate (with a tick) how frequently each of these 
comments were true for you DURING THE PAST SEVEN DAYS. 
With regard to your bereavement… Not at 
all  
Rarely  Sometimes  Often  
1. I thought about it when I didn't mean 
to   
    
2. I avoided letting myself get upset 
when I thought about it or was 
reminded of it   
    
3. I tried to remove it from memory      
4. I had trouble falling asleep or staying 
asleep because of pictures or thoughts 
about it that came into my mind 
    
5. I had waves of strong feelings about 
it   
    
6. I had dreams about it       
7. I stayed away from reminders of it       
8. I felt as if it hadn't happened or wasn't 
real   
    
9. I tried not to talk about it       
10. Pictures about it popped into my 
mind   
    
11. Other things kept making me think 
about it   
    
12. I was aware that I still had a lot of 
feelings about it, but I didn't deal with 
them   
    
13. I tried not to think about it       
14. Any reminder brought back feelings 
about it   
    
15. My feelings about it were kind of 
numb   
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